<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">87705</article-id><article-id pub-id-type="doi">10.7554/eLife.87705</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Searching for molecular hypoxia sensors among oxygen-dependent enzymes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-310834"><name><surname>Li</surname><given-names>Li</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1018-104X</contrib-id><email>Li.Li3@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-311065"><name><surname>Shen</surname><given-names>Susan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5558-294X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-311066"><name><surname>Bickler</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37976"><name><surname>Jacobson</surname><given-names>Matthew P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-210532"><name><surname>Wu</surname><given-names>Lani F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0052-7537</contrib-id><email>Lani.Wu@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-208670"><name><surname>Altschuler</surname><given-names>Steven J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9142-0796</contrib-id><email>steven.altschuler@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Psychiatry, University of California, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Hypoxia Research Laboratory, University of California San Francisco, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Center for Health Equity in Surgery and Anesthesia, University of California San Francisco, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Anesthesia and Perioperative Care, University of California San Francisco, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Leiser</surname><given-names>Scott F</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>University of Michigan</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Andreotti</surname><given-names>Amy H</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04rswrd78</institution-id><institution>Iowa State University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>26</day><month>07</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e87705</elocation-id><history><date date-type="received" iso-8601-date="2023-03-20"><day>20</day><month>03</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-07-09"><day>09</day><month>07</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Li et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Li et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-87705-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-87705-figures-v1.pdf"/><abstract><p>The ability to sense and respond to changes in cellular oxygen levels is critical for aerobic organisms and requires a molecular oxygen sensor. The prototypical sensor is the oxygen-dependent enzyme PHD: hypoxia inhibits its ability to hydroxylate the transcription factor HIF, causing HIF to accumulate and trigger the classic HIF-dependent hypoxia response. A small handful of other oxygen sensors are known, all of which are oxygen-dependent enzymes. However, hundreds of oxygen-dependent enzymes exist among aerobic organisms, raising the possibility that additional sensors remain to be discovered. This review summarizes known and potential hypoxia sensors among human O<sub>2</sub>-dependent enzymes and highlights their possible roles in hypoxia-related adaptation and diseases.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hypoxia sensors</kwd><kwd>oxygen</kwd><kwd>oxygen-dependent enzymes</kwd><kwd>hypoxia</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000854</institution-id><institution>Human Frontier Science Program</institution></institution-wrap></funding-source><award-id>LT000908/2020-C</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Li</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R38AG070171</award-id><principal-award-recipient><name><surname>Shen</surname><given-names>Susan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R25MH0602</award-id><principal-award-recipient><name><surname>Shen</surname><given-names>Susan</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000185</institution-id><institution>Defense Advanced Research Projects Agency</institution></institution-wrap></funding-source><award-id>HR0011-19-2-0018</award-id><principal-award-recipient><name><surname>Jacobson</surname><given-names>Matthew P</given-names></name><name><surname>Altschuler</surname><given-names>Steven J</given-names></name><name><surname>Wu</surname><given-names>Lani F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A survey of oxygen-dependent enzymes suggests new candidates for oxygen sensors, expanding potential mechanisms underlying hypoxia-related adaptations or diseases in humans.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>In aerobic organisms, the dioxygen molecule (O<sub>2</sub>) is essential for many biochemical pathways, particularly as the final electron acceptor for bioenergetics. Hypoxiaâconditions of decreased O<sub>2</sub> availabilityâis both an essential stimulus for normal development and a pathological trigger of cellular dysfunction and eventual cell death for humans and other mammals (<xref ref-type="bibr" rid="bib26">Bickler and Buck, 2007</xref>). To maintain O<sub>2</sub> homeostasis, aerobic organisms have developed diverse cellular mechanisms for sensing and responding to alterations in O<sub>2</sub> level. For multiorgan organisms, the term âhypoxiaâ is often loosely used to describe decreased O<sub>2</sub> levels. More precisely, the term âtissue hypoxiaâ is meaningful when used in comparison to the baseline for the tissue. Physiological tissue O<sub>2</sub> (physoxia, the typical range of function), physiological hypoxia (reduction or fluctuation of pO<sub>2</sub> into a range at which adaptation is possible), and hypoxia with pathological impact (pO<sub>2</sub> at which cellular injury and death occur) are often cited as ~5, 2, and 1%, respectively, for humans (<xref ref-type="bibr" rid="bib155">McKeown, 2014</xref>). However, these values can vary widely across tissues and even within a tissue and are affected by tissue-level regulation (e.g., blood flow) and cellular effects (e.g., changes in metabolic state) (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="bibr" rid="bib155">McKeown, 2014</xref>; <xref ref-type="bibr" rid="bib166">Ortiz-Prado et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Carreau et al., 2011</xref>; <xref ref-type="bibr" rid="bib114">Jagannathan et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Cigognini et al., 2016</xref>; <xref ref-type="bibr" rid="bib62">Donovan et al., 2010</xref>; <xref ref-type="bibr" rid="bib149">Mas-Bargues et al., 2019</xref>). Here, we focus on O<sub>2</sub> sensing in humans, using the term âhypoxiaâ to denote decreased O<sub>2</sub> level relative to physoxia, that is, encompassing both physiological hypoxia and hypoxia with pathological impact.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Physiological O<sub>2</sub> distribution in different organs/tissues<xref ref-type="table-fn" rid="table1fn1">*</xref>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Organ/tissue</th><th align="left" valign="bottom">%O<sub>2</sub></th><th align="left" valign="bottom">pO<sub>2</sub> (mmHg)</th><th align="left" valign="bottom">Concentration(Î¼M)</th></tr></thead><tbody><tr><td align="left" valign="bottom">Ambient air</td><td align="left" valign="bottom">21</td><td align="left" valign="bottom">160</td><td align="left" valign="bottom">206</td></tr><tr><td align="left" valign="bottom">Alveoli</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">104</td><td align="left" valign="bottom">134</td></tr><tr><td align="left" valign="bottom">Arterial blood</td><td align="left" valign="bottom">13</td><td align="left" valign="bottom">100</td><td align="left" valign="bottom">129</td></tr><tr><td align="left" valign="bottom">Kidney</td><td align="left" valign="bottom">4â9.5</td><td align="left" valign="bottom">30â73</td><td align="left" valign="bottom">39â94</td></tr><tr><td align="left" valign="bottom">Liver</td><td align="left" valign="bottom">4â7</td><td align="left" valign="bottom">30â54</td><td align="left" valign="bottom">39â69</td></tr><tr><td align="left" valign="bottom">Heart</td><td align="left" valign="bottom">2â6</td><td align="left" valign="bottom">15â46</td><td align="left" valign="bottom">19â59</td></tr><tr><td align="left" valign="bottom">Brain</td><td align="left" valign="bottom">3â5</td><td align="left" valign="bottom">23â39</td><td align="left" valign="bottom">29â50</td></tr><tr><td align="left" valign="bottom">Small intestine</td><td align="left" valign="bottom">2â9</td><td align="left" valign="bottom">15â69</td><td align="left" valign="bottom">19â89</td></tr><tr><td align="left" valign="bottom">Large intestine</td><td align="left" valign="bottom">0â6</td><td align="left" valign="bottom">0â46</td><td align="left" valign="bottom">0â59</td></tr><tr><td align="left" valign="bottom">Bone marrow</td><td align="left" valign="bottom">1.5â7</td><td align="left" valign="bottom">11â54</td><td align="left" valign="bottom">14â69</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>The O<sub>2</sub> levels in different organs are adjusted from references <xref ref-type="bibr" rid="bib37">Burmester and Hankeln, 2014</xref>; <xref ref-type="bibr" rid="bib136">Lecomte et al., 2005</xref>; <xref ref-type="bibr" rid="bib90">Hatefi, 1985</xref>; <xref ref-type="bibr" rid="bib248">Zaccara et al., 2019</xref>; <xref ref-type="bibr" rid="bib13">Ball et al., 2014</xref> and the partial pressure and concentration are calculated according to references <xref ref-type="bibr" rid="bib166">Ortiz-Prado et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Carreau et al., 2011</xref>; <xref ref-type="bibr" rid="bib114">Jagannathan et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Cigognini et al., 2016</xref>; <xref ref-type="bibr" rid="bib62">Donovan et al., 2010</xref>; <xref ref-type="bibr" rid="bib149">Mas-Bargues et al., 2019</xref>; <xref ref-type="bibr" rid="bib175">Place et al., 2017</xref>.</p></fn></table-wrap-foot></table-wrap><p>Discovery of the PHD-HIF-pVHL pathway was pivotal to understanding hypoxia responses and has been reviewed extensively (<xref ref-type="bibr" rid="bib145">Majmundar et al., 2010</xref>; <xref ref-type="bibr" rid="bib120">Kaelin and Ratcliffe, 2008</xref>; <xref ref-type="bibr" rid="bib107">Ivan and Kaelin, 2017</xref>; <xref ref-type="bibr" rid="bib200">Schofield and Ratcliffe, 2004</xref>). Briefly, in normoxia, prolyl hydroxylase domain proteins (PHDs) use O<sub>2</sub> as a substrate to hydroxylate prolines on the transcription factor hypoxia-inducible factor Î± subunit (HIFÎ±, i.e., HIF1Î± or HIF2Î±). The hydroxylated form of HIFÎ± is recognized by the E3 ubiquitin ligase pVHL (von Hippel-Lindau protein), which promotes degradation of HIFÎ±. By contrast, in hypoxia, the decreased catalytic activity of PHDs results in decreased hydroxylation and hence decreased pVHL recognition of HIFÎ±, promoting the accumulation of HIFÎ±. HIFÎ± then translocates to the nucleus and, as a heterodimer with HIF1Î², regulates transcription of a broad range of target genes. Thus, PHDs directly sense a decrease in the availability of molecular O<sub>2</sub> and transduce this signal to downstream effectors.</p><p>What defines a molecular hypoxia sensor? In engineering, a sensor is a device that detects changes to a physical property and transmits this information so that a system can respond to this change. Here, by analogy to human-engineered sensors, we define biological hypoxia sensors as proteins that (1) directly interact with O<sub>2</sub> molecules, (2) have activities that are strongly affected by physiological hypoxia, and (3) are coupled to downstream responses that depend on changes of their activities. Of note, many proteins respond to hypoxia by acting downstream of a sensor (e.g., HIF acting downstream of PHD) or by responding to changes in the cellular redox state. In this review, we specifically exclude these as they are not direct sensors of molecular O<sub>2</sub> âthat is, their response to changes in O<sub>2</sub> levels does not involve direct interaction with O<sub>2</sub> (<xref ref-type="bibr" rid="bib25">Bickler and Donohoe, 2002</xref>).</p><p>Strong candidates for hypoxia sensors include O<sub>2</sub>-dependent enzymes, which by definition meet criterion 1. These enzymes constitute a mechanistically, structurally, and biologically diverse group of proteins. There are a number of reviews on the enzymology (<xref ref-type="bibr" rid="bib103">Islam et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Palfey and McDonald, 2010</xref>; <xref ref-type="bibr" rid="bib56">Decker and Solomon, 2005</xref>; <xref ref-type="bibr" rid="bib115">Jasniewski and Que, 2018</xref>; <xref ref-type="bibr" rid="bib30">Biringer, 2020</xref>; <xref ref-type="bibr" rid="bib72">Ferguson-Miller and Babcock, 1996</xref>; <xref ref-type="bibr" rid="bib73">Finney et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Bassan et al., 2003</xref>; <xref ref-type="bibr" rid="bib83">Guengerich, 2007</xref>; <xref ref-type="bibr" rid="bib176">Ponnaluri et al., 2013</xref>; <xref ref-type="bibr" rid="bib109">Ivanov et al., 2010</xref>; <xref ref-type="bibr" rid="bib51">Daff, 2010</xref>; <xref ref-type="bibr" rid="bib234">WikstrÃ¶m et al., 2018</xref>; <xref ref-type="bibr" rid="bib99">Huang and Groves, 2018</xref>; <xref ref-type="bibr" rid="bib190">Romero et al., 2018</xref>; <xref ref-type="bibr" rid="bib212">Sono et al., 1996</xref>; <xref ref-type="bibr" rid="bib148">Martinez and Hausinger, 2015</xref>; <xref ref-type="bibr" rid="bib187">Roberts and Fitzpatrick, 2013</xref>; <xref ref-type="bibr" rid="bib104">Itoh, 2006</xref>; <xref ref-type="bibr" rid="bib211">Solomon et al., 2001</xref>; <xref ref-type="bibr" rid="bib35">Bugg, 2001</xref>; <xref ref-type="bibr" rid="bib1">Abu-Omar et al., 2005</xref>), biological function (<xref ref-type="bibr" rid="bib200">Schofield and Ratcliffe, 2004</xref>; <xref ref-type="bibr" rid="bib103">Islam et al., 2018</xref>; <xref ref-type="bibr" rid="bib170">Paton and Ntambi, 2009</xref>; <xref ref-type="bibr" rid="bib205">Shmakova et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Danielson, 2002</xref>; <xref ref-type="bibr" rid="bib61">DonkÃ³ et al., 2005</xref>; <xref ref-type="bibr" rid="bib36">Bundred et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Fletcher and Coleman, 2020</xref>; <xref ref-type="bibr" rid="bib129">Kuhn et al., 2015</xref>; <xref ref-type="bibr" rid="bib253">Zhuang et al., 2015</xref>; <xref ref-type="bibr" rid="bib127">Kooistra and Helin, 2012</xref>; <xref ref-type="bibr" rid="bib150">Mashima and Okuyama, 2015</xref>; <xref ref-type="bibr" rid="bib239">Wu and Zhang, 2017</xref>; <xref ref-type="bibr" rid="bib117">Johansson et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Daubner et al., 2011</xref>; <xref ref-type="bibr" rid="bib75">Fong and Takeda, 2008</xref>; <xref ref-type="bibr" rid="bib146">Markolovic et al., 2015</xref>), and evolution (<xref ref-type="bibr" rid="bib52">Danielson, 2002</xref>; <xref ref-type="bibr" rid="bib218">Taylor and McElwain, 2010</xref>; <xref ref-type="bibr" rid="bib43">Chandrasekharan and Simmons, 2004</xref>; <xref ref-type="bibr" rid="bib235">Wilks, 2002</xref>) of individual subclasses of O<sub>2</sub>-dependent enzymes. Here, we provide a global map of human O<sub>2</sub>-dependent enzymes in potential hypoxia sensing. We first survey the broad categories and then discuss specific members that are known or speculated hypoxia sensors. Finally, we investigate the links between O<sub>2</sub>-dependent enzymes and hypoxia-related evolutionary adaptations and diseases.</p><sec id="s1-1"><title>O<sub>2</sub>-dependent enzymes as hypoxia sensor candidates</title><p>We start by providing background and taxonomies for considering the three basic âsensorâ requirements discussed above.</p><p>First, O<sub>2</sub>-dependent enzymes directly interact with O<sub>2</sub> molecules as one of the substrates. Non-enzymatic proteins that directly interact with O<sub>2</sub>, for example, globins, have been reviewed elsewhere (<xref ref-type="bibr" rid="bib37">Burmester and Hankeln, 2014</xref>; <xref ref-type="bibr" rid="bib136">Lecomte et al., 2005</xref>). In humans, 221 enzymes are known or likely to be O<sub>2</sub>-dependent (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), that is, utilizing O<sub>2</sub> as an electron acceptor for the oxidation of other substrates. Based on their catalyzed reactions, O<sub>2</sub>-dependent enzymes can be divided into three subclasses: <italic>dioxygenases</italic>, which catalyze the insertion of both oxygen atoms of the O<sub>2</sub> molecule into substrates; <italic>monooxygenases</italic>, which catalyze the insertion of one oxygen atom of the O<sub>2</sub> molecule into a substrate and the reduction of the other oxygen atom to H<sub>2</sub>O; and <italic>oxidases</italic>, which catalyze the reduction of O<sub>2</sub> molecules to 2H<sub>2</sub>O or H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Three classes of by O<sub>2</sub>-dependent enzymes (dioxygenases, monooxygenases, and oxidases) and the reactions they catalyze.</title><p>Dioxygenases catalyze the insertion of both oxygen atoms of the dioxygen molecule into substrates. Monooxygenases catalyze the insertion of one oxygen atom of the dioxygen molecule into a substrate and the other oxygen atom is reduced to H<sub>2</sub>O. Oxidases catalyze the reduction of dioxygen to H<sub>2</sub>O or H<sub>2</sub>O<sub>2</sub>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87705-fig1-v1.tif"/></fig><p>Second, O<sub>2</sub>-dependent enzymes have diverse mechanisms for utilizing O<sub>2</sub> as a substrate, resulting in different sensitivities to O<sub>2</sub> concentrations. Sensitivity is determined, in part, by the binding affinity of O<sub>2</sub> with the enzymeâs catalytic center. Most O<sub>2</sub>-dependent enzymes (177/221) use, or are speculated to use, O<sub>2</sub>-binding metal ions at their catalytic centers. Factors affecting the O<sub>2</sub>-binding affinity include the metal center (iron or copper in humans), ligands (enzyme residues and other substrates) for the metal center, and the environment of the catalytic pocket. The other O<sub>2</sub>-dependent enzymes with known non-metal catalytic centers (37/221) utilize flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) to activate O<sub>2</sub>. For these enzymes, the accessibility of O<sub>2</sub> to FAD or FMN at the catalytic center affects the binding affinity. Dioxygenases, monooxygenases, and oxidases can be further subdivided by their catalytic centers (<xref ref-type="table" rid="table2">Table 2</xref>). Ultimately, these mechanisms affect the threshold at which enzymatic activities are saturated with O<sub>2</sub>, thus determining whether the enzymeâs activities are strongly affected by physiological-range hypoxia.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Categories of O<sub>2</sub>-dependent enzymes.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Category</th><th align="left" valign="bottom">Subcategory by catalytic center</th><th align="left" valign="bottom">Metal species at catalytic center</th><th align="left" valign="bottom">Ligands for the metal species at catalytic center (cofactor/substrate and enzyme residues)</th><th align="left" valign="bottom">Number of enzymes</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="4">Dioxygenase</td><td align="left" valign="bottom">2-OG-dependent dioxygenase</td><td align="left" valign="bottom">Fe</td><td align="left" valign="bottom">2-OG, His, His, Asp/Glu</td><td align="char" char="." valign="bottom">59</td></tr><tr><td align="left" valign="bottom">Heme-dependent dioxygenase</td><td align="left" valign="bottom">Fe</td><td align="left" valign="bottom">Heme, His</td><td align="char" char="." valign="bottom">5</td></tr><tr><td align="left" valign="bottom">Lipoxygenase</td><td align="left" valign="bottom">Fe</td><td align="left" valign="bottom">His, His, His, Ile, His/Asa/Asn/none</td><td align="char" char="." valign="bottom">6</td></tr><tr><td align="left" valign="bottom">Others</td><td align="left" valign="bottom">Fe</td><td align="left" valign="bottom">His, His, His/Asp/Glu<xref ref-type="table-fn" rid="table2fn1">*</xref></td><td align="char" char="." valign="bottom">10</td></tr><tr><td align="left" valign="bottom" rowspan="5">Monooxygenase</td><td align="left" valign="bottom">Heme-dependent monooxygenase</td><td align="left" valign="bottom">Fe</td><td align="left" valign="bottom">Heme, Cys/His/Glu</td><td align="char" char="." valign="bottom">61</td></tr><tr><td align="left" valign="bottom">Non-Heme Fe-dependent monooxygenase</td><td align="left" valign="bottom">Fe</td><td align="left" valign="bottom">His, His, His/Asp/Glu<xref ref-type="table-fn" rid="table2fn1">*</xref></td><td align="char" char="." valign="bottom">9</td></tr><tr><td align="left" valign="bottom">Cu-dependent monooxygenase</td><td align="left" valign="bottom">Cu</td><td align="left" valign="bottom">His, His, Met</td><td align="char" char="." valign="bottom">5</td></tr><tr><td align="left" valign="bottom">Flavin-dependent monooxygenase</td><td align="left" valign="bottom">None (uses flavin)</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">12</td></tr><tr><td align="left" valign="bottom">Others<xref ref-type="table-fn" rid="table2fn2">â </xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">2</td></tr><tr><td align="left" valign="bottom" rowspan="5">Oxidase</td><td align="left" valign="bottom">Heme-copper</td><td align="left" valign="bottom">Fe and Cu</td><td align="left" valign="bottom">His, His, His for Cu; Heme and His for Fe</td><td align="char" char="." valign="bottom">1</td></tr><tr><td align="left" valign="bottom">Fe-dependent oxidase</td><td align="left" valign="bottom">Fe</td><td align="left" valign="bottom">Varies</td><td align="char" char="." valign="bottom">14</td></tr><tr><td align="left" valign="bottom">Cu-dependent oxidase</td><td align="left" valign="bottom">Cu</td><td align="left" valign="bottom">Varies</td><td align="char" char="." valign="bottom">7</td></tr><tr><td align="left" valign="bottom">Flavin-dependent oxidase</td><td align="left" valign="bottom">None (uses flavin)</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">25</td></tr><tr><td align="left" valign="bottom">Others<xref ref-type="table-fn" rid="table2fn2">â </xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">5</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><label>*</label><p>Substrates/cofactor ligands for this category varies for each member depending on the reaction it catalyzes.</p></fn><fn id="table2fn2"><label>â </label><p>Members in this category are not fully studied.</p></fn></table-wrap-foot></table-wrap><p>Third, O<sub>2</sub>-dependent enzymes regulate diverse cellular processes: (1) oxidative phosphorylation is responsible for mitochondrial ATP production and cellular survival (<xref ref-type="bibr" rid="bib90">Hatefi, 1985</xref>); (2) post-translational modifications (hydroxylation, demethylation, or thiol oxidation) of proteins can regulate protein conformation, stability, and activity (<xref ref-type="bibr" rid="bib200">Schofield and Ratcliffe, 2004</xref>; <xref ref-type="bibr" rid="bib36">Bundred et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Fletcher and Coleman, 2020</xref>; <xref ref-type="bibr" rid="bib127">Kooistra and Helin, 2012</xref>; <xref ref-type="bibr" rid="bib117">Johansson et al., 2014</xref>); (3) hydroxylation and demethylation of DNA/RNA can regulate DNA damage repair, epigenetic modifications, and transcription/translation (<xref ref-type="bibr" rid="bib239">Wu and Zhang, 2017</xref>; <xref ref-type="bibr" rid="bib248">Zaccara et al., 2019</xref>); (4) metabolism of amino acids and lipids can maintain cellular hemostasis and regulate cellular pathways through signaling molecules (<xref ref-type="bibr" rid="bib170">Paton and Ntambi, 2009</xref>; <xref ref-type="bibr" rid="bib129">Kuhn et al., 2015</xref>; <xref ref-type="bibr" rid="bib150">Mashima and Okuyama, 2015</xref>; <xref ref-type="bibr" rid="bib54">Daubner et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Chandrasekharan and Simmons, 2004</xref>; <xref ref-type="bibr" rid="bib13">Ball et al., 2014</xref>); and (5) metabolism of xenobiotics can regulate drug clearance and detoxification (<xref ref-type="bibr" rid="bib52">Danielson, 2002</xref>; <xref ref-type="bibr" rid="bib178">Poulos and Johnson, 2005</xref>). Typically, dioxygenases have macromolecules as substrates and regulate cellular processes at a transcriptional or translational level (<xref ref-type="bibr" rid="bib200">Schofield and Ratcliffe, 2004</xref>; <xref ref-type="bibr" rid="bib103">Islam et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Bundred et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Fletcher and Coleman, 2020</xref>; <xref ref-type="bibr" rid="bib127">Kooistra and Helin, 2012</xref>; <xref ref-type="bibr" rid="bib239">Wu and Zhang, 2017</xref>; <xref ref-type="bibr" rid="bib117">Johansson et al., 2014</xref>; <xref ref-type="bibr" rid="bib88">Hancock et al., 2015</xref>), while monooxygenases and oxidases often have small molecules as substrates and function in metabolism (<xref ref-type="bibr" rid="bib190">Romero et al., 2018</xref>; <xref ref-type="bibr" rid="bib170">Paton and Ntambi, 2009</xref>; <xref ref-type="bibr" rid="bib52">Danielson, 2002</xref>; <xref ref-type="bibr" rid="bib54">Daubner et al., 2011</xref>). Together, O<sub>2</sub>-dependent enzymes are integral to a plethora of physiological processes in aerobic animals.</p><p>Candidate hypoxia sensors can be identified among the O<sub>2</sub>-dependent enzymes, in part by the binding affinity between O<sub>2</sub> and the enzyme as quantified by the O<sub>2</sub> K<sub>m</sub> value, which suggests the level at which the enzyme is most sensitive to changes in O<sub>2</sub> (<xref ref-type="bibr" rid="bib120">Kaelin and Ratcliffe, 2008</xref>; <xref ref-type="bibr" rid="bib200">Schofield and Ratcliffe, 2004</xref>; <xref ref-type="bibr" rid="bib205">Shmakova et al., 2014</xref>; <xref ref-type="bibr" rid="bib88">Hancock et al., 2015</xref>; <xref ref-type="bibr" rid="bib237">Wilson et al., 2020</xref>; <xref ref-type="bibr" rid="bib96">Holdsworth and Gibbs, 2020</xref>; <xref ref-type="bibr" rid="bib12">Baik and Jain, 2020</xref>). (The Km value, also known as the Michaelis constant, is the concentration of a substrate at which an enzymatic reaction rate is 50% of the maximum reaction rate. A larger K<sub>m</sub> value reflects lower O<sub>2</sub> affinity.) Importantly, the measured K<sub>m</sub> value is affected by the measurement method, for example, mass spectrometry vs. isotope assays. Besides the Km value, other cellular factors such as the concentration and conformation of the enzyme, as well as concentrations of other substrates or products, also affect the net enzymatic activity and hence the downstream effects of the enzyme. Beyond cellular-level effects, whether an O<sub>2</sub>-dependent enzyme functions as a hypoxia sensor in vivo can depend on the tissue pO<sub>2</sub> context (<xref ref-type="table" rid="table1">Table 1</xref>). Taken together, whether an O<sub>2</sub>-dependent enzyme functions as a hypoxia sensor in vivo depends not only on the O<sub>2</sub> K<sub>m</sub> value but also on multiple other factors.</p></sec><sec id="s1-2"><title>O<sub>2</sub>-dependent enzymes that are known or potential hypoxia sensors</title><p>Below, we classify dioxygenases, monooxygenases, and oxidases into different subgroups based on their catalytic centers and discuss known (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and potential (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) hypoxia sensors in each subgroup.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Known and candidate sensors for hypoxia inside O<sub>2</sub>-dependent enzymes.</title><p>(<bold>A</bold>) Known hypoxia sensors and their corresponding cellular responses to hypoxia. Decreased O<sub>2</sub> concentration inhibits activities of hypoxia sensors in O<sub>2</sub>-dependent enzyme category and results in changes downstream signaling pathway as the cellular response to hypoxia. PHD catalyzes the hydroxylation at two prolyl residues of HIFÎ±, and then the hydroxylated HIFÎ± is recognized and ubiquitylated by pVHL. Following ubiquitilation, HIFÎ± is degraded by proteasome. During hypoxia, activity of PHD is diminished and HIFÎ± is stabilized. Accumulated HIFÎ± translocates to the nucleus, and in dimerization with HIF1Î², recruits other transcriptional coactivators (p300, CBP), binds with the hypoxia response elements (HREs) and activates the transcription of HIF target genes. The products of these genes participate in adaptation to hypoxia including metabolic shift, EPO production, vasculogenesis, etc. FIH catalyzes the asparaginyl hydroxylation of HIFÎ±, and this hydroxylation inhibits HIFÎ± from recruiting transcriptional coactivators. Compared with PHD, FIH is inhibited by more severe hypoxia. KDM3A catalyzes the demethylation of K244 monomethylation of PGC-1Î±, which is a transcriptional coactivator and regulates mitochondrial biogenesis. Under normoxia, PGC-1Î± binds with transcriptional factor NRF1/2 and activates the transcription of nucleus-encoded mitochondrial genes. Under hypoxia, the inhibited activity of KDM3A leads to accumulation of K224 monomethylation at PGC-1Î±. The maintained monomethylation at K224 of PGC-1Î± reduces its binding ability with NRF1/2 and results in decreased mitochondrial biogenesis. KDM5A catalyzes the demethylation at Lys4 of histone H3 (H3K4). Hypoxia inhibits its activity and results in the hypermethylation at H3K4, which is responsible for the gene activation. Similarly, hypoxia also inhibits KDM6A, and results in the hypermethylation at its target site H3K27 and gene repression. TET methylcytosine dioxygenases (TET1, TET2, and TET3) catalyze conversion of DNA 5-methylcytosine (5-mC) to the 5-hydroxymethylcytosine (5hmC) and mediates DNA demethylation. Hypoxia reduces TET activity and causes DNA hypermethylation. Together, these proteins sense hypoxia and lead to transcription alteration by chromatin reprogramming. KDM5C catalyzes the demethylation of ULK1 R170me2s, which regulates ULK1 activity. Under normoxia, R170me2s of ULK1 is removed by KDM5C and ULK1 remains inactive. Under hypoxia, the inhibited activity of KDM5C leads to accumulation of ULK1 R170me2s, and results in ULK1 activation and autophagy induction. ADO catalyzes the thiol oxidation at the N terminal Cys of a protein, which then triggers its degradation through N-degron pathway. Hypoxia inhibits the activity of ADO and leads to the stabilization of its substrates. One of the identified ADO substrates is RSG4/5, regulators of the G protein signaling. Stabilization of RGS4/5 results in the modulation of G-protein-coupled calcium ion signaling. (<bold>B</bold>) Candidate O<sub>2</sub> sensors with reduced enzymatic activities in hypoxia. Hypoxia leads to: inhibition of KDM4A and KDM4B and accumulated hypermethylation at H3K9; inhibition of SCD and increased cellular fatty acid saturation; inhibition of IDO and changes of immunoregulation; inhibition of PAM and reduced protein amidation; in vitro inhibition of RIOX1 and RIOX2 which are responsible for ribosome hydroxylation; in vitro inhibition of AOC3; RNA hypermethylation possibly through inhibition of FTO/ALKBH5; potential inhibition of DUOX1 and DUOX2. PHD: prolyl hydroxylase domain-containing protein; HIF: hypoxia-inducible factor; pVHL: von Hippel-Lindau protein E3 ligase; CBP, cyclic-AMP response element binding protein binding protein; EPO: erythropoietin; FIH: factor inhibiting HIF1; KDM: JmjC (Jumonji C) domain lysine demethylase; PGC: peroxisome proliferator-activated receptor gamma coactivator; NRF: nuclear respiratory factor; TET: ten-eleven translocation methylcytosine dioxygenases; ADO: cysteamine (2-aminoethanethiol) dioxygenase; RGS: regulators of G protein signalling; SCD: stearoyl-CoA desaturases; IDO: indoleamine 2,3-dioxygenase; AOC: amine oxidase, copper containing; PAM: peptidylglycine Î±-amidating monooxygenase; RIOX: ribosomal oxygenase, FTO: fat mass and obesity-associated protein; ALKBH: AlkB homolog; DUOX: dual oxidase.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87705-fig2-v1.tif"/></fig></sec><sec id="s1-3"><title>Dioxygenases</title><p>Based on their catalytic centers, the dioxygenase family members can be further classified into 2-OG-dependent dioxygenase, heme-dependent dioxygenases, lipoxygenases, and other dioxygenases (<xref ref-type="table" rid="table2">Table 2</xref>).</p><sec id="s1-3-1"><title>2-Oxyglutarate (2-OG)-dependent dioxygenases</title><p>In humans, there are ~60 identified or postulated dioxygenases (<xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) that use 2-OG as the co-substrate to catalyze the hydroxylation of their primary substrates, which include proteins, nucleic acids, and lipids (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>; <xref ref-type="bibr" rid="bib103">Islam et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Fletcher and Coleman, 2020</xref>; <xref ref-type="bibr" rid="bib191">Rose et al., 2011</xref>). We note that when hydroxylation occurs on the carbon of an N-methyl group, this can lead to demethylation, which occurs through spontaneous fragmentation to formaldehyde and the demethylated product (<xref ref-type="fig" rid="fig3">Figure 3B</xref>; <xref ref-type="bibr" rid="bib103">Islam et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Fletcher and Coleman, 2020</xref>; <xref ref-type="bibr" rid="bib191">Rose et al., 2011</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Enzymatic reactions catalyzed by discussed O<sub>2</sub>-dependent enzymes.</title><p>(<bold>A</bold>) Examples of hydroxylation reactions catalyzed by 2-OG-dependent dioxygenases. (<bold>B</bold>) Examples of demethylation reactions catalyzed by 2-OG-dependent dioxygenases. (<bold>CâK</bold>) Reactions catalyzed by indoleamine 2,3-dioxygenase (IDO)/tryptophan 2,3-dioxygenase (TDO) (<bold>C</bold>), arachidonate lipoxygenases (ALOXs) (<bold>D</bold>), (2-aminoethanethiol) dioxygenase (ADO) (<bold>E</bold>), heme oxygenases (HOs) (<bold>F</bold>), nitric oxide synthases (NOSs) (<bold>G</bold>), tyrosine 3-hydroxylase (TH) (<bold>H</bold>), peptidylglycine Î±-amidating monooxygenase (PAM) (<bold>I</bold>), stearoyl-CoA desaturase 1 (SCD1), (<bold>J</bold>) and copper amine oxidases (CAOs) (<bold>K</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87705-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 1.</label><caption><title>Catalytic mechanism for 2-OG-dependent dioxygenases.</title><p>2-OG-dependent dioxygenases share consensus mechanisms for the catalyzed hydroxylation (<xref ref-type="bibr" rid="bib103">Islam et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Fletcher and Coleman, 2020</xref>; <xref ref-type="bibr" rid="bib191">Rose et al., 2011</xref>): the Fe(II) at the catalytic center is initially coordinated by 2 His side chains and a carboxylate from Glu or Asp, plus three additional H<sub>2</sub>O molecules to complete the octahedral coordination geometry. Then, bidentate coordination of 2-OG to Fe(II) replaces 2 H<sub>2</sub>O molecules, and the third Fe(II)-bound H<sub>2</sub>O molecule leaves after the binding of the primary substrate into the active site, making a vacant coordination site for O<sub>2</sub>. After the binding and activation of O<sub>2</sub> at the Fe(II) center, one of the O<sub>2</sub> atoms inserts into the primary substrate for hydroxylation, while the other O<sub>2</sub> atom facilitates the oxidative decarboxylation of 2-OG, forming succinate and CO<sub>2</sub> as co-products.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87705-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 2.</label><caption><title>O<sub>2</sub>-binding sites for dioxygenases using heme.</title><p>The heme Fe(II) is coordinated by the four N atoms from the porphyrin and one N atom from one histidyl residue in the catalytic pocket, leaving the vacant coordination site for O<sub>2</sub> binding and activation (<xref ref-type="bibr" rid="bib210">Singleton et al., 2014</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87705-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 3.</label><caption><title>Mitochondrial electron transport chain (ETC).</title><p>The ETC consists of NADH ubiquinone oxireductase (Complex I), succinate dehydrogenase (Complex II), CoQH<sub>2</sub>-cytochrome c reductase (Complex III), and cytochrome <italic>c</italic> oxidase (Complex IV). In the ETC, electrons are transported from the NADH or FADH<sub>2</sub> to ubiquinone at Complex I or II, then to cytochrome <italic>c</italic> at Complex III, and finally to O<sub>2</sub> at Complex IV. This process is coupled with ATP generation at ATP synthase (Complex V) to form the oxidative phosphorylation (OxPhos) process, which is the major source of energy production.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87705-fig3-figsupp3-v1.tif"/></fig></fig-group><p>Among O<sub>2</sub>-dependent enzymes, 2-OG-dependent dioxygenases are relatively well studied. A majority of members in this subgroup catalyze hydroxylation or demethylation on proteins, DNA, and RNA, and are involved in the regulation of transcription and translation (<xref ref-type="bibr" rid="bib103">Islam et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Fletcher and Coleman, 2020</xref>; <xref ref-type="bibr" rid="bib191">Rose et al., 2011</xref>). We focus on three subgroups relevant to hypoxia biology: direct HIF modulators, epigenetic modulators, and translational modulators. These subgroups encompass most known hypoxia sensors, including PHDs, factor inhibiting HIF (FIH1), lysine demethylases (KDMs), and ten-eleven translocation methylcytosine dioxygenases (TET1-3), as well as potential sensors that have impaired activities during hypoxia. For each subgroup, we highlight the most well-known sensors and propose additional, potential sensors.</p></sec><sec id="s1-3-2"><title>Direct HIF modulators</title><p>These include PHDs (which catalyze prolyl hydroxylation of HIFÎ±) and FIH (which catalyzes asparaginyl hydroxylation of HIFÎ±) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Direct HIF modulator in 2-OG-dependent dioxygenases.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Gene symbol</th><th align="left" valign="bottom">Protein name</th><th align="left" valign="bottom">Type of reaction</th><th align="left" valign="bottom">Hydroxylation sites in HIFÎ±</th><th align="left" valign="bottom">Non-HIF substrate examples</th></tr></thead><tbody><tr><td align="left" valign="bottom">EGLN1</td><td align="left" valign="bottom">PHD2</td><td align="left" valign="bottom">Prolyl hydroxylation</td><td align="left" valign="bottom">HIF1Î± Pro402, Pro564;<break/>HIF2Î± Pro405, Pro531;<break/>HIF3Î± Pro492</td><td align="left" valign="bottom">FLNA, Akt</td></tr><tr><td align="left" valign="bottom">EGLN2</td><td align="left" valign="bottom">PHD1</td><td align="left" valign="bottom">Prolyl hydroxylation</td><td align="left" valign="bottom">HIF1Î± Pro402, Pro564;<break/>HIF2Î± Pro405, Pro531;<break/>HIF3Î± Pro492</td><td align="left" valign="bottom">FOXO3, Cep192, TP53</td></tr><tr><td align="left" valign="bottom">EGLN3</td><td align="left" valign="bottom">PHD3</td><td align="left" valign="bottom">Prolyl hydroxylation</td><td align="left" valign="bottom">HIF1Î± Pro564;<break/>HIF2Î± Pro405, Pro531;<break/>HIF3Î± Pro492</td><td align="left" valign="bottom">ATF-4, ADRB2, TP53</td></tr><tr><td align="left" valign="bottom">HIF1AN</td><td align="left" valign="bottom">FIH1</td><td align="left" valign="bottom">Asparaginyl hydroxylation</td><td align="left" valign="bottom">HIF1Î± Asn803,<break/>HIF2Î± Asn847</td><td align="left" valign="bottom">IÎºBÎ±, Notch, OTUB1, RIPK4</td></tr></tbody></table></table-wrap><p>The PHD enzymes and their critical role in regulating the PHDâHIF-pVHL signaling pathway are a paradigm for cellular sensing and response to hypoxia (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib145">Majmundar et al., 2010</xref>; <xref ref-type="bibr" rid="bib120">Kaelin and Ratcliffe, 2008</xref>; <xref ref-type="bibr" rid="bib107">Ivan and Kaelin, 2017</xref>; <xref ref-type="bibr" rid="bib200">Schofield and Ratcliffe, 2004</xref>). In humans, HIF is composed of an Î± subunit (HIF1Î±, HIF2Î±, or HIF3Î±) and invariant Î² subunit (HIF1Î²), and there are three PHD isoforms, namely PHD1 (EGLN2), PHD2 (EGLN1), and PHD3 (EGLN3). These PHDs are canonical sensors that illustrate our criteria for O<sub>2</sub> sensors.</p><p>First, PHDs directly interact with O<sub>2</sub>, utilizing O<sub>2</sub> to hydroxylate prolines in the O<sub>2</sub>-dependent degradation domain (ODD) of HIFÎ± (<xref ref-type="bibr" rid="bib71">Epstein et al., 2001</xref>; <xref ref-type="bibr" rid="bib94">HirsilÃ¤ et al., 2003</xref>).</p><p>Second, the enzymatic activities of PHDs are sensitive to cellular/tissue hypoxia. The O<sub>2</sub>-binding affinities of all three PHDs, represented by O<sub>2</sub> Km values, have been measured in vitro with HIF1Î± peptides as substrates. Using a short 19-residue HIF1Î± fragment as the substrate, the reported O<sub>2</sub> Km values for PHD1-3 are in the range of 229â1746 Î¼M (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib94">HirsilÃ¤ et al., 2003</xref>; <xref ref-type="bibr" rid="bib53">Dao et al., 2009</xref>; <xref ref-type="bibr" rid="bib217">Tarhonskaya et al., 2014</xref>). However, recent measurements using longer HIF1Î± fragments estimate O<sub>2</sub> Km values for PHD2 in the range of 67â85 Î¼M (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib65">Ehrismann et al., 2007</xref>), corresponding to pO<sub>2</sub> values in the (physoxia) range of 6â8% (<xref ref-type="table" rid="table1">Table 1</xref>), consistent with the sensitivities of PHDs to changes in physiological O<sub>2</sub> concentrations.</p><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Reported Km values of O<sub>2</sub>-dependent enzymes.</title><p>Km values vary based on the assay method and tested substrate. Some enzymes have multiple Km values listed, reflecting measurements from different studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Category</th><th align="left" valign="bottom">Enzyme<xref ref-type="table-fn" rid="table4fn1">*</xref></th><th align="left" valign="bottom">Km for O<sub>2</sub></th><th align="left" valign="bottom">Assay details</th><th align="left" valign="bottom">Reference</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="26">Dioxygenase</td><td rowspan="4" style="author-callout-style-b4"><named-content content-type="author-callout-style-a3">PHD2 (EGLN1)</named-content></td><td align="left" valign="bottom"><bold>250</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with HIF1Î± (556â574) peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib94">HirsilÃ¤ et al., 2003</xref></td></tr><tr><td align="left" valign="bottom"><bold>1746</bold> Î¼M</td><td align="left" valign="bottom">In vitro time-resolved fluorescence resonance energy transfer assay with P564-HIF1Î± peptide (DLEMLAPYIPMDDDFQL) as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib53">Dao et al., 2009</xref></td></tr><tr><td align="left" valign="bottom"><bold>67</bold> Î¼M</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay with HIF1Î± (502â697) peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Ehrismann et al., 2007</xref></td></tr><tr><td align="left" valign="bottom"><bold>81</bold> Î¼M</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay with HIF1Î± (530â698) peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Ehrismann et al., 2007</xref></td></tr><tr><td style="author-callout-style-b4"><named-content content-type="author-callout-style-a3"><bold>PHD1 (EGLN2</bold>)</named-content></td><td align="left" valign="bottom"><bold>230</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with HIF1Î± (556â574) peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib94">HirsilÃ¤ et al., 2003</xref></td></tr><tr><td style="author-callout-style-b4"><bold>PHD3</bold></td><td align="left" valign="bottom"><bold>230</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with HIF1Î± (556â574) peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib94">HirsilÃ¤ et al., 2003</xref></td></tr><tr><td style="author-callout-style-b4">KDM4E</td><td align="left" valign="bottom">197 Î¼M</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay with ARK(me3)STGGK peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Cascella and Mirica, 2012</xref></td></tr><tr><td rowspan="3" style="author-callout-style-b4"><named-content content-type="author-callout-style-a3">KDM4A</named-content></td><td align="left" valign="bottom">173 Î¼M</td><td align="left" valign="bottom">In vitro MALDI-TOF-MS assay with H31â15K9me3 peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib89">Hancock et al., 2017</xref></td></tr><tr><td align="left" valign="bottom">57 Î¼M</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay with ARK(me3)STGGK peptide substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Cascella and Mirica, 2012</xref></td></tr><tr><td align="left" valign="bottom">60 Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(1â19)K9me3 as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td style="author-callout-style-b4"><bold>KDM6A</bold></td><td align="left" valign="bottom"><bold>180</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(21â44)K27(me3) as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td style="author-callout-style-b4">KDM4C</td><td align="left" valign="bottom">158 Î¼M</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay with ARK(me3)STGGK peptide substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Cascella and Mirica, 2012</xref></td></tr><tr><td align="left" valign="bottom">KDM4B</td><td align="left" valign="bottom">150 Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(1â19)K9me3 as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td style="author-callout-style-b4"><named-content content-type="author-callout-style-a3"><bold>FIH</bold></named-content></td><td align="left" valign="bottom"><bold>90</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with HIF1Î± (788â822) peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib125">Koivunen et al., 2004</xref></td></tr><tr><td style="author-callout-style-b4"><named-content content-type="author-callout-style-a3"><bold>KDM5A</bold></named-content></td><td align="left" valign="bottom"><bold>90</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(1â21)K4me3 as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td style="author-callout-style-b4"><bold>KDM3A</bold></td><td align="left" valign="bottom"><bold>75 Î¼M (7.6% O<sub>2</sub></bold>) <xref ref-type="table-fn" rid="table4fn2">â </xref></td><td align="left" valign="bottom">In vitro demethylation-formaldehyde dehydrogenase-coupled reaction assay with K224-monomethylated PGC-1Î± peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib181">Qian et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">KDM5B</td><td align="left" valign="bottom">40 Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(1â21)K4me3 as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">P4HA1</td><td align="left" valign="bottom">40 Î¼M</td><td align="left" valign="bottom">Standard P4H activity assay with (Pro-Pro-Gly)<sub>10</sub> (Peptide Institute) as a substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib94">HirsilÃ¤ et al., 2003</xref></td></tr><tr><td style="author-callout-style-b4">KDM5C</td><td align="left" valign="bottom">35 Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(1â21)K4me3 as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td rowspan="2" style="author-callout-style-b4"><bold>TET1</bold></td><td align="left" valign="bottom"><bold>30</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with oligonucleotides containing a 5-mC as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib135">Laukka et al., 2016</xref></td></tr><tr><td align="left" valign="bottom"><bold>3.0 Î¼M (0.31% O<sub>2</sub></bold>) <xref ref-type="table-fn" rid="table4fn2">â </xref></td><td align="left" valign="bottom">In vitro DNA hydroxymethylation assay with genomic DNA as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib220">Thienpont et al., 2016</xref></td></tr><tr><td rowspan="2" style="author-callout-style-b4"><bold>TET2</bold></td><td align="left" valign="bottom"><bold>30</bold> Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with oligonucleotides containing a 5-mC as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib135">Laukka et al., 2016</xref></td></tr><tr><td align="left" valign="bottom"><bold>5.2 Î¼M (0.53% O<sub>2</sub></bold>) <xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="left" valign="bottom">In vitro DNA hydroxymethylation assay with genomic DNA as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib220">Thienpont et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">KDM5D</td><td align="left" valign="bottom">25 Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(1â21)K4me3 as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">KDM6B</td><td align="left" valign="bottom">20 Î¼M</td><td align="left" valign="bottom">In vitro radioactivity 2-OG turnover assay with histone H3(21â44)K27(me3) as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">IDO1</td><td align="left" valign="bottom">11.5â24 Î¼M</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay with L-Trp as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib126">Kolawole et al., 2015</xref></td></tr><tr><td align="left" valign="bottom" rowspan="7"/><td align="left" valign="bottom">PTGS1</td><td align="left" valign="bottom">10 Î¼M (sheep)</td><td align="left" valign="bottom">In vitro radioactivity label assay with [1-<sup>14</sup>C]arachidonic acid as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref></td></tr><tr><td align="left" valign="bottom">PTGS2</td><td align="left" valign="bottom">13 Î¼M (mouse)</td><td align="left" valign="bottom">In vitro radioactivity label assay with [1-<sup>14</sup>C]arachidonic acid as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref></td></tr><tr><td align="left" valign="bottom">ALOX5</td><td align="left" valign="bottom">13 Î¼M (porcine)</td><td align="left" valign="bottom">In vitro radioactivity label assay with [1-<sup>14</sup>C]arachidonic acid as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref></td></tr><tr><td align="left" valign="bottom">ALOX12</td><td align="left" valign="bottom">13 Î¼M</td><td align="left" valign="bottom">In vitro radioactivity label assay with [1-<sup>14</sup>C]arachidonic acid as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref></td></tr><tr><td align="left" valign="bottom">ALOX15</td><td align="left" valign="bottom">26 Î¼M (porcrine)</td><td align="left" valign="bottom">In vitro radioactivity label assay with [1-<sup>14</sup>C]arachidonic acid as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref></td></tr><tr><td align="left" valign="bottom">ALOX15</td><td align="left" valign="bottom">26 Î¼M (rabbit)</td><td align="left" valign="bottom">In vitro radioactivity label assay with [1-<sup>14</sup>C]arachidonic acid as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref></td></tr><tr><td style="author-callout-style-b4"><bold>ADO</bold></td><td align="left" valign="bottom"><bold>&gt;500</bold> Î¼M</td><td align="left" valign="bottom">In vitro UPLC-MS-TOF assay with RGS4(2â15) peptide as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref></td></tr><tr><td align="left" valign="middle" rowspan="10">Monooxygenase</td><td align="left" valign="bottom"><named-content content-type="author-callout-style-a3">NOS1</named-content><break/><named-content content-type="author-callout-style-a3">(nNOS)</named-content></td><td align="left" valign="bottom">350 Î¼M (rat)</td><td align="left" valign="bottom">In vitro heme-NO complex formation assay with L-arginine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Abu-Soud et al., 1996</xref></td></tr><tr><td align="left" valign="bottom"><named-content content-type="author-callout-style-a3">NOS2</named-content><break/><named-content content-type="author-callout-style-a3">(iNOS)</named-content></td><td align="left" valign="bottom">130 Î¼M (mouse)</td><td align="left" valign="bottom">In vitro heme-NO complex formation assay with L-arginine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Abu-Soud et al., 2001</xref></td></tr><tr><td align="left" valign="bottom" rowspan="2">NOS3<break/>(eNOS)</td><td align="left" valign="bottom">4 Î¼M (bovine)</td><td align="left" valign="bottom">In vitro heme-NO complex formation assay with L-arginine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Abu-Soud et al., 2000</xref></td></tr><tr><td align="left" valign="bottom">25 Î¼M (bovine)</td><td align="left" valign="bottom">In vitro heme-NO complex formation assay with N-hydroxy-L-arginine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Abu-Soud et al., 2000</xref></td></tr><tr><td rowspan="3" style="author-callout-style-b4">TH</td><td align="left" valign="bottom">16.2 Î¼M (low-activity state);<break/>46.1 Î¼M (high- activity state);</td><td align="left" valign="bottom">In vitro radioactivity label assay with <sup>3</sup>H-tyrosine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib192">Rostrup et al., 2008</xref></td></tr><tr><td align="left" valign="bottom">12.6â26.7 Î¼M (low-activity state);<break/>28.8â42.9 Î¼M (high-activity state)<xref ref-type="table-fn" rid="table4fn3"><sup>â¡</sup></xref>;</td><td align="left" valign="bottom">In vitro oxygraphic assay with tyrosine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib192">Rostrup et al., 2008</xref></td></tr><tr><td align="left" valign="bottom">2.6â3.9 Î¼M (2â3 mmHg, rat) <xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="left" valign="bottom">In vitro radioactivity label assay with <sup>3</sup>H-tyrosine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib122">Katz, 1980</xref></td></tr><tr><td align="left" valign="bottom">TPH1</td><td align="left" valign="bottom">3.9~12.9 Î¼M (3â10 mmHg, rat) <xref ref-type="table-fn" rid="table4fn2">â </xref></td><td align="left" valign="bottom">In vitro radioactivity label assay with <sup>3</sup>H-tryptophan as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib122">Katz, 1980</xref></td></tr><tr><td align="left" valign="bottom">PAH</td><td align="left" valign="bottom">17 Î¼M</td><td align="left" valign="bottom">In vitro oxygraphic assay with phenylalanine as substrate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib192">Rostrup et al., 2008</xref></td></tr><tr><td style="author-callout-style-b4">PAM</td><td align="left" valign="bottom">70 Î¼M (rat)</td><td align="left" valign="bottom">In vitro radioactivity label assay with [Î±-<sup>2</sup>H2]-N-acylglycine of different chain length as substrates</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib154">McIntyre et al., 2010</xref></td></tr><tr><td align="left" valign="middle" rowspan="4">Oxidase</td><td rowspan="3" style="author-callout-style-b4">Cytochrome <italic>c</italic> oxidase</td><td align="left" valign="bottom">&lt;0.1 Î¼M (rat)</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay measuring O<sub>2</sub> consumption of purified rat mitochondria at low phosphate potential ([ATP]/[ADP]<xref ref-type="table-fn" rid="table4fn1">*</xref>[Pi])</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Bienfait et al., 1975</xref></td></tr><tr><td align="left" valign="bottom">1â3 Î¼M (rat)</td><td align="left" valign="bottom">In vitro O<sub>2</sub> consumption assay measuring O<sub>2</sub> consumption of purified rat mitochondria at high phosphate potential</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Bienfait et al., 1975</xref></td></tr><tr><td align="left" valign="bottom">0.5 Î¼M (mouse)</td><td align="left" valign="bottom">Cellular assay measuring the âapparent K (m)â for O<sub>2</sub> or p <sub>50</sub> of respiration in 32D cells using high-resolution respirometry</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib195">Scandurra and Gnaiger, 2010</xref></td></tr><tr><td align="left" valign="bottom">AOC3</td><td align="left" valign="bottom">38 Î¼M</td><td align="left" valign="bottom">In vitro enzymatic assay using purified human AOC3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib204">Shen et al., 2012</xref></td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><label>*</label><p>O<sub>2</sub>-dependent enzymes that are known sensors are highlighted in bold; that are reported to be inhibited under hypoxia are highlighted in a light orange background; that are reported to be associated with positive selections in high-altitude populations are highlighted in red (also see <xref ref-type="table" rid="table6">Table 6</xref>).</p></fn><fn id="table4fn2"><label>â </label><p>Km of these enzyme were reported with units as % O<sub>2</sub> or mmHg, and calculated according to <xref ref-type="bibr" rid="bib149">Mas-Bargues et al., 2019</xref>; <xref ref-type="bibr" rid="bib175">Place et al., 2017</xref>.</p></fn><fn id="table4fn3"><label>â¡</label><p>Combined data for TH1/3/4 splicing isoforms.</p></fn></table-wrap-foot></table-wrap><p>Third, the decreased activity of PHDs during hypoxia triggers specific downstream responses (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib145">Majmundar et al., 2010</xref>; <xref ref-type="bibr" rid="bib120">Kaelin and Ratcliffe, 2008</xref>; <xref ref-type="bibr" rid="bib107">Ivan and Kaelin, 2017</xref>; <xref ref-type="bibr" rid="bib200">Schofield and Ratcliffe, 2004</xref>). Under normoxia, hydroxylated HIFÎ± is recognized and polyubiquitinylated by the E3 ubiquitin ligase von Hippel-Lindau protein (pVHL), which then leads to proteasome-mediated degradation of HIFÎ±. Under hypoxia, decreased O<sub>2</sub> concentration suppresses the activity of PHDs. This allows HIFÎ± to accumulate and translocate to nucleus, where it associates with the constitutively expressed HIF1Î² and forms the heterodimer transcriptional factor HIF. HIF then recruits transcriptional co-activators p300 and CREP-binding protein (CBP), binds with hypoxia-responsive elements (HREs) on DNA, and subsequently activates its target genes. Products of HIF-regulated genes are involved in multiple cellular and systematic adaptations to hypoxia, including metabolic shift from OXPHOS to glycolysis, redox homeostasis, angiogenesis, and erythropoiesis.</p><p>Although all PHD isoforms have similar O<sub>2</sub> affinities, their different expression patterns and substrate preferences among the HIFÎ± isoforms lead to differential regulation of hypoxia sensing and response by the PHD-HIF-pVHL pathway. Of the three PHD isoforms, PHD2 exerts the greatest control over the PHD-HIF-VHL pathway response to hypoxia (<xref ref-type="bibr" rid="bib22">Berra et al., 2003</xref>) and it is ubiquitously expressed across mouse tissues and is the most abundant isoform (<xref ref-type="bibr" rid="bib10">Appelhoff et al., 2004</xref>; <xref ref-type="bibr" rid="bib236">Willam et al., 2006</xref>). PHD1 and PHD3 are more tissue-specific, with PHD1 most expressed in testis and PHD3 in heart (<xref ref-type="bibr" rid="bib236">Willam et al., 2006</xref>). PHD2 favors HIF1Î± as substrate, while PHD1 and PHD3 favor HIF2Î± (<xref ref-type="table" rid="table3">Table 3</xref>; <xref ref-type="bibr" rid="bib10">Appelhoff et al., 2004</xref>). Interestingly, PHD2 and PHD3 are themselves HIF target genes and can be induced during hypoxia to provide feedback regulation for the PHD-HIF-pVHL pathway (<xref ref-type="bibr" rid="bib71">Epstein et al., 2001</xref>). The nonoverlapping and complex roles of different PHD isoforms are evidenced by knockout mice: Phd2-/- mice are embryonic lethal due to placental and heart defects, while postnatal whole-body knockout of Phd2 leads to polycythemia, increased angiogenesis, and heart defects (<xref ref-type="bibr" rid="bib216">Takeda et al., 2006</xref>; <xref ref-type="bibr" rid="bib158">Minamishima et al., 2008</xref>). Tissue-specific knockout of Phd2 in mouse heart or brain is protective against ischemic cardiac or neural injury, respectively (<xref ref-type="bibr" rid="bib132">Kunze et al., 2012</xref>; <xref ref-type="bibr" rid="bib97">HÃ¶lscher et al., 2011</xref>). Phd1 knockout mice have altered metabolism in skeletal muscles and overall enhanced hypoxia tolerance (<xref ref-type="bibr" rid="bib11">AragonÃ©s et al., 2008</xref>); and germline Phd3 knockout mice are hypotensive due to a hypofunctional sympathoadrenal system (<xref ref-type="bibr" rid="bib31">Bishop et al., 2008</xref>).</p><p>There has been interest to identify non-HIF substrates for PHDs and other pathways that are regulated through PHD-catalyzed hydroxylation. In the last two decades, more than 20 non-HIF substrates for PHDs have been reported, and hypoxia-mediated hydroxylation of these proteins alters response of downstream pathways (<xref ref-type="bibr" rid="bib49">Cockman et al., 2019</xref>; <xref ref-type="bibr" rid="bib214">Strowitzki et al., 2019</xref>). Most of these substrates were identified through cellular studies, suggesting that PHDs may act upon non-HIF substrates under physiological conditions (<xref ref-type="bibr" rid="bib214">Strowitzki et al., 2019</xref>; <xref ref-type="bibr" rid="bib251">Zheng et al., 2014</xref>; <xref ref-type="bibr" rid="bib162">Moser et al., 2013</xref>; <xref ref-type="bibr" rid="bib202">Segura et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Guo et al., 2016</xref>; <xref ref-type="bibr" rid="bib124">KÃ¶ditz et al., 2007</xref>; <xref ref-type="bibr" rid="bib241">Xie et al., 2009</xref>; <xref ref-type="bibr" rid="bib222">Ullah et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Deschoemaeker et al., 2015</xref>; <xref ref-type="bibr" rid="bib189">Rodriguez et al., 2018</xref>). One group found in in vitro enzymatic assays that PHDs lacked detectable activities on these non-HIF substrates. This difference in findings between cellular and in vitro enzymatic assays suggests that the action of PHDs on non-HIF substrates requires additional cellular machinery, such as adaptors or post-translational modifications (<xref ref-type="bibr" rid="bib49">Cockman et al., 2019</xref>).</p><p>FIH1 is another 2-OG dioxygenase that is known to sense hypoxia and regulate the HIF pathway (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib133">Lando et al., 2002a</xref>; <xref ref-type="bibr" rid="bib144">Mahon et al., 2001</xref>). Under normoxia, FIH1 catalyzes the asparaginyl hydroxylation of the C-terminal transactivation domain (CTAD) of HIFÎ± (<xref ref-type="table" rid="table3">Table 3</xref>; <xref ref-type="bibr" rid="bib125">Koivunen et al., 2004</xref>; <xref ref-type="bibr" rid="bib134">Lando et al., 2002b</xref>), which is responsible for its binding with the transcriptional coactivator p300/CBP (<xref ref-type="bibr" rid="bib134">Lando et al., 2002b</xref>; <xref ref-type="bibr" rid="bib77">Freedman et al., 2002</xref>). FIH1-catalyzed asparaginyl hydroxylation of the CTAD impairs the recruitment of p300/CBP and reduces transcriptional activity of HIF (<xref ref-type="bibr" rid="bib133">Lando et al., 2002a</xref>; <xref ref-type="bibr" rid="bib134">Lando et al., 2002b</xref>). In hypoxia, FIH1 activity is also reduced by hypoxia, enabling HIFÎ± to recruit p300/CBP for transcriptional activation of its target genes (<xref ref-type="bibr" rid="bib133">Lando et al., 2002a</xref>; <xref ref-type="bibr" rid="bib134">Lando et al., 2002b</xref>). The reported O<sub>2</sub> Km value for FIHs is 90 Î¼M, using a HIF1Î± peptide containing site Asn803 (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib125">Koivunen et al., 2004</xref>). Compared with the Km values of PHDs in similar assays, FIH1 appears to be less sensitive to hypoxia, that is, as O<sub>2</sub> levels decrease, PHDs are inhibited before FIH1 (<xref ref-type="bibr" rid="bib221">Tian et al., 2011</xref>). Thus, FIH1 is considered a fine modulator of the HIF pathway in sensing severe hypoxia. Consistent with the notion that its role is more limited, FIH1 knockout mice have abnormal metabolism but not other HIF-regulated processes (<xref ref-type="bibr" rid="bib249">Zhang et al., 2010</xref>; <xref ref-type="bibr" rid="bib206">Sim et al., 2018</xref>). There are also non-HIF substrates identified for FIH1 that may also be regulated in an O<sub>2</sub>-dependent manner (<xref ref-type="table" rid="table3">Table 3</xref>; <xref ref-type="bibr" rid="bib48">Cockman et al., 2009b</xref>; <xref ref-type="bibr" rid="bib201">Scholz et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Cockman et al., 2009a</xref>).</p></sec><sec id="s1-3-3"><title>Epigenetic modulators</title><p>These include the lysine demethylase (KDM) Jumonji C (JmjC) domain-containing proteins, and the DNA demethylases ten-eleven translocation enzymes (TETs).</p><p>JmjC domain-containing proteins contain domains for Fe(II) and 2-OG binding and catalytic activities (<xref ref-type="bibr" rid="bib205">Shmakova et al., 2014</xref>; <xref ref-type="bibr" rid="bib127">Kooistra and Helin, 2012</xref>). They also bind with O<sub>2</sub> and utilize it as a substrate, therefore having the potential to function as hypoxia sensors if their O<sub>2</sub>-binding affinities allow (<xref ref-type="bibr" rid="bib205">Shmakova et al., 2014</xref>). Of the 32 identified JmjC proteins in humans, at least 23 conduct lysine demethylation reactions (<xref ref-type="bibr" rid="bib205">Shmakova et al., 2014</xref>). Their substrates include both histone lysines (K4, K9, K27, and K36 on histone 3) and some non-histone lysines. (<xref ref-type="table" rid="table5">Table 5</xref>). Histone methylations affect chromatin structure and compactness and consequently regulate gene expression in either activating or silencing mode (<xref ref-type="table" rid="table5">Table 5</xref>; <xref ref-type="bibr" rid="bib205">Shmakova et al., 2014</xref>; <xref ref-type="bibr" rid="bib127">Kooistra and Helin, 2012</xref>; <xref ref-type="bibr" rid="bib226">Walport et al., 2016</xref>; <xref ref-type="bibr" rid="bib140">Li et al., 2022</xref>). H3K4me2/3, H3K9me2, H3K27me3, and H3K36me3 levels increase after hypoxia, possibly due to KDMs acting as O<sub>2</sub> sensors and effecting chromatin changes.</p><table-wrap id="table5" position="float"><label>Table 5.</label><caption><title>JmjC domain-containing histone demethylases and their substrates<xref ref-type="table-fn" rid="table5fn1">*</xref>.</title><p>(A = activating transcription, S = silencing transcription).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">KDM class</th><th align="left" valign="bottom">Members (gene symbol)</th><th align="left" valign="bottom">Histone lysyl residue substrates</th><th align="left" valign="bottom">Other substrates</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="2">KDM2</td><td align="left" valign="bottom">KDM2A</td><td align="left" valign="bottom">H3K36me1/me2 (A)</td><td align="left" valign="bottom">p65, NF-ÎºB</td></tr><tr><td align="left" valign="bottom">KDM2B</td><td align="left" valign="bottom">H3K36me1/me2 (A), H3K4me3 (A)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom" rowspan="3">KDM3</td><td align="left" valign="bottom">KDM3A</td><td align="left" valign="bottom">H3K9me1/me2 (S)</td><td align="left" valign="bottom">PGC-1Î± K224me</td></tr><tr><td align="left" valign="bottom">KDM3B</td><td align="left" valign="bottom">H3K9me1/me2 (S)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">JJMJD1C</td><td align="left" valign="bottom">H3K9me1/me2 (S)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom" rowspan="5">KDM4</td><td align="left" valign="bottom">KDM4A</td><td align="left" valign="bottom">H3K9me2/me3 (S), H3K36me2 (A), H1.4K26me2/me3</td><td align="left" valign="bottom">WIZ, CDYL1, CSB, and G9a</td></tr><tr><td align="left" valign="bottom">KDM4B</td><td align="left" valign="bottom">H3K9me2/me3 (S), H3K36me2 (A), H1.4K26me2/me3</td><td align="left" valign="bottom">WIZ, CDYL1, CSB, and G9a</td></tr><tr><td align="left" valign="bottom">KDM4C</td><td align="left" valign="bottom">H3K9me2/me3 (S), H3K36me2 (A), H1.4K26me2/me3</td><td align="left" valign="bottom">WIZ, CDYL1, CSB, and G9a</td></tr><tr><td align="left" valign="bottom">KDM4D</td><td align="left" valign="bottom">H3K9me2/me3 (S)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">KDM4E</td><td align="left" valign="bottom">H3K9me3 (S)</td><td align="left" valign="bottom">H3R2me2/me1, H3R8me2/me1, H3R26me2/me1, H4R3me2</td></tr><tr><td align="left" valign="bottom" rowspan="4">KDM5</td><td align="left" valign="bottom">KDM5A</td><td align="left" valign="bottom">H3K4me2/me3 (A)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">KDM5B</td><td align="left" valign="bottom">H3K4me2/me3 (A)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">KDM5C</td><td align="left" valign="bottom">H3K4me2/me3 (A)</td><td align="left" valign="bottom">H3R2me2/me1, H3R8me2, H4R3me2a, ULK1R170me2a</td></tr><tr><td align="left" valign="bottom">KDM5D</td><td align="left" valign="bottom">H3K4me2/me3 (A)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom" rowspan="3">KDM6</td><td align="left" valign="bottom">KDM6A</td><td align="left" valign="bottom">H3K27me2/me3 (S)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">KDM6B</td><td align="left" valign="bottom">H3K27me2/me3 (S)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">KDM6C</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom" rowspan="3">KDM7</td><td align="left" valign="bottom">KDM7A</td><td align="left" valign="bottom">H3K9me1/me2 (S), H3K27me1/me2 (S)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">PHF8</td><td align="left" valign="bottom">H3K27me1/me2 (S), H4K20me1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">PHF2</td><td align="left" valign="bottom">H3K9me2/me3 (S)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom" rowspan="4">Jmjc domain only</td><td align="left" valign="bottom">NO66</td><td align="left" valign="bottom">H3K4me2/me3 (A), H3K36me2/me3 (A)</td><td align="left" valign="bottom">Rpl8</td></tr><tr><td align="left" valign="bottom">MINA53</td><td align="left" valign="bottom">H3K9me3 (S)</td><td align="left" valign="bottom">Rpl27a</td></tr><tr><td align="left" valign="bottom">KDM8</td><td align="left" valign="bottom">H3K36me2 (A)</td><td align="left" valign="bottom">NFATc1</td></tr><tr><td align="left" valign="bottom">JMJD6</td><td align="left" valign="bottom"/><td align="left" valign="bottom">H3R2me2,H4R3me2/me1, U2AF2/U2AF65, LUC7L2</td></tr></tbody></table><table-wrap-foot><fn id="table5fn1"><label>*</label><p>Known hydroxylation/demethylation sites are indicated.</p></fn></table-wrap-foot></table-wrap><p>KDM6A, also known as UTX, catalyzes demethylation at H3K27me2/me3 (<xref ref-type="table" rid="table5">Table 5</xref>; <xref ref-type="bibr" rid="bib98">Hong et al., 2007</xref>). In 2019, Chakraborty et al. reported that increase in H3K27me3 levels during hypoxia is HIF-independent and is caused by the direct inhibition of KDM6A due to decreased pO<sub>2</sub> under hypoxia (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref>). The O<sub>2</sub> sensitivity of KDM6A was further confirmed by its O<sub>2</sub> Km value of 180 Î¼M (<xref ref-type="table" rid="table4">Table 4</xref>), in a similar range as the PHDs and FIH and the highest among KDM6 members (<xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref>). Sensing of hypoxia by KDM6A can control cell fate by chromatin reprogramming (<xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref>). For example, it is reported that in mouse myoblast C2C12 cells, increase in H3K27me3 levels due to inactivation of KDM6A represses the expression of myogenic genes and blocks myogenic differentiation (<xref ref-type="bibr" rid="bib40">Chakraborty et al., 2019</xref>).</p><p>KDM5A catalyzes demethylation at H3K4me2/me3 (<xref ref-type="table" rid="table5">Table 5</xref>) and was recently reported by Batie et al. to be another hypoxia sensor that could directly regulate cell fate through chromatin reprogramming (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib45">Christensen et al., 2007</xref>; <xref ref-type="bibr" rid="bib16">Batie et al., 2019</xref>). KDM5A also has a relatively low O<sub>2</sub> affinity, with a Km ~90 Î¼M (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib16">Batie et al., 2019</xref>). Inactivation of KDM5A by hypoxia results in rapidly increasing H3K4me3 levels, and downstream effects include active transcriptions of genes associated with antiproliferation, antiapoptosis, etc. (<xref ref-type="bibr" rid="bib16">Batie et al., 2019</xref>). Excitingly, a new study found that KDM5A binding to H3K4me3 is enhanced by PHD1-mediated hydroxylation of H3 at proline residue 16 (H3P16OH) (<xref ref-type="bibr" rid="bib141">Liu et al., 2022</xref>). This KDM5A-PHD1 axis raises the possibility of other cross-talk between O<sub>2</sub> sensors.</p><p>KDM4 family enzymes mainly catalyze the demethylation at H3K9me2/me3 and H3K36me2 (<xref ref-type="table" rid="table5">Table 5</xref>; <xref ref-type="bibr" rid="bib93">Hillringhaus et al., 2011</xref>). Their O<sub>2</sub>-binding affinities have also been investigated in vitro: the O<sub>2</sub> Km values of KDM4A, KDM4B, KDM4C, and KDM4E are all within the range of 57â197 Î¼M (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib39">Cascella and Mirica, 2012</xref>; <xref ref-type="bibr" rid="bib89">Hancock et al., 2017</xref>). These Km values suggest the potential of KDM4 members to be hypoxia sensors, but this depends on their cellular roles and the downstream responses of their speculated inhibition during hypoxia (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Of these KDM4 members, cellular activity of KDM4A is reported to show a graded response to O<sub>2</sub> concentration in U2OS cells and so does the demethylation levels on H3K9me3 (<xref ref-type="bibr" rid="bib89">Hancock et al., 2017</xref>). It is also reported that KDM4A regulates the transcription of HIF1Î± through the H3K9 methylation status at HIF1Î± locus during hypoxia in tumors (<xref ref-type="bibr" rid="bib60">Dobrynin et al., 2017</xref>). More studies for the function of other KDM4 demethylases during hypoxia are still needed.</p><p>There are also cases where the JmjC-containing KDMs function as hypoxia sensors through non-histone substrates. One such example is KDM3A, a histone demethylase for H3K9me2/1 sites (<xref ref-type="table" rid="table5">Table 5</xref>), whose activity on H3K9me2 is maintained even under severe hypoxia (0.2% O<sub>2</sub>), suggesting a high binding affinity with O<sub>2</sub> with this substrate (<xref ref-type="bibr" rid="bib244">Yamane et al., 2006</xref>; <xref ref-type="bibr" rid="bib34">Brauchle et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Beyer et al., 2008</xref>). However, recently Qian et al. discovered that the demethylation activity of KDM3A on a non-histone substrate, peroxisome proliferator-activated receptor gamma coactivator (PGC-1Î±) K224me, is inhibited by hypoxia (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), with Km ~7.6% O<sub>2</sub> (~75 Î¼M), high enough to function as a hypoxia sensor under physiological conditions (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib181">Qian et al., 2019</xref>). PGC-1Î± is a transcriptional coactivator that binds with transcriptional factor nuclear respiratory factor (NRF1/2) for activating transcription of nucleus-encoded mitochondrial genes (<xref ref-type="bibr" rid="bib181">Qian et al., 2019</xref>; <xref ref-type="bibr" rid="bib196">Scarpulla et al., 2012</xref>). The inhibited activity of KDM3A causes the accumulation of K224 mono-methylation on PCG-1Î±, which reduces the interaction between PCG-1Î± and NRF1/2, decreasing mitochondrial biogenesis (<xref ref-type="bibr" rid="bib181">Qian et al., 2019</xref>). Another example is KDM5C, a histone demethylase for H3K4me2/me3 sites, which can also function as an arginine demethylase (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib140">Li et al., 2022</xref>; <xref ref-type="bibr" rid="bib111">Iwase et al., 2007</xref>). Its demethylation of ULK1 R170me2s site is inhibited by 1% O<sub>2</sub> level in LN229 and several other cell lines (<xref ref-type="bibr" rid="bib140">Li et al., 2022</xref>). This inhibited demethylation stabilizes ULK1 R170me2s, which further activates ULK1 and induces autophagy as a downstream response (<xref ref-type="bibr" rid="bib140">Li et al., 2022</xref>). The cases of KDM3A and KDM5C suggest the possibility of other JmjC-containing KDMs to sense and respond to hypoxia through undiscovered non-histone substrates.</p><p>Besides KDMs, another set of 2-OG-dependent dioxygenases that act as epigenetic regulators are the TET enzymes (TET1, TET2, and TET3 in humans). These enzymes catalyze the hydroxylation of DNA 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) (<xref ref-type="bibr" rid="bib176">Ponnaluri et al., 2013</xref>; <xref ref-type="bibr" rid="bib239">Wu and Zhang, 2017</xref>). This facilitates the subsequent demethylation of 5hmC into an unmodified cytosine (<xref ref-type="bibr" rid="bib176">Ponnaluri et al., 2013</xref>; <xref ref-type="bibr" rid="bib239">Wu and Zhang, 2017</xref>). Since CpG methylation is typically silencing, TETs tend to promote gene activation. A large variance exists in different reports about the O<sub>2</sub> Km values of TET1 and TET2, ranging from 0.31% and 0.53% (3.0 Î¼M and 5.2 Î¼M) using genomic DNA as substrates to 30 Î¼M using oligonucleotides as substrates (<xref ref-type="table" rid="table4">Table 4</xref>); however, these measurements show much tighter O<sub>2</sub> binding of TET1 and TET2 compared with the aforementioned reported hypoxia sensors (KDM3A, KDM5A, and KDM6A) (<xref ref-type="bibr" rid="bib135">Laukka et al., 2016</xref>; <xref ref-type="bibr" rid="bib220">Thienpont et al., 2016</xref>). Severe hypoxia, such as 0.5% O<sub>2</sub> treatment, is reported to directly impair the cellular activities of TETs, increase DNA hypermethylation, and decrease the expression levels of associated genes (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib220">Thienpont et al., 2016</xref>). DNA hypermethylation caused by TETs inhibition also happens during pathophysiological hypoxia found in tumors (<xref ref-type="bibr" rid="bib220">Thienpont et al., 2016</xref>). Considering their O<sub>2</sub> sensitivity, TETs are more likely to function as hypoxia sensors under extreme hypoxic conditions.</p></sec><sec id="s1-3-4"><title>Translational modulators</title><p>Translational modulators in the 2-OG-dependent dioxygenases include the mRNA hydroxylases and ribosome hydroxylases.</p><p>The most abundant RNA modification is N<sup>6</sup>-methylation of adenosine (m<sup>6</sup>A), which affects the processing, splicing, translation, and degradation of modified mRNAs (<xref ref-type="bibr" rid="bib248">Zaccara et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Chen et al., 2019</xref>). The dynamics of m<sup>6</sup>A modification is coordinated by methyltransferases (so-called âwritersâ), demethylases (âerasersâ), and identifiers (âreadersâ) (<xref ref-type="bibr" rid="bib248">Zaccara et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Chen et al., 2019</xref>). Two m<sup>6</sup>A RNA demethylases have been identified thus far: FTO and ALKBH5, with demonstrated demethylase activity in vitro and in vivo, respectively (<xref ref-type="bibr" rid="bib250">Zheng et al., 2013</xref>; <xref ref-type="bibr" rid="bib116">Jia et al., 2011</xref>.<xref ref-type="bibr" rid="bib248">Zaccara et al., 2019</xref>; <xref ref-type="bibr" rid="bib250">Zheng et al., 2013</xref>; <xref ref-type="bibr" rid="bib153">Mauer et al., 2017</xref>). Indirect evidence for a sensor role of these enzymes in hypoxia response is that despite their protein levels staying relatively constant, hypoxia leads to m<sup>6</sup>A accumulation in cancer cells and breast cancer. Thus, it is possible that hypoxia plays a role in direct inhibition of ALKBH5 and/or FTO (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). More studies about other possible demethylases for m<sup>6</sup>A in mRNA and the O<sub>2</sub>-binding affinities of these enzymes are needed to determine which of them directly sense and respond to hypoxia.</p><p>The translational apparatus may itself be targeted by ribosome hydroxylases, which modify the histidyl or prolyl residues of ribosomal subunit proteins (<xref ref-type="bibr" rid="bib36">Bundred et al., 2018</xref>; <xref ref-type="bibr" rid="bib253">Zhuang et al., 2015</xref>). These ribosome hydroxylases regulate translation and participate in physiological or disease processes, including cellular growth, skeletal bone formation, tumorigenesis, and immune regulation (<xref ref-type="bibr" rid="bib36">Bundred et al., 2018</xref>; <xref ref-type="bibr" rid="bib253">Zhuang et al., 2015</xref>; <xref ref-type="bibr" rid="bib80">Ge et al., 2012</xref>; <xref ref-type="bibr" rid="bib210">Singleton et al., 2014</xref>). Currently, three ribosome hydroxylases have been identified: histidyl hydroxylases MINA53 (RIOX2) and NO66 (RIOX1) targeting the 60S large subunits Rpl27a and Rpl8, respectively; and prolyl hydroxylase OGFOD1 targeting the 40S small subunit Rpl23 (<xref ref-type="bibr" rid="bib80">Ge et al., 2012</xref>; <xref ref-type="bibr" rid="bib210">Singleton et al., 2014</xref>). Among these, NO66 has its activity inhibited by 0.1â1% O<sub>2</sub> in cellular studies (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). By contrast, OGFOD1 still retains 80% of its cellular activity even under severe hypoxia (0.2% O<sub>2</sub>) (<xref ref-type="bibr" rid="bib80">Ge et al., 2012</xref>; <xref ref-type="bibr" rid="bib210">Singleton et al., 2014</xref>). While this suggests the potential for NO66 to be a sensor in severe hypoxia, more studies of the O<sub>2</sub> affinity of NO66 and the downstream response of its inhibition by hypoxia are needed.</p></sec><sec id="s1-3-5"><title>Heme-dependent dioxygenases</title><p>Heme prosthetic groups are used by these enzymes for O<sub>2</sub> binding and activation (<xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>; <xref ref-type="bibr" rid="bib99">Huang and Groves, 2018</xref>; <xref ref-type="bibr" rid="bib64">Efimov et al., 2011</xref>; <xref ref-type="bibr" rid="bib184">Raven, 2017</xref>). Five known heme-dependent dioxygenases in humans are indoleamine 2,3-dioxygenase (IDO) 1 and 2, tryptophan 2,3-dioxygenase (TDO), and prostaglandin G/H synthase (PGHS) 1 and 2 (<xref ref-type="bibr" rid="bib170">Paton and Ntambi, 2009</xref>; <xref ref-type="bibr" rid="bib64">Efimov et al., 2011</xref>; <xref ref-type="bibr" rid="bib184">Raven, 2017</xref>). Except for IDO2 that has not been measured, these dioxygenases have reported Km values of 10â30 Î¼M (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref>; <xref ref-type="bibr" rid="bib126">Kolawole et al., 2015</xref>). As reflected by their lower O<sub>2</sub> Km values, heme-dependent dioxygenases tend to have stronger O<sub>2</sub> binding than 2-OG-dependent dioxygenases.</p><p>Both TDO and IDOs catalyze the conversion of L-tryptophan to N-formyl-L-kynurenine (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; <xref ref-type="bibr" rid="bib219">Thackray et al., 2011</xref>). They have similar heme- and substrate-binding pockets, although they share low sequence identity overall, and are believed to be an example of convergent evolution (<xref ref-type="bibr" rid="bib13">Ball et al., 2014</xref>; <xref ref-type="bibr" rid="bib219">Thackray et al., 2011</xref>). Both TDO and IDO regulate immune responses, possibly by modifying tryptophan homeostasis. TDO and IDO have distinct tissue expression patterns, with TDO mostly restricted to liver and epidermis, while IDO is found throughout the body and can be induced by certain immune or inflammation signals (<xref ref-type="bibr" rid="bib13">Ball et al., 2014</xref>). Their expression patterns may further regulate their relative importance in different tissues or toward different stimuli (<xref ref-type="bibr" rid="bib13">Ball et al., 2014</xref>). The cellular activity of TDO is reported to be inhibited by hypoxia (1â10% O<sub>2</sub>) in HeLa cells transfected with TDO, while TDO protein level remains unaltered (<xref ref-type="bibr" rid="bib68">Elbers et al., 2016</xref>). Cellular activity of IDO1 is also decreased by hypoxia (1% O<sub>2</sub>) in 86HG39 and HeLa cells with unaltered IDO1 protein level (<xref ref-type="bibr" rid="bib198">Schmidt et al., 2013</xref>). Impaired immune responses are observed in both cases as downstream effects (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib68">Elbers et al., 2016</xref>; <xref ref-type="bibr" rid="bib198">Schmidt et al., 2013</xref>). Further studies are needed to clarify whether hypoxia directly inhibits the enzymatic activities of TDO and IDO1 and how this might trigger downstream responses in a more physiological system.</p></sec><sec id="s1-3-6"><title>Lipoxygenases</title><p>Lipoxygenases (LOXs) are iron-containing dioxygenases that catalyze the insertion of O<sub>2</sub> into polyunsaturated fatty acids (PUFA) and their derivatives, forming hydroperoxyl eicosatetraenoic acid (HPETE) products (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). HPETE products are chemically unstable and reduced by peroxidases to hydroxyl eicosatetraenoic acid (HETE) (<xref ref-type="bibr" rid="bib30">Biringer, 2020</xref>; <xref ref-type="bibr" rid="bib109">Ivanov et al., 2010</xref>; <xref ref-type="bibr" rid="bib129">Kuhn et al., 2015</xref>). In humans, there are six known LOXs with arachidonic acid as the most common substrate (<xref ref-type="bibr" rid="bib30">Biringer, 2020</xref>; <xref ref-type="bibr" rid="bib129">Kuhn et al., 2015</xref>). These arachidonate lipoxygenases (ALOXs) are named according to the positional specificity in their catalyzed hydroperoxyl reactions as the ALOX5, ALOX12, ALOX12B, ALOX15, ALOX15B, and ALOXE3 (<xref ref-type="bibr" rid="bib30">Biringer, 2020</xref>; <xref ref-type="bibr" rid="bib129">Kuhn et al., 2015</xref>). Functions of ALOXs include biosynthesis of inflammatory mediators as well as regulation of cellular redox state (<xref ref-type="bibr" rid="bib129">Kuhn et al., 2015</xref>).</p><p>ALOXs demonstrate that O<sub>2</sub>-binding affinities can be affected by the specific substrate, as illustrated by ALOX15. The reported O<sub>2</sub> Km values of human ALOX12, rat ALOX5, and rabbit ALOX15 are all within the range of 8â26 Î¼M, as measured by biochemical studies with arachidonic acid as the substrate (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib119">JurÃ¡nek et al., 1999</xref>; <xref ref-type="bibr" rid="bib230">Wecksler et al., 2009</xref>). While the rabbit ALOX15 reaches its V<sub>max</sub> under normoxia with arachidonic acid as the substrate, its reaction rate with hydroxyl arachidonic acids as substrates still increases with increasing O<sub>2</sub> concentration under hyperoxic conditions (<xref ref-type="bibr" rid="bib108">Ivanov et al., 2005</xref>). This suggests a higher O<sub>2</sub> Km value, a lower O<sub>2</sub>-binding affinity, and the ability to sense the change of O<sub>2</sub> concentration from normoxic to hypoxic conditions when hydroxyl arachidonic acids are the substrates for rabbit ALOX15. Similarly, human ALOX15 has O<sub>2</sub> Km values for different substrates, namely 24 Î¼M for arachidonic acid and 9.6 Î¼M for linoleic acid. Furthermore, allosteric binding of 12-HEHE to ALOX15 affects its O<sub>2</sub> affinity (<xref ref-type="bibr" rid="bib230">Wecksler et al., 2009</xref>).</p><p>The fact that substrates affect O<sub>2</sub> affinity is not a mere laboratory curiosity. Multiple ALOX substrates may be involved in hypoxia-related diseases, including pulmonary hypertension and cardiovascular diseases (<xref ref-type="bibr" rid="bib150">Mashima and Okuyama, 2015</xref>; <xref ref-type="bibr" rid="bib252">Zhu and Ran, 2012</xref>; <xref ref-type="bibr" rid="bib110">Ivanov et al., 2015</xref>). Studying the substrate-dependent O<sub>2</sub> sensitivity of human ALOXs in various biological contexts will be necessary to ascertain whether and how these enzymes sense and respond to hypoxia in vivo.</p></sec><sec id="s1-3-7"><title>Other dioxygenases</title><p>Ten other human dioxygenases have been identified (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). They have the shared property of using an octahedral Fe(II) as the catalytic center.</p><p>Among these 10 enzymes, cysteamine (2-aminoethanethiol) dioxygenase (ADO) has been identified as a hypoxia sensor (<xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref>). ADO catalyzes the oxidation of protein N-terminal cysteines to cysteine sulfinic acid (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) and promotes the degradation of the oxidized substrate protein through the N-degron pathway (<xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref>). Human ADO has a relatively low O<sub>2</sub>-binding affinity (Km &gt; 500 Î¼M, <xref ref-type="table" rid="table4">Table 4</xref>, <xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref>). As a result, even mild hypoxia inhibits ADO activity, allowing stabilization of its substrates, including the regulator of G protein signaling (RGS4/5) and cytokine interleukin (IL)-32 (<xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref>). During hypoxia, inhibited ADO results in the stabilization of RGS4/5 and subsequently modulates G protein-coupled calcium ion signals and mitogen-activated protein kinase (MAPK) signaling (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref>). Hypoxia sensing by ADO provides a faster response compared with HIF-mediated transcriptional regulation (<xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref>).</p></sec></sec><sec id="s1-4"><title>Monooxygenases</title><p>The monooxygenase members can be further classified into iron-dependent, copper-dependent, and flavin-dependent monooxygenases based on their catalytic centers (<xref ref-type="table" rid="table2">Table 2</xref>).</p><sec id="s1-4-1"><title>Iron-dependent monooxygenases</title><p>Most monooxygenases utilize iron as the catalytic center for oxygen insertion and can be further divided into heme-dependent and non-heme-dependent ones.</p></sec><sec id="s1-4-2"><title>Heme-dependent monooxygenases</title><p>In humans, these include cytochrome P450 enzymes, heme oxygenases, and nitric oxide synthases.</p><p>Cytochrome P450 enzymes (CYPs), which comprise ~60% of all human monooxygenases (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), are responsible for the oxidative metabolism of both endogenous and exogenous chemicals (<xref ref-type="bibr" rid="bib83">Guengerich, 2007</xref>; <xref ref-type="bibr" rid="bib52">Danielson, 2002</xref>; <xref ref-type="bibr" rid="bib178">Poulos and Johnson, 2005</xref>). They play an important role in the synthesis and metabolism of hormones, cholesterols, and vitamins, and the clearance and detoxification of xenobiotics (<xref ref-type="bibr" rid="bib52">Danielson, 2002</xref>; <xref ref-type="bibr" rid="bib178">Poulos and Johnson, 2005</xref>). Not only do they have diverse biological functions, but their biochemical properties vary widely as well. For instance, the substrate specificity of CYPs ranges from a single substrate (such as CYP19A1) to a diverse repertoire of substrates (<xref ref-type="bibr" rid="bib178">Poulos and Johnson, 2005</xref>). The O<sub>2</sub> sensitivities of CYPs have been assessed for drug clearance in cellular systems or subcellular systems such as liver microsomes (<xref ref-type="bibr" rid="bib76">Fradette and Du Souich, 2004</xref>). With different drug substrates used in the assays, a wide range of O<sub>2</sub> Km values of mixed CYPs have been reported, ranging from 0.5 to 200 Î¼M in mammalian species (<xref ref-type="bibr" rid="bib118">Jones, 1981</xref>). This is consistent with reports that hypoxia could increase the half-life and/or toxicity of certain drugs. However, it is currently unclear whether CYPs do, in fact, function as hypoxia sensors. Direct evidence is lacking that cellular CYP activity is affected by hypoxia, and their O<sub>2</sub> Kms with endogenous substrates are largely unknown. It is known, however, that hypoxia affects the expression levels of some CYPs, suggesting that these CYPs may have a role in hypoxia response (<xref ref-type="bibr" rid="bib76">Fradette and Du Souich, 2004</xref>). In principle, a given CYP could act as both a hypoxia sensor and downstream effector.</p><p>Heme oxygenases (HO) catalyze the degradation of cellular heme to biliverdin, also producing ferrous iron and carbon monoxide (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; <xref ref-type="bibr" rid="bib247">Yoshida and Migita, 2000</xref>). There are two catalytically active human heme oxygenases, HO-1 and HO-2. They do not contain prosthetic heme groups for their catalytic reactions; instead, they bind heme substrates that are used for O<sub>2</sub> binding, activation, and reduction (<xref ref-type="bibr" rid="bib247">Yoshida and Migita, 2000</xref>). Although their O<sub>2</sub> Kms are unknown, their estimated dissociation constant (Kd) is 0.012â0.034 Î¼M (<xref ref-type="bibr" rid="bib157">Migita et al., 1998</xref>). These very high O<sub>2</sub>-binding affinities suggest that HOs are unlikely to be direct O<sub>2</sub> sensors. Instead, the activity of HO-2 may indirectly be regulated by O<sub>2</sub> through redox potential, which has implications for whole-body sensing in the carotid body (<xref ref-type="bibr" rid="bib142">LÃ³pez-Barneo et al., 2008</xref>; <xref ref-type="bibr" rid="bib183">Ragsdale and Yi, 2011</xref>), thereby affecting whole-body physiological response to hypoxia.</p><p>Nitric oxide synthases (NOSs) convert L-arginine into nitric oxide (NO) in two steps, each using one O<sub>2</sub> molecule activated by the heme iron (<xref ref-type="fig" rid="fig3">Figure 3G</xref>; <xref ref-type="bibr" rid="bib51">Daff, 2010</xref>). NO is a gas signaling molecule with an array of functions, including regulation of vascular tone, immune defense, neural development, and hypoxia signaling (<xref ref-type="bibr" rid="bib159">Moncada and Higgs, 1991</xref>; <xref ref-type="bibr" rid="bib95">Ho et al., 2012</xref>). There are three human NOS enzymes: neuronal NOS (NOS1 or nNOS) is constitutively expressed in nerve, skeletal muscle, and heart muscle cells; inducible NOS (NOS2 or iNOS) is induced in multiple immune cells after stimuli; and endothelial NOS (NOS3 or eNOS) is constitutively expressed in vascular endothelial cells (<xref ref-type="bibr" rid="bib51">Daff, 2010</xref>).</p><p>The O<sub>2</sub> Km values for all three NOSs have been reported and are quite different from each other: 350 Î¼M for rat nNOS, 130 Î¼M for mouse iNOS, and 4 Î¼M for bovine eNOS when using L-Arg as substrate (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib215">Stuehr et al., 2004</xref>; <xref ref-type="bibr" rid="bib193">Santolini et al., 2001a</xref>; <xref ref-type="bibr" rid="bib3">Abu-Soud et al., 2000</xref>; <xref ref-type="bibr" rid="bib4">Abu-Soud et al., 2001</xref>; <xref ref-type="bibr" rid="bib194">Santolini et al., 2001b</xref>; <xref ref-type="bibr" rid="bib2">Abu-Soud et al., 1996</xref>). (Although measured from different species, these values have been compared with each other to illustrate the different O<sub>2</sub> affinities of these three NOSs; <xref ref-type="bibr" rid="bib4">Abu-Soud et al., 2001</xref>; <xref ref-type="bibr" rid="bib203">Semenza, 2005</xref>.) These differences in O<sub>2</sub> Km values, together with tissue-specific expression patterns of different NOS isoforms, account for their distinct roles in response to hypoxia. The low O<sub>2</sub> Km value of eNOS may help eNOS enzymatic activity remain constant across O<sub>2</sub> concentration ranges in vascular endothelial cells (<xref ref-type="bibr" rid="bib95">Ho et al., 2012</xref>; <xref ref-type="bibr" rid="bib203">Semenza, 2005</xref>). The high Km value of nNOS indicates its enzymatic activity is more dependent on O<sub>2</sub> concentrations, and it is reported to have a linear relationship between O<sub>2</sub> concentration and its NO-producing activity over the entire physiological O<sub>2</sub> range (<xref ref-type="bibr" rid="bib193">Santolini et al., 2001a</xref>; <xref ref-type="bibr" rid="bib203">Semenza, 2005</xref>; <xref ref-type="bibr" rid="bib67">Elayan et al., 2000</xref>). This suggests the activity of nNOS decreases during acute hypoxia, which should be neuroprotective as excessive NO is reported to increase neurotoxicity during acute ischemic stroke (<xref ref-type="bibr" rid="bib95">Ho et al., 2012</xref>; <xref ref-type="bibr" rid="bib55">Dawson and Dawson, 1996</xref>). In fact, hyperbaric O<sub>2</sub> treatment can increase NO production in rat nNOS and lead to neurotoxicity, a hint that nNOS could also function to sense hyperoxia (<xref ref-type="bibr" rid="bib67">Elayan et al., 2000</xref>). During chronic hypoxia, nNOS functions more as an effector: upregulation of nNOS expression level leads to the increase of NO production to increase blood flow by vasodilation (<xref ref-type="bibr" rid="bib228">Ward et al., 2005</xref>). The Km value of iNOS is also high enough for a hypoxia sensor, but iNOS is not typically expressed and needs to be induced by different stimulus in most human tissues, making the condition for it to function as a sensor more complicated (<xref ref-type="bibr" rid="bib4">Abu-Soud et al., 2001</xref>; <xref ref-type="bibr" rid="bib188">Robinson et al., 2011</xref>).</p><p>In addition, the NOSs can also cross-talk with the PHD-HIF-pVHL pathway by NO-derived cysteine S-nitrosylation of HIF1Î± and pVHL protein, which can inhibit the binding between hydroxylated HIF1Î± and pVHL and stabilize HIF1Î± even when O<sub>2</sub> is not limiting (<xref ref-type="bibr" rid="bib139">Li et al., 2007</xref>; <xref ref-type="bibr" rid="bib168">Palmer et al., 2007</xref>). This may play a role in immune cells where iNOS can be induced to activate HIF-mediated immune response (<xref ref-type="bibr" rid="bib139">Li et al., 2007</xref>).</p></sec><sec id="s1-4-3"><title>Non-heme Fe-dependent monooxygenases</title><p>There are eight identified non-heme Fe-dependent monooxygenases in humans (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) that utilize several different cofactors for iron coordination. Five use (6R)-<italic>L-</italic>erythro-5,6,7,8-tetrahydrobiopterin (BH<sub>4</sub>) as an electron donor and co-substrate, namely tyrosine 3-hydroxylase (TH), tryptophan 5-hydroxylase 1 and 2 (TPH1 and TPH2), phenylalanine-4-hydroxylase (PAH), and alkylglycerol monooxygenase (<xref ref-type="bibr" rid="bib15">Bassan et al., 2003</xref>; <xref ref-type="bibr" rid="bib229">Watschinger et al., 2010</xref>). Similar to 2-OG-dependent dioxygenases, the catalytic iron is coordinated in an octahedral mode for binding and activation of O<sub>2</sub> (<xref ref-type="bibr" rid="bib15">Bassan et al., 2003</xref>).</p><p>TH catalyzes the hydroxylation of L-tyrosine into L-3,4-dihydroxyphenylalanine (L-DOPA) (<xref ref-type="fig" rid="fig3">Figure 3H</xref>), the rate-limiting step in biosynthesis of catecholamines (dopamine, noradrenaline, and adrenaline) (<xref ref-type="bibr" rid="bib192">Rostrup et al., 2008</xref>). The O<sub>2</sub> Km values of TH vary by splice isoform, ranging from 12 to 47 Î¼M across the four splice isoforms as measured in in vitro enzymatic assays (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib192">Rostrup et al., 2008</xref>; <xref ref-type="bibr" rid="bib122">Katz, 1980</xref>). In cellular assays, the activity of TH in PC12 cells was inhibited when O<sub>2</sub> concentration decreased from 139 to 33 Î¼M (<xref ref-type="bibr" rid="bib192">Rostrup et al., 2008</xref>). These measurements suggest that acute hypoxia inhibiting TH could lead to decreased synthesis of catecholamines (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib182">Raghuraman et al., 2012</xref>; <xref ref-type="bibr" rid="bib213">Souvannakitti et al., 2009</xref>). Since dopamine inhibits the chemotransduction of the carotid body in most mammals, suppression of TH activity during acute hypoxia may sensitize the carotid body to hypoxia (<xref ref-type="bibr" rid="bib105">Iturriaga and Alcayaga, 2004</xref>; <xref ref-type="bibr" rid="bib106">Iturriaga et al., 2009</xref>). In contrast to acute hypoxia, chronic or intermittent hypoxia leads to upregulation of TH activity via increased mRNA and/or phosphorylation, countering its decreased enzymatic activity (<xref ref-type="bibr" rid="bib131">Kumar et al., 2003</xref>; <xref ref-type="bibr" rid="bib102">Hui et al., 2003</xref>; <xref ref-type="bibr" rid="bib199">Schnell et al., 2003</xref>).</p><p>PAH and TPH, like TH, are also aromatic amino acid hydroxylases, with similar structures and catalytic mechanisms (<xref ref-type="bibr" rid="bib15">Bassan et al., 2003</xref>). The O<sub>2</sub> Km values of human PAH and rat TPH are reported to be 17 uM and 3.9â12.9 uM in enzymatic assay, respectively (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib122">Katz, 1980</xref>). Their potential for hypoxia sensing and responding needs further exploration.</p></sec><sec id="s1-4-4"><title>Copper-dependent monooxygenases</title><p>Besides iron, copper is also frequently used for O<sub>2</sub> binding and activation by oxidizing enzymes. In humans, there are five identified or speculated monooxygenases that use copper as the catalytic center (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). These enzymes all have two copper ions at their active sites but employ different strategies for O<sub>2</sub> binding and activation, depending on whether the two copper irons are in sufficient proximity to be magnetically coupled (<xref ref-type="bibr" rid="bib56">Decker and Solomon, 2005</xref>; <xref ref-type="bibr" rid="bib138">Lewis and Tolman, 2004</xref>). The coupled binuclear Cu enzymes such as tyrosinase (TYR) use both copper ions for O<sub>2</sub> binding and activation, while the non-coupled binuclear Cu enzymes such as peptidylglycine Î±-amidating monooxygenase (PAM) and dopamine b-monooxygenase (DÎ²M) use only one copper iron (Cu<sub>B</sub>) for this process (<xref ref-type="bibr" rid="bib56">Decker and Solomon, 2005</xref>; <xref ref-type="bibr" rid="bib138">Lewis and Tolman, 2004</xref>). The crystal structure of PAM shows that Cu<sub>B</sub> has a tetrahedral structure, coordinated by two His residues and one Met residues, with the other position for O<sub>2</sub> binding (<xref ref-type="bibr" rid="bib179">Prigge et al., 2004</xref>).</p><p>PAM catalyzes the amidation of C-terminal glycines in peptides (<xref ref-type="fig" rid="fig3">Figure 3I</xref>), a post-translational modification that may affect substrate stability (<xref ref-type="bibr" rid="bib208">Simpson et al., 2015</xref>). PAM activity is progressively inhibited from mild (7% O<sub>2</sub>) to severe (1% O<sub>2</sub>) hypoxia in mammalian cells (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib208">Simpson et al., 2015</xref>). Rat PAM has been shown to have high O<sub>2</sub> Km values (100â550 Î¼M), with this wide range attributable to different degrees of substrate hydrophobicity (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib154">McIntyre et al., 2010</xref>). The best-characterized substrates of PAM are endocrine peptides, for example, chromogranin A (CgA), whose amidation by PAM is profoundly suppressed by hypoxia (<xref ref-type="bibr" rid="bib208">Simpson et al., 2015</xref>; <xref ref-type="bibr" rid="bib156">Merkler, 1994</xref>). However, the functional consequence of this change in amidation remains unclear (<xref ref-type="bibr" rid="bib208">Simpson et al., 2015</xref>).</p></sec><sec id="s1-4-5"><title>Flavin-dependent monooxygenases</title><p>Flavin-dependent monooxygenases utilize a non-covalently bound FAD prosthetic group to activate O<sub>2</sub> (<xref ref-type="bibr" rid="bib167">Palfey and McDonald, 2010</xref>; <xref ref-type="bibr" rid="bib190">Romero et al., 2018</xref>). Unlike above discussed O<sub>2</sub>-dependent enzymes whose reaction rates are saturated above an O<sub>2</sub> threshold, reaction rates for these enzymes are thought to be directly proportional to O<sub>2</sub> concentration. This suggests that decreased O<sub>2</sub> concentration from normoxia to hypoxia could decrease reaction rates of these enzymes (<xref ref-type="bibr" rid="bib151">Massey, 2002</xref>), although it is not clear how their cellular activities are affected by hypoxia.</p></sec></sec><sec id="s1-5"><title>Oxidases</title><p>The oxidase members can be further classified into heme-copper, iron-dependent, copper-dependent, flavin-dependent, and other oxidases based on their catalytic centers (<xref ref-type="table" rid="table2">Table 2</xref>).</p><sec id="s1-5-1"><title>Heme-copper oxidases</title><p>Heme-copper oxidases (HCO) are the terminal oxidases in the aerobic respiratory chain that catalyze the 4-electron reduction of O<sub>2</sub> to water (<xref ref-type="bibr" rid="bib72">Ferguson-Miller and Babcock, 1996</xref>; <xref ref-type="bibr" rid="bib165">Nolfi-Donegan et al., 2020</xref>). In mammals, this is the cytochrome c oxidase (CcO), also known as the Complex IV of the electron transport chain (ETC) in mitochondria (<xref ref-type="bibr" rid="bib165">Nolfi-Donegan et al., 2020</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3âfigure supplement 3</xref>). Mammalian CcOs utilize a hetero-binuclear heme-copper center to activate O<sub>2</sub> (<xref ref-type="bibr" rid="bib234">WikstrÃ¶m et al., 2018</xref>; <xref ref-type="bibr" rid="bib163">Namslauer and Brzezinski, 2004</xref>). O<sub>2</sub> binds with both the heme iron and the copper as a ligand bridge and is then reduced with electrons passed from the reduced form of cytochrome c through other metal prosthetic sites (<xref ref-type="bibr" rid="bib234">WikstrÃ¶m et al., 2018</xref>; <xref ref-type="bibr" rid="bib163">Namslauer and Brzezinski, 2004</xref>; <xref ref-type="bibr" rid="bib9">Aoyama et al., 2009</xref>). Compared with other O<sub>2</sub>-dependent enzymes, CcO has a high O<sub>2</sub> affinity, with O<sub>2</sub> Km values measured to be &lt;1 Î¼M in assays using intact cells or purified mitochondria with sufficient substrates (<xref ref-type="table" rid="table4">Table 4</xref>; <xref ref-type="bibr" rid="bib173">Petersen et al., 1974</xref>; <xref ref-type="bibr" rid="bib27">Bienfait et al., 1975</xref>; <xref ref-type="bibr" rid="bib81">Gnaiger et al., 1995</xref>; <xref ref-type="bibr" rid="bib195">Scandurra and Gnaiger, 2010</xref>). Based solely on its low Km values, CcO would not be expected to act as hypoxia sensors.</p><p>However, CcO appears to be inhibited during hypoxia (1â3% O<sub>2</sub>) (<xref ref-type="bibr" rid="bib41">Chandel et al., 1997</xref>; <xref ref-type="bibr" rid="bib63">Duranteau et al., 1998</xref>). Inhibition of CcO disrupts the ETC, which is related to electron leakage from Complex III and Complex I (<xref ref-type="bibr" rid="bib63">Duranteau et al., 1998</xref>; <xref ref-type="bibr" rid="bib78">Fuhrmann and BrÃ¼ne, 2017</xref>; <xref ref-type="bibr" rid="bib91">Hernansanz-AgustÃ­n et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Guzy et al., 2007</xref>), increased mitochondrial produced ROS (<xref ref-type="bibr" rid="bib63">Duranteau et al., 1998</xref>; <xref ref-type="bibr" rid="bib78">Fuhrmann and BrÃ¼ne, 2017</xref>; <xref ref-type="bibr" rid="bib91">Hernansanz-AgustÃ­n et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Guzy et al., 2007</xref>; <xref ref-type="bibr" rid="bib42">Chandel et al., 2000</xref>), and altered downstream HIF, PI3K/Akt, AMPK, and MAPK signaling (<xref ref-type="bibr" rid="bib78">Fuhrmann and BrÃ¼ne, 2017</xref>; <xref ref-type="bibr" rid="bib86">Guzy et al., 2007</xref>; <xref ref-type="bibr" rid="bib42">Chandel et al., 2000</xref>; <xref ref-type="bibr" rid="bib33">Brand, 2016</xref>; <xref ref-type="bibr" rid="bib123">Kim et al., 2018</xref>; <xref ref-type="bibr" rid="bib69">Emerling et al., 2005</xref>; <xref ref-type="bibr" rid="bib130">Kulisz et al., 2002</xref>; <xref ref-type="bibr" rid="bib70">Emerling et al., 2009</xref>). Thus, despite CcOâs low Km values it has hypoxia sensor-like properties. How CcOâs activities are regulated during hypoxia remains to be elucidated.</p></sec><sec id="s1-5-2"><title>Iron-dependent oxidases</title><p>Iron-dependent oxidases include the desaturases and ferroxidases (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; <xref ref-type="bibr" rid="bib115">Jasniewski and Que, 2018</xref>). The structures and catalytic mechanisms are relatively poorly characterized, but the studied ones all have two Fe(II) ions, coordinated by five His/Glu residues from the enzymes, that bind and active O<sub>2</sub> (<xref ref-type="bibr" rid="bib115">Jasniewski and Que, 2018</xref>; <xref ref-type="bibr" rid="bib92">Hess et al., 2010</xref>; <xref ref-type="bibr" rid="bib23">Bertini et al., 2012</xref>).</p><p>Stearoyl-CoA desaturase 1 (SCD1) catalyzes the formation of the monounsaturated fatty acid oleic acid from the saturated fatty acid stearic acid (<xref ref-type="fig" rid="fig3">Figure 3J</xref>; <xref ref-type="bibr" rid="bib170">Paton and Ntambi, 2009</xref>), thereby playing an important role in lipid metabolism, membrane fluidity, and cell integrity (<xref ref-type="bibr" rid="bib170">Paton and Ntambi, 2009</xref>), as increased fatty acid saturation could result in lipotoxicity and cell death (<xref ref-type="bibr" rid="bib92">Hess et al., 2010</xref>; <xref ref-type="bibr" rid="bib227">Wang et al., 2006</xref>; <xref ref-type="bibr" rid="bib82">Green and Olson, 2011</xref>). Inhibition of SCD1 activates the unfolded protein response (UPR) through ER stress (<xref ref-type="bibr" rid="bib82">Green and Olson, 2011</xref>; <xref ref-type="bibr" rid="bib224">Volmer et al., 2013</xref>). Although the O<sub>2</sub> affinity of SCD1 is unknown, hypoxia (1% O<sub>2</sub>) impairs the cellular activity of SCD1 in A549 and HeLa cells, increasing the saturated fatty acid ratio and thereby altering the cellular lipid composition (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib121">Kamphorst et al., 2013</xref>). SCD1 may well be a hypoxia sensor if the decrease in its activity is directly due to reduced O<sub>2</sub> concentration.</p></sec><sec id="s1-5-3"><title>Copper-dependent oxidases</title><p>Copper-dependent oxidases include the copper amine oxidases (CAOs) and lysyl oxidases (LOXs), both of which catalyze oxidative deamination of amines to the corresponding aldehydes, also producing hydrogen peroxide and ammonia (<xref ref-type="fig" rid="fig3">Figure 3K</xref>; <xref ref-type="bibr" rid="bib73">Finney et al., 2014</xref>). Human CAO member AOC3 is reported to have an O<sub>2</sub> Km ~38 Î¼M in enzymatic assays (<xref ref-type="table" rid="table4">Table 4</xref>), and its cellular activity in adipocyte lysate is inhibited by hypoxia in a HIF-independent manner (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib204">Shen et al., 2012</xref>; <xref ref-type="bibr" rid="bib185">RepessÃ© et al., 2015</xref>; <xref ref-type="bibr" rid="bib8">AndrÃ©s et al., 2001</xref>; <xref ref-type="bibr" rid="bib161">Morris et al., 1997</xref>). The cellular function of AOC3 is not clear since its endogenous substrates are unknown, although in vitro kinetics studies suggest dopamine and cysteamine as potential substrates (<xref ref-type="bibr" rid="bib204">Shen et al., 2012</xref>).</p></sec><sec id="s1-5-4"><title>Flavin-dependent oxidases</title><p>Similar to flavin-dependent monooxygenases, this group of oxidases utilize either FAD or FMN for the activation of O<sub>2</sub> and have reaction rates proportional to the O<sub>2</sub> concentration (<xref ref-type="bibr" rid="bib151">Massey, 2002</xref>). The &gt;20 members of this group (<xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) in humans have substrates ranging from small molecules (e.g., fatty acids and amino acids) to protein residues (<xref ref-type="bibr" rid="bib190">Romero et al., 2018</xref>). Their role in hypoxia sensing and responding is unknown.</p></sec><sec id="s1-5-5"><title>Other oxidases</title><p>Several other oxidases remain poorly characterized (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The dual oxidases DUOX1 and DUOX2 catalyze the formation of H<sub>2</sub>O<sub>2</sub> from O<sub>2</sub> molecules with electrons provided by NADPH (<xref ref-type="bibr" rid="bib61">DonkÃ³ et al., 2005</xref>). In HIF1-deficient <italic>Caenorhabditis elegans</italic>, hypoxia-induced extracellular matrix (ECM) remodeling could be phenocopied by inactivation of BLI-3, the ortholog of human DUOXs. This suggests a potential role of BLI-3 as a hypoxia sensor independent from the HIF pathway (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib225">Vozdek et al., 2018</xref>) and raises the possibility that human DUOXs also sense and respond to hypoxia in an HIF-independent manner.</p></sec><sec id="s1-5-6"><title>ODE as hypoxia sensors in other organisms</title><p>ODEs are evolutionary ancient. The major emergence of ODEs occurred at the separation of terrestrial and marine bacteria, coinciding with the emergence of oxygenic photosynthesis ~3.1 billion years ago (<xref ref-type="bibr" rid="bib112">JabÅoÅska and Tawfik, 2021</xref>). Given the importance of hypoxia sensing, the evolutionary conservation of the HIF pathway across metazoans comes as no surprise. HIF1Î± and PHD2 (EGLN1 in <italic>C. elegans</italic>) emerged early in evolution, whereas additional HIFÎ± and PHD isoforms emerged later in more complex organisms as context-dependent and fine-tuned hypoxia sensing became necessary (<xref ref-type="bibr" rid="bib218">Taylor and McElwain, 2010</xref>).</p><p>What about plants? Plants have a hypoxia sensor, ADO, shared with metazoans. ADO is a thiol dioxygenase that modulates Arg/N-degron pathways and was found to be a sensor in both humans and <italic>Arabidopsis thaliana</italic> (<xref ref-type="bibr" rid="bib152">Masson et al., 2019</xref>). Besides ADO, plant cysteine oxidases (PCOs), homologs of ADO, also function as hypoxia sensors, regulating Arg/N-degron pathways in plants (<xref ref-type="bibr" rid="bib232">White et al., 2017</xref>; <xref ref-type="bibr" rid="bib231">Weits et al., 2014</xref>; <xref ref-type="bibr" rid="bib233">White et al., 2018</xref>).</p><p>What about single-celled organisms? In fission yeast, two hypoxia-sensing mechanisms exist that converge on activation of Sre1 (the yeast SREBP homolog), a transcription factor that triggers a downstream hypoxia response. One mechanism is that hypoxia inhibits multiple ODEs that are required for sterol synthesis, and this suppression of sterol synthesis stimulates the cleavage (and hence activation) of Sre1 (<xref ref-type="bibr" rid="bib100">Hughes et al., 2005</xref>). The other mechanism is that hypoxia inhibits Ofd1, a yeast prolyl 4-hydroxylase-like 2-OG-dependent dioxygenase. Similar to how PHD inhibition allows HIF1Î± stabilization, Ofd1 inhibition allows Sre1 stabilization (<xref ref-type="bibr" rid="bib101">Hughes and Espenshade, 2008</xref>). Protozoa also have prolyl hydroxylases that regulate the stability of S-phase kinase-associated protein 1 (Skp1) and alter the cell cycle (<xref ref-type="bibr" rid="bib243">Xu et al., 2012</xref>).</p><p>What about prokaryotes? Prokaryotes also sense O<sub>2</sub>, although they do not appear to use ODEs as sensors. In nitrogen-fixing bacteria (<italic>Rhizobium meliloti</italic>), changes in O<sub>2</sub> levels impact the kinase activity of FixL, which phosphorylates the transcription factor FixJ to regulate the expression of nitrogen-fixing genes (<xref ref-type="bibr" rid="bib160">Monson et al., 1995</xref>; <xref ref-type="bibr" rid="bib5">Agron et al., 1994</xref>). In this case, O<sub>2</sub> actually acts as an allosteric binding cofactor that leads to a conformation change of FixL (<xref ref-type="bibr" rid="bib160">Monson et al., 1995</xref>). Hence, FixL directly interacts with O<sub>2</sub> molecules, but O<sub>2</sub> is not used as a substrate. In most of all of the above, although the details may differ, the key criteria for a hypoxia sensor are met: (1) direct interaction with O<sub>2</sub>, (2) utilization of O<sub>2</sub> as a substrate except in the case of FixL, and (3) causing a downstream response.</p></sec></sec><sec id="s1-6"><title>Connection of O<sub>2</sub>-dependent enzymes to hypoxia adaptations and diseases</title><p>Hypoxia is related to many diseases. Decreased O<sub>2</sub> at high altitudes can lead to systemic, organismal-level hypoxia and induce acute and chronic mountain sickness (AMC, CMC) (<xref ref-type="bibr" rid="bib186">Roach and Hackett, 2001</xref>; <xref ref-type="bibr" rid="bib223">Villafuerte and Corante, 2016</xref>). Systemic hypoxia is also seen in some respiratory diseases and anemic conditions that have disruption in O<sub>2</sub> uptake or transport (<xref ref-type="bibr" rid="bib137">Lee et al., 2019</xref>). Ischemia resulting from the blockage of blood flow leads to cell death and failure of affected tissues, most notably heart (in myocardial infarction) and brain (in ischemic stroke). (<xref ref-type="bibr" rid="bib137">Lee et al., 2019</xref>) However, other tissues can also be affected, including the intestine, kidney, and skeletal muscle.</p><p>As previously mentioned, many O<sub>2</sub>-dependent enzymes are regulated at a transcriptional, translational, and/or post-translational level in response to hypoxia. Depending on the specific downstream responses and cellular context, a change in enzymatic activity may confer protection or further injury in hypoxia. One of the greatest challenges in understanding the effects of hypoxia is discerning the effects of adaptation and hypoxia tolerance versus maladaptation and hypoxia-mediated tissue injury. Injury and adaptation almost always overlap, either in time, development, or tissue domains.</p><p>We conclude below with two scenarios illustrating the role of O<sub>2</sub>-dependent enzymes in hypoxia adaptation or diseases: (1) positively selected genetic adaptations associated with O<sub>2</sub>-dependent enzymes in high-altitude populations; and (2) mutations in genes targeted by drugs associated with O<sub>2</sub>-dependent enzymes for hypoxia-related diseases.</p><sec id="s1-6-1"><title>O<sub>2</sub>-dependent enzymes in hypoxia adaptations of high-altitude populations</title><p>Tibetan, Andean, and Ethiopian populations reside at altitudes above 3500 m with a decreased O<sub>2</sub> pressure (&lt;60% of sea level) due to hypobaric hypoxia. Distinct genetic adaptations and physiological characteristics have developed within each population to promote survival at altitude (<xref ref-type="bibr" rid="bib20">Beall, 2006</xref>). These three groups of humans have resided at high altitude for different lengths of time: Andeans for 10,000â15,000 years (<xref ref-type="bibr" rid="bib6">Aldenderfer, 2003</xref>), Tibetans for over 30,000 years (<xref ref-type="bibr" rid="bib180">Qi et al., 2013</xref>), and Ethiopians for even longer (<xref ref-type="bibr" rid="bib7">Alkorta-Aranburu et al., 2012</xref>).</p><p>In lowlanders, one of the major adaptations upon exposure to hypoxia is increased red blood cell production (erythropoiesis) (<xref ref-type="bibr" rid="bib238">Windsor and Rodway, 2007</xref>). Acutely, the increased hemoglobin helps compensate for decreased blood pO<sub>2</sub>, but in the long run, this increases blood viscosity and thereby increases risk of blood clots and ischemia (<xref ref-type="bibr" rid="bib32">Braekkan et al., 2010</xref>; <xref ref-type="bibr" rid="bib169">Parati et al., 2018</xref>). Erythropoiesis during exposure to hypoxia is mainly regulated by EPO, a downstream target of HIF that regulates erythropoiesis by activating EPO receptors on erythroid progenitors in the bone marrow (<xref ref-type="bibr" rid="bib87">Haase, 2013</xref>).</p><p>Do Tibetan highlanders maintain higher levels of hemoglobin compared to populations living at sea level? Somewhat surprisingly, their hemoglobin levels are actually similar to those of lowlanders (<xref ref-type="bibr" rid="bib18">Beall et al., 1998</xref>; <xref ref-type="bibr" rid="bib17">Beall et al., 1997</xref>), but they have increased vasodilation and blood flow to compensate for O<sub>2</sub> delivery to tissues. Genetic studies have identified variants under positive selection at the <italic>EGLN1 (PHD2</italic>) and <italic>EPAS1 (HIF2A</italic>) loci (<xref ref-type="bibr" rid="bib87">Haase, 2013</xref>; <xref ref-type="bibr" rid="bib143">Lorenzo et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Bigham et al., 2010</xref>; <xref ref-type="bibr" rid="bib246">Yi et al., 2010</xref>; <xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>; <xref ref-type="bibr" rid="bib242">Xu et al., 2011</xref>; <xref ref-type="bibr" rid="bib245">Yang et al., 2017</xref>; <xref ref-type="bibr" rid="bib171">Peng et al., 2011</xref>; <xref ref-type="bibr" rid="bib240">Wuren et al., 2014</xref>). One variant of EGLN1 exhibits a lower O<sub>2</sub> Km value, which enhances HIF degradation under hypoxia and contributes to blunting of EPO-mediated erythropoiesis (<xref ref-type="bibr" rid="bib143">Lorenzo et al., 2014</xref>).</p><p>Interestingly, positive selection is also observed at the <italic>EGLN1</italic> and <italic>EGLN2</italic> loci in Andean populations, but unlike Tibetans, Andeans have higher hemoglobin levels than lowlanders (<xref ref-type="bibr" rid="bib18">Beall et al., 1998</xref>; <xref ref-type="bibr" rid="bib29">Bigham et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Bigham et al., 2009</xref>). Genetic studies suggest that Andeans cope with the risks of augmented erythropoiesis by enhancing cardiovascular function associated with positive selection in <italic>BRINP3</italic>, <italic>NOS2</italic>, and <italic>TBX5</italic> (<xref ref-type="bibr" rid="bib50">Crawford et al., 2017</xref>). Among these, NOS2, also known as iNOS (discussed above in the sensor section), synthesizes NO as a gas signaling molecule to modulate vascular tone upon induction of this gene (<xref ref-type="bibr" rid="bib159">Moncada and Higgs, 1991</xref>; <xref ref-type="bibr" rid="bib188">Robinson et al., 2011</xref>). How these gene variants mechanistically lead to adaptation awaits further study.</p><p>Ethiopians have a distinct adaptation pattern compared with Tibetans and Andeans. Some studies suggest that they maintain both normal blood saturation and hemoglobin concentration (<xref ref-type="bibr" rid="bib19">Beall et al., 2002</xref>). A genome-wide scan identified HIF pathway-related genes, <italic>ARNT2</italic> and <italic>THRB</italic>, as candidate genes for positive selection with potential roles in the physiological response to hypoxia (<xref ref-type="bibr" rid="bib197">Scheinfeldt et al., 2012</xref>).</p><p>Apart from these relatively well-studied HIF pathway-related genes, there are multiple other genes harboring variants associated with positive selection in these three highlander populations (<xref ref-type="table" rid="table6">Table 6</xref>). Notably, these include other known hypoxia sensors, such as <italic>HIF1AN</italic> and <italic>KDM5A</italic>, as well as potential hypoxia sensors, including <italic>KDM4A</italic>, <italic>HMOX4</italic>, <italic>SCD,</italic> and <italic>DUOX2</italic>. It will be interesting to further explore how these positively selected variants enhance hypoxia adaptation of highlanders.</p><table-wrap id="table6" position="float"><label>Table 6.</label><caption><title>O<sub>2</sub>-dependent enzymes encoded by genes associated with positive selection in different high-altitude populations.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Population</th><th align="left" valign="bottom">Genes<xref ref-type="table-fn" rid="table6fn1">*</xref></th></tr></thead><tbody><tr><td align="left" valign="bottom">Tibetan</td><td align="left" valign="bottom">EGLN1 (<xref ref-type="bibr" rid="bib143">Lorenzo et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Bigham et al., 2010</xref>; <xref ref-type="bibr" rid="bib246">Yi et al., 2010</xref>; <xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>; <xref ref-type="bibr" rid="bib242">Xu et al., 2011</xref>; <xref ref-type="bibr" rid="bib245">Yang et al., 2017</xref>; <xref ref-type="bibr" rid="bib171">Peng et al., 2011</xref>; <xref ref-type="bibr" rid="bib240">Wuren et al., 2014</xref>), CYP2E1 (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), HMOX2 (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>; <xref ref-type="bibr" rid="bib171">Peng et al., 2011</xref>; <xref ref-type="bibr" rid="bib240">Wuren et al., 2014</xref>), CYP17A1 (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>; <xref ref-type="bibr" rid="bib240">Wuren et al., 2014</xref>), SCD (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), HIF1AN (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), SC5D (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), KDM5A (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), HPD (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), DOHH (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), XDH (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), CYP20A1 (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), TMEM189 (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), KDM4A (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>), PAOX (<xref ref-type="bibr" rid="bib207">Simonson et al., 2010</xref>)</td></tr><tr><td align="left" valign="bottom">Andean</td><td align="left" valign="bottom">EGLN1 (<xref ref-type="bibr" rid="bib29">Bigham et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Bigham et al., 2009</xref>), EGLN2 (<xref ref-type="bibr" rid="bib28">Bigham et al., 2009</xref>), NOS1 (<xref ref-type="bibr" rid="bib28">Bigham et al., 2009</xref>), NOS2 (<xref ref-type="bibr" rid="bib29">Bigham et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Bigham et al., 2009</xref>; <xref ref-type="bibr" rid="bib50">Crawford et al., 2017</xref>), DUOX2 (<xref ref-type="bibr" rid="bib113">Jacovas et al., 2018</xref>), CYP39A1 (<xref ref-type="bibr" rid="bib66">Eichstaedt et al., 2014</xref>), KDM2A (<xref ref-type="bibr" rid="bib66">Eichstaedt et al., 2014</xref>), KMO (<xref ref-type="bibr" rid="bib66">Eichstaedt et al., 2014</xref>), PLOD3 (<xref ref-type="bibr" rid="bib66">Eichstaedt et al., 2014</xref>), P3H3 (<xref ref-type="bibr" rid="bib66">Eichstaedt et al., 2014</xref>), CPOX (<xref ref-type="bibr" rid="bib66">Eichstaedt et al., 2014</xref>), CYP24A1 (<xref ref-type="bibr" rid="bib66">Eichstaedt et al., 2014</xref>)</td></tr><tr><td align="left" valign="bottom">Ethiopian</td><td align="left" valign="bottom">PCYOX1 (<xref ref-type="bibr" rid="bib197">Scheinfeldt et al., 2012</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="table6fn1"><label>*</label><p>Known hypoxia sensors are highlighted in red.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s1-6-2"><title>Pathogenic mutations and drug targets within O<sub>2</sub>-dependent enzymes for hypoxia-related diseases</title><p>Erythrocytosis commonly results from exposure to hypoxia. Genetic mutations in the pathway regulating erythropoiesis can also cause pathogenic erythrocytosis with excessive blood viscosity. Such pathogenic mutations have been found in genes, including (1) <italic>VHL</italic>, <italic>EGLN1</italic> (<italic>PHD2</italic>), and <italic>EPAS1</italic> (<italic>HIF2A</italic>) that affect EPO production, (2) <italic>EPOR</italic> and its regulator <italic>JAK2</italic> that affect erythroid progenitor maturation, and (3) hemoglobin subunits <italic>HBA</italic> and <italic>HBB</italic> that affect O<sub>2</sub> delivery and tissue pO<sub>2</sub> (<xref ref-type="bibr" rid="bib21">Bento, 2018</xref>). Specifically, for <italic>EGLN1</italic>, more than 10 variants have been associated with erythrocytosis onset (<xref ref-type="bibr" rid="bib79">Gardie et al., 2014</xref>). For example, one such mutation (P317R) has significantly decreased enzymatic activity (<xref ref-type="bibr" rid="bib172">Percy et al., 2006</xref>). No mutations associated with pathogenic erythrocytosis have been identified in <italic>EGLN2</italic> and <italic>EGLN3</italic>, consistent with the notion that <italic>EGLN1/PHD2</italic> is the major isoform involved in HIF-mediated EPO upregulation.</p><p>Conversely, chronic kidney diseases (CKDs) lead to diminished EPO production and anemia. In adults, EPO is mainly produced by erythropoietin-producing cells (EPCs) in the kidney (<xref ref-type="bibr" rid="bib87">Haase, 2013</xref>). The dysfunction of EPCs during CKDs results in EPO deficiency and is a key factor leading to associated anemia (<xref ref-type="bibr" rid="bib128">Koury and Haase, 2015</xref>). Injectable erythropoiesis-stimulating agents (ESAs), such as recombinant human erythropoietin (rhEPO), are a cornerstone of CKD treatment (<xref ref-type="bibr" rid="bib209">Singh et al., 2006</xref>; <xref ref-type="bibr" rid="bib174">Pfeffer et al., 2009</xref>; <xref ref-type="bibr" rid="bib177">PortolÃ©s et al., 2021</xref>). In recent years, PHD inhibitors have been developed as an alternative route to HIF stabilization and subsequent EPO production (<xref ref-type="bibr" rid="bib177">PortolÃ©s et al., 2021</xref>; <xref ref-type="bibr" rid="bib85">Gupta and Wish, 2017</xref>). Unlike rhEPO, PHD inhibitors ameliorate not only EPO deficiency but also inflammation and altered iron metabolism in CKD, both of which are regulated by HIF (<xref ref-type="bibr" rid="bib128">Koury and Haase, 2015</xref>; <xref ref-type="bibr" rid="bib177">PortolÃ©s et al., 2021</xref>). Currently, four PHD inhibitors (Roxadustat, Vadadustat, Daprodustat, and Molidustat) have entered or completed phase III clinical trials for treatment of the anemia of CKD (<xref ref-type="bibr" rid="bib177">PortolÃ©s et al., 2021</xref>). Of them, Roxadustat and Daprodustat have been approved for use in Japan and/or China (<xref ref-type="bibr" rid="bib58">Dhillon, 2019</xref>; <xref ref-type="bibr" rid="bib59">Dhillon, 2020</xref>).</p></sec><sec id="s1-6-3"><title>Open questions for discovering hypoxia sensors within the ODE members</title><p>Although we have an in-depth understanding of a small handful of O<sub>2</sub> sensors, the potential landscape of hypoxia sensing in humans remains largely uncharted. Even once an ODE is confirmed to be a hypoxia sensor, much remains to be investigated.</p></sec><sec id="s1-6-4"><title>At the enzymatic level</title><p>Most reported O<sub>2</sub> Km values for ODEs are based on in vitro testing of the enzyme. However, in vivo, O<sub>2</sub> Km depends on (1) the substrate (e.g., as discussed for ALOX12), and (2) the regulation of the ODE by other proteins and cofactors (e.g., as discussed for HO-2). Regarding (1), for a given ODE, what are its O<sub>2</sub> affinities when catalyzing reactions using its various endogenous substrates in vivo? Answering this question requires identifying the in vivo substrates and then measuring O<sub>2</sub> Km for each substrate. Regarding (2), how is the O<sub>2</sub> Km of the ODE affected by modifying factors (e.g., PTMs and cofactor binding)? Answering this question requires identifying the modifying factors and then measuring O<sub>2</sub> Km in the appropriate cellular contexts.</p></sec><sec id="s1-6-5"><title>At the cellular level</title><p>Most studies of ODEs have focused on individual pathways directly responsible for downstream effects. However, these pathways do not act in isolation but rather as part of a network. Each ODE could have roles in multiple downstream response pathways, feedback loops, and cross-talk with other pathways. Ultimately, a systems-level understanding is needed to capture the complexity of O<sub>2</sub> sensing within the cell.</p></sec><sec id="s1-6-6"><title>At the tissue level</title><p>Currently, most studies of ODEs use cell models in which the O<sub>2</sub> level is set to a single level controlled experimentally. However, this ignores the fact that from tissue-to-tissue, O<sub>2</sub> levels vary substantially even at baseline. Furthermore, when an organism is exposed to hypoxic stress, the O<sub>2</sub> levels from tissue-to-tissue and within a tissue can vary even further due to tissue-level changes such as vasodilation. This raises the question: what is the tissue specificity (and/or cell type specificity) of hypoxia sensors under basal and stressed conditions? An intriguing possibility is that each tissue might have a unique set of ODEs in order to sense and respond to the ongoing fluctuations in O<sub>2</sub> concentration during maintenance of homeostasis, in accordance with tissue-specific O<sub>2</sub> levels.</p></sec><sec id="s1-6-7"><title>At the organismal level</title><p>Although an impressive diversity of molecular O<sub>2</sub> sensors has been identified, their role in organismal-level adaptations to hypoxia remains unexplored territory. By far the best studied system for hypoxia sensing and response at the organismal level is PHD-HIF-pVHL pathway. Its role in improving O<sub>2</sub> transport by increasing EPO synthesis by the kidney is well understood and has been the subject of many reviews (<xref ref-type="bibr" rid="bib87">Haase, 2013</xref>; <xref ref-type="bibr" rid="bib164">Nangaku and Eckardt, 2007</xref>).</p><p>There are numerous other adaptations to hypoxia that are much less well understood than HIF adaptations. An important one is the regulation of breathing. The mystery in this fundamental adaptation is the basis for gradually increasing breathing volume with time at altitude, such that blood O<sub>2</sub> level is restored toward normal. This respiratory adaptation has several different time domains, and each likely has a unique set of sensors and effectors. O<sub>2</sub> sensing at the carotid body is the first part of this response, and carotid body chemoreceptors have been the target of numerous attempts to identify molecular O<sub>2</sub> sensors and the transduction pathways involved (<xref ref-type="bibr" rid="bib142">LÃ³pez-Barneo et al., 2008</xref>). O<sub>2</sub>-sensitive potassium channels, redox sensors, and others have been proposed. Final agreement on the nature of the O<sub>2</sub> sensor remains surprisingly elusive, perhaps reflecting that a diversity of O<sub>2</sub> sensors take part in shaping the breathing response, not just one.</p><p>One of the challenges in linking molecular O<sub>2</sub> sensors to responses at the organismal level is that organismal-level responses and adaptations are diverse. Vertebrate animals vary enormously on their tolerance of O<sub>2</sub> deprivation. Some vertebrates, such as the crucian carp and the Western painted turtle, can survive for months without O<sub>2</sub> (<xref ref-type="bibr" rid="bib26">Bickler and Buck, 2007</xref>). These animals exceed the hypoxia tolerance of humans by a factor of at least 10,000 (<xref ref-type="bibr" rid="bib26">Bickler and Buck, 2007</xref>). The molecular switches that orchestrate this impressive capability remain poorly defined. Certainly, if one is searching for molecular O<sub>2</sub>sensors, animals such as the carp and turtle would be fertile ground.</p></sec><sec id="s1-6-8"><title>At the developmental level</title><p>Development as a model for changing O<sub>2</sub> sensing and response has been little explored. Changes in O<sub>2</sub> during development can be dramatic: the intrauterine environment of placental gas exchange has been likened to that of ascent of Mt. Everest, with a rapid increase in O<sub>2</sub> upon aerial respiration at birth (<xref ref-type="bibr" rid="bib14">Barcroft, 1946</xref>; <xref ref-type="bibr" rid="bib147">Martin et al., 2010</xref>). The changes in O<sub>2</sub> availability may signal crucial changes in synaptic physiology in the brain. How O<sub>2</sub> sensing is regulated throughout development in accordance with changes in O<sub>2</sub> levels is an important question to be answered.</p></sec></sec><sec id="s1-7"><title>Summary</title><p>Aerobic organisms have evolved mechanisms to sense and respond to changes in O<sub>2</sub> levels. O<sub>2</sub> participates in hundreds of biochemical reactions regulating diverse, essential cellular processes. The enzymes responsible for these reactions directly interact with O<sub>2</sub> and may function as hypoxia sensors by transducing the signal of low O<sub>2</sub> via a decrease in enzymatic activity (rate or product yield). Here, we summarized and discussed the known and potential hypoxia sensors within each subcategory of O<sub>2</sub>-dependent enzymes in human, expanding from the well-known PHD enzymes, to the more recently identified sensors within the KDM family, to other enzymes with emerging roles in hypoxia sensing. We also discussed O<sub>2</sub>-dependent enzymes involved in hypoxia-related evolutionary adaptations and diseases, highlighting their relevance beyond chemical reactions. Much remains to be explored for most O<sub>2</sub>-dependent enzymes and roles in hypoxia. Are there new hypoxia sensors still to be discovered within O<sub>2</sub>-dependent enzymes? How do various hypoxia sensors coordinate with each other to regulate downstream cellular responses? What is the mechanism for each tissue to set its own hypoxia sensing threshold based on the specific physiological pO<sub>2</sub>? Furthermore, how can these discoveries help with hypoxia adaptation and disease treatment? All these questions await future research.</p></sec></sec></body><back><sec sec-type="additional-information" id="s2"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Funding acquisition, Visualization, Writing - original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con2"><p>Funding acquisition, Writing â review and editing</p></fn><fn fn-type="con" id="con3"><p>Writing â review and editing</p></fn><fn fn-type="con" id="con4"><p>Writing â review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing â review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s3"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Detailed information of 221 oxygen-dependent enzymes in human.</title></caption><media xlink:href="elife-87705-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><ack id="ack"><title>Acknowledgements</title><p>We gratefully acknowledge support from the DARPA Panacea program (HR0011-19-2-0018) to LFW; the Human Frontiers Science Program (LT000908/2020-C) to LL; and the National Institute on Aging (R38AG070171) and the National Institute of Mental Health (R25MH0602) to SQS. We thank Heinz Hammerlindl, Sabrina Hammerlindl, Feng Bao, and all members of the Altschuler &amp; Wu labs for their input.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Omar</surname><given-names>MM</given-names></name><name><surname>Loaiza</surname><given-names>A</given-names></name><name><surname>Hontzeas</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Reaction mechanisms of mononuclear non-heme iron oxygenases</article-title><source>Chemical Reviews</source><volume>105</volume><fpage>2227</fpage><lpage>2252</lpage><pub-id pub-id-type="doi">10.1021/cr040653o</pub-id><pub-id pub-id-type="pmid">15941213</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Soud</surname><given-names>HM</given-names></name><name><surname>Rousseau</surname><given-names>DL</given-names></name><name><surname>Stuehr</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension</article-title><source>Journal of Biological Chemistry</source><volume>271</volume><fpage>32515</fpage><lpage>32518</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.51.32515</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Soud</surname><given-names>HM</given-names></name><name><surname>Ichimori</surname><given-names>K</given-names></name><name><surname>Presta</surname><given-names>A</given-names></name><name><surname>Stuehr</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Electron transfer, oxygen binding, and nitric oxide feedback inhibition in endothelial nitric-oxide synthase</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>17349</fpage><lpage>17357</lpage><pub-id pub-id-type="doi">10.1074/jbc.M000050200</pub-id><pub-id pub-id-type="pmid">10749853</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Soud</surname><given-names>HM</given-names></name><name><surname>Ichimori</surname><given-names>K</given-names></name><name><surname>Nakazawa</surname><given-names>H</given-names></name><name><surname>Stuehr</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulation of inducible nitric oxide synthase by self-generated NO</article-title><source>Biochemistry</source><volume>40</volume><fpage>6876</fpage><lpage>6881</lpage><pub-id pub-id-type="doi">10.1021/bi010066m</pub-id><pub-id pub-id-type="pmid">11389602</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agron</surname><given-names>PG</given-names></name><name><surname>Monson</surname><given-names>EK</given-names></name><name><surname>Ditta</surname><given-names>GS</given-names></name><name><surname>Helinski</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Oxygen regulation of expression of nitrogen fixation genes in Rhizobium meliloti</article-title><source>Research in Microbiology</source><volume>145</volume><fpage>454</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/0923-2508(94)90094-9</pub-id><pub-id pub-id-type="pmid">7855432</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldenderfer</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Moving up in the world: archaeologists seek to understand how and when people came to occupy the Andean and Tibetan plateaus</article-title><source>American Scientist</source><volume>91</volume><fpage>542</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1511/2003.6.542</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkorta-Aranburu</surname><given-names>G</given-names></name><name><surname>Beall</surname><given-names>CM</given-names></name><name><surname>Witonsky</surname><given-names>DB</given-names></name><name><surname>Gebremedhin</surname><given-names>A</given-names></name><name><surname>Pritchard</surname><given-names>JK</given-names></name><name><surname>Di Rienzo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The genetic architecture of adaptations to high altitude in Ethiopia</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1003110</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003110</pub-id><pub-id pub-id-type="pmid">23236293</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AndrÃ©s</surname><given-names>N</given-names></name><name><surname>Lizcano</surname><given-names>JM</given-names></name><name><surname>RodrÃ­guez</surname><given-names>MJ</given-names></name><name><surname>Romera</surname><given-names>M</given-names></name><name><surname>Unzeta</surname><given-names>M</given-names></name><name><surname>Mahy</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase</article-title><source>The Journal of Histochemistry and Cytochemistry</source><volume>49</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1177/002215540104900208</pub-id><pub-id pub-id-type="pmid">11156689</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyama</surname><given-names>H</given-names></name><name><surname>Muramoto</surname><given-names>K</given-names></name><name><surname>Shinzawa-Itoh</surname><given-names>K</given-names></name><name><surname>Hirata</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>E</given-names></name><name><surname>Tsukihara</surname><given-names>T</given-names></name><name><surname>Ogura</surname><given-names>T</given-names></name><name><surname>Yoshikawa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A peroxide bridge between Fe and Cu ions in the O2 reduction site of fully oxidized cytochrome c oxidase could suppress the proton pump</article-title><source>PNAS</source><volume>106</volume><fpage>2165</fpage><lpage>2169</lpage><pub-id pub-id-type="doi">10.1073/pnas.0806391106</pub-id><pub-id pub-id-type="pmid">19164527</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appelhoff</surname><given-names>RJ</given-names></name><name><surname>Tian</surname><given-names>Y-M</given-names></name><name><surname>Raval</surname><given-names>RR</given-names></name><name><surname>Turley</surname><given-names>H</given-names></name><name><surname>Harris</surname><given-names>AL</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Gleadle</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>38458</fpage><lpage>38465</lpage><pub-id pub-id-type="doi">10.1074/jbc.M406026200</pub-id><pub-id pub-id-type="pmid">15247232</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AragonÃ©s</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Van Geyte</surname><given-names>K</given-names></name><name><surname>Fraisl</surname><given-names>P</given-names></name><name><surname>Dresselaers</surname><given-names>T</given-names></name><name><surname>Mazzone</surname><given-names>M</given-names></name><name><surname>Dirkx</surname><given-names>R</given-names></name><name><surname>Zacchigna</surname><given-names>S</given-names></name><name><surname>Lemieux</surname><given-names>H</given-names></name><name><surname>Jeoung</surname><given-names>NH</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name><name><surname>Bishop</surname><given-names>T</given-names></name><name><surname>Lafuste</surname><given-names>P</given-names></name><name><surname>Diez-Juan</surname><given-names>A</given-names></name><name><surname>Harten</surname><given-names>SK</given-names></name><name><surname>Van Noten</surname><given-names>P</given-names></name><name><surname>De Bock</surname><given-names>K</given-names></name><name><surname>Willam</surname><given-names>C</given-names></name><name><surname>Tjwa</surname><given-names>M</given-names></name><name><surname>Grosfeld</surname><given-names>A</given-names></name><name><surname>Navet</surname><given-names>R</given-names></name><name><surname>Moons</surname><given-names>L</given-names></name><name><surname>Vandendriessche</surname><given-names>T</given-names></name><name><surname>Deroose</surname><given-names>C</given-names></name><name><surname>Wijeyekoon</surname><given-names>B</given-names></name><name><surname>Nuyts</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>B</given-names></name><name><surname>Silasi-Mansat</surname><given-names>R</given-names></name><name><surname>Lupu</surname><given-names>F</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Pugh</surname><given-names>C</given-names></name><name><surname>Salmon</surname><given-names>P</given-names></name><name><surname>Mortelmans</surname><given-names>L</given-names></name><name><surname>Gallez</surname><given-names>B</given-names></name><name><surname>Gorus</surname><given-names>F</given-names></name><name><surname>Buyse</surname><given-names>J</given-names></name><name><surname>Sluse</surname><given-names>F</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name><name><surname>Gnaiger</surname><given-names>E</given-names></name><name><surname>Hespel</surname><given-names>P</given-names></name><name><surname>Van Hecke</surname><given-names>P</given-names></name><name><surname>Schuit</surname><given-names>F</given-names></name><name><surname>Van Veldhoven</surname><given-names>P</given-names></name><name><surname>Ratcliffe</surname><given-names>P</given-names></name><name><surname>Baes</surname><given-names>M</given-names></name><name><surname>Maxwell</surname><given-names>P</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism</article-title><source>Nature Genetics</source><volume>40</volume><fpage>170</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1038/ng.2007.62</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baik</surname><given-names>AH</given-names></name><name><surname>Jain</surname><given-names>IH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Turning the oxygen dial: Balancing the highs and lows</article-title><source>Trends in Cell Biology</source><volume>30</volume><fpage>516</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2020.04.005</pub-id><pub-id pub-id-type="pmid">32386878</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ball</surname><given-names>HJ</given-names></name><name><surname>Jusof</surname><given-names>FF</given-names></name><name><surname>Bakmiwewa</surname><given-names>SM</given-names></name><name><surname>Hunt</surname><given-names>NH</given-names></name><name><surname>Yuasa</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tryptophan-catabolizing enzymes - party of three</article-title><source>Frontiers in Immunology</source><volume>5</volume><elocation-id>485</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2014.00485</pub-id><pub-id pub-id-type="pmid">25346733</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Barcroft</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1946">1946</year><source>Researches on Pre-Natal Life</source><publisher-loc>Oxford</publisher-loc><publisher-name>Blackwell Scientific Publications</publisher-name></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassan</surname><given-names>A</given-names></name><name><surname>Blomberg</surname><given-names>MRA</given-names></name><name><surname>Siegbahn</surname><given-names>PEM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mechanism of dioxygen cleavage in tetrahydrobiopterin-dependent amino acid hydroxylases</article-title><source>Chemistry</source><volume>9</volume><fpage>106</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1002/chem.200390006</pub-id><pub-id pub-id-type="pmid">12506369</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batie</surname><given-names>M</given-names></name><name><surname>Frost</surname><given-names>J</given-names></name><name><surname>Frost</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>JW</given-names></name><name><surname>Schofield</surname><given-names>P</given-names></name><name><surname>Rocha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hypoxia induces rapid changes to histone methylation and reprograms chromatin</article-title><source>Science</source><volume>363</volume><fpage>1222</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1126/science.aau5870</pub-id><pub-id pub-id-type="pmid">30872526</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beall</surname><given-names>CM</given-names></name><name><surname>Strohl</surname><given-names>KP</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Williams-Blangero</surname><given-names>S</given-names></name><name><surname>Almasy</surname><given-names>LA</given-names></name><name><surname>Decker</surname><given-names>MJ</given-names></name><name><surname>Worthman</surname><given-names>CM</given-names></name><name><surname>Goldstein</surname><given-names>MC</given-names></name><name><surname>Vargas</surname><given-names>E</given-names></name><name><surname>Villena</surname><given-names>M</given-names></name><name><surname>Soria</surname><given-names>R</given-names></name><name><surname>Alarcon</surname><given-names>AM</given-names></name><name><surname>Gonzales</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Ventilation and hypoxic ventilatory response of Tibetan and Aymara high altitude natives</article-title><source>American Journal of Physical Anthropology</source><volume>104</volume><fpage>427</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-8644(199712)104:4&lt;427::AID-AJPA1&gt;3.0.CO;2-P</pub-id><pub-id pub-id-type="pmid">9453694</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beall</surname><given-names>CM</given-names></name><name><surname>Brittenham</surname><given-names>GM</given-names></name><name><surname>Strohl</surname><given-names>KP</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Williams-Blangero</surname><given-names>S</given-names></name><name><surname>Goldstein</surname><given-names>MC</given-names></name><name><surname>Decker</surname><given-names>MJ</given-names></name><name><surname>Vargas</surname><given-names>E</given-names></name><name><surname>Villena</surname><given-names>M</given-names></name><name><surname>Soria</surname><given-names>R</given-names></name><name><surname>Alarcon</surname><given-names>AM</given-names></name><name><surname>Gonzales</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara</article-title><source>American Journal of Physical Anthropology</source><volume>106</volume><fpage>385</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-8644(199807)106:3&lt;385::AID-AJPA10&gt;3.0.CO;2-X</pub-id><pub-id pub-id-type="pmid">9696153</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beall</surname><given-names>CM</given-names></name><name><surname>Decker</surname><given-names>MJ</given-names></name><name><surname>Brittenham</surname><given-names>GM</given-names></name><name><surname>Kushner</surname><given-names>I</given-names></name><name><surname>Gebremedhin</surname><given-names>A</given-names></name><name><surname>Strohl</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>An Ethiopian pattern of human adaptation to high-altitude hypoxia</article-title><source>PNAS</source><volume>99</volume><fpage>17215</fpage><lpage>17218</lpage><pub-id pub-id-type="doi">10.1073/pnas.252649199</pub-id><pub-id pub-id-type="pmid">12471159</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beall</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Andean, Tibetan, and Ethiopian patterns of adaptation to high-altitude hypoxia</article-title><source>Integrative and Comparative Biology</source><volume>46</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1093/icb/icj004</pub-id><pub-id pub-id-type="pmid">21672719</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bento</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic basis of congenital erythrocytosis</article-title><source>International Journal of Laboratory Hematology</source><volume>40 Suppl 1</volume><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1111/ijlh.12828</pub-id><pub-id pub-id-type="pmid">29741264</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berra</surname><given-names>E</given-names></name><name><surname>Benizri</surname><given-names>E</given-names></name><name><surname>GinouvÃ¨s</surname><given-names>A</given-names></name><name><surname>Volmat</surname><given-names>V</given-names></name><name><surname>Roux</surname><given-names>D</given-names></name><name><surname>PouyssÃ©gur</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia</article-title><source>The EMBO Journal</source><volume>22</volume><fpage>4082</fpage><lpage>4090</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg392</pub-id><pub-id pub-id-type="pmid">12912907</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertini</surname><given-names>I</given-names></name><name><surname>Lalli</surname><given-names>D</given-names></name><name><surname>Mangani</surname><given-names>S</given-names></name><name><surname>Pozzi</surname><given-names>C</given-names></name><name><surname>Rosa</surname><given-names>C</given-names></name><name><surname>Theil</surname><given-names>EC</given-names></name><name><surname>Turano</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Structural insights into the ferroxidase site of ferritins from higher eukaryotes</article-title><source>Journal of the American Chemical Society</source><volume>134</volume><fpage>6169</fpage><lpage>6176</lpage><pub-id pub-id-type="doi">10.1021/ja210084n</pub-id><pub-id pub-id-type="pmid">22424302</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyer</surname><given-names>S</given-names></name><name><surname>Kristensen</surname><given-names>MM</given-names></name><name><surname>Jensen</surname><given-names>KS</given-names></name><name><surname>Johansen</surname><given-names>JV</given-names></name><name><surname>Staller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>36542</fpage><lpage>36552</lpage><pub-id pub-id-type="doi">10.1074/jbc.M804578200</pub-id><pub-id pub-id-type="pmid">18984585</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickler</surname><given-names>PE</given-names></name><name><surname>Donohoe</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Adaptive responses of vertebrate neurons to hypoxia</article-title><source>The Journal of Experimental Biology</source><volume>205</volume><fpage>3579</fpage><lpage>3586</lpage><pub-id pub-id-type="doi">10.1242/jeb.205.23.3579</pub-id><pub-id pub-id-type="pmid">12409484</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickler</surname><given-names>PE</given-names></name><name><surname>Buck</surname><given-names>LT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Hypoxia tolerance in reptiles, amphibians, and fishes: life with variable oxygen availability</article-title><source>Annual Review of Physiology</source><volume>69</volume><fpage>145</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1146/annurev.physiol.69.031905.162529</pub-id><pub-id pub-id-type="pmid">17037980</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bienfait</surname><given-names>HF</given-names></name><name><surname>Jacobs</surname><given-names>JM</given-names></name><name><surname>Slater</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Mitochondrial oxygen affinity as a function of redox and phosphate potentials</article-title><source>Biochimica et Biophysica Acta</source><volume>376</volume><fpage>446</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/0005-2728(75)90166-8</pub-id><pub-id pub-id-type="pmid">1125221</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigham</surname><given-names>AW</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Mei</surname><given-names>R</given-names></name><name><surname>Brutsaert</surname><given-names>T</given-names></name><name><surname>Wilson</surname><given-names>MJ</given-names></name><name><surname>Julian</surname><given-names>CG</given-names></name><name><surname>Parra</surname><given-names>EJ</given-names></name><name><surname>Akey</surname><given-names>JM</given-names></name><name><surname>Moore</surname><given-names>LG</given-names></name><name><surname>Shriver</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Identifying positive selection candidate loci for high-altitude adaptation in Andean populations</article-title><source>Human Genomics</source><volume>4</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1186/1479-7364-4-2-79</pub-id><pub-id pub-id-type="pmid">20038496</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigham</surname><given-names>A</given-names></name><name><surname>Bauchet</surname><given-names>M</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Akey</surname><given-names>JM</given-names></name><name><surname>Mei</surname><given-names>R</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name><name><surname>Julian</surname><given-names>CG</given-names></name><name><surname>Wilson</surname><given-names>MJ</given-names></name><name><surname>LÃ³pez HerrÃ¡ez</surname><given-names>D</given-names></name><name><surname>Brutsaert</surname><given-names>T</given-names></name><name><surname>Parra</surname><given-names>EJ</given-names></name><name><surname>Moore</surname><given-names>LG</given-names></name><name><surname>Shriver</surname><given-names>MD</given-names></name><name><surname>Begun</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data</article-title><source>PLOS Genetics</source><volume>6</volume><elocation-id>e1001116</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1001116</pub-id><pub-id pub-id-type="pmid">20838600</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biringer</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The enzymology of human eicosanoid pathways: the lipoxygenase branches</article-title><source>Molecular Biology Reports</source><volume>47</volume><fpage>7189</fpage><lpage>7207</lpage><pub-id pub-id-type="doi">10.1007/s11033-020-05698-8</pub-id><pub-id pub-id-type="pmid">32748021</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>T</given-names></name><name><surname>Gallagher</surname><given-names>D</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Lygate</surname><given-names>CA</given-names></name><name><surname>de Bono</surname><given-names>JP</given-names></name><name><surname>Nicholls</surname><given-names>LG</given-names></name><name><surname>Ortega-Saenz</surname><given-names>P</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name><name><surname>Wijeyekoon</surname><given-names>B</given-names></name><name><surname>Sutherland</surname><given-names>AI</given-names></name><name><surname>Grosfeld</surname><given-names>A</given-names></name><name><surname>Aragones</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>van Geyte</surname><given-names>K</given-names></name><name><surname>Teixeira</surname><given-names>D</given-names></name><name><surname>Diez-Juan</surname><given-names>A</given-names></name><name><surname>Lopez-Barneo</surname><given-names>J</given-names></name><name><surname>Channon</surname><given-names>KM</given-names></name><name><surname>Maxwell</surname><given-names>PH</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Davies</surname><given-names>AM</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice</article-title><source>Molecular and Cellular Biology</source><volume>28</volume><fpage>3386</fpage><lpage>3400</lpage><pub-id pub-id-type="doi">10.1128/MCB.02041-07</pub-id><pub-id pub-id-type="pmid">18332118</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braekkan</surname><given-names>SK</given-names></name><name><surname>Mathiesen</surname><given-names>EB</given-names></name><name><surname>NjÃ¸lstad</surname><given-names>I</given-names></name><name><surname>Wilsgaard</surname><given-names>T</given-names></name><name><surname>Hansen</surname><given-names>J-B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hematocrit and risk of venous thromboembolism in a general population: the Tromso study</article-title><source>Haematologica</source><volume>95</volume><fpage>270</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.3324/haematol.2009.008417</pub-id><pub-id pub-id-type="pmid">19833630</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling</article-title><source>Free Radical Biology &amp; Medicine</source><volume>100</volume><fpage>14</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.04.001</pub-id><pub-id pub-id-type="pmid">27085844</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brauchle</surname><given-names>M</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Arora</surname><given-names>R</given-names></name><name><surname>Thigale</surname><given-names>S</given-names></name><name><surname>Clay</surname><given-names>I</given-names></name><name><surname>Inverardi</surname><given-names>B</given-names></name><name><surname>Fletcher</surname><given-names>J</given-names></name><name><surname>Taslimi</surname><given-names>P</given-names></name><name><surname>Acker</surname><given-names>MG</given-names></name><name><surname>Gerrits</surname><given-names>B</given-names></name><name><surname>Voshol</surname><given-names>J</given-names></name><name><surname>Bauer</surname><given-names>A</given-names></name><name><surname>SchÃ¼beler</surname><given-names>D</given-names></name><name><surname>Bouwmeester</surname><given-names>T</given-names></name><name><surname>Ruffner</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Protein complex interactor analysis and differential activity of KDM3 subfamily members towards H3K9 methylation</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e60549</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0060549</pub-id><pub-id pub-id-type="pmid">23593242</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugg</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Oxygenases: mechanisms and structural motifs for O(2) activation</article-title><source>Current Opinion in Chemical Biology</source><volume>5</volume><fpage>550</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/s1367-5931(00)00236-2</pub-id><pub-id pub-id-type="pmid">11578928</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bundred</surname><given-names>JR</given-names></name><name><surname>Hendrix</surname><given-names>E</given-names></name><name><surname>Coleman</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The emerging roles of ribosomal histidyl hydroxylases in cell biology, physiology and disease</article-title><source>Cellular and Molecular Life Sciences</source><volume>75</volume><fpage>4093</fpage><lpage>4105</lpage><pub-id pub-id-type="doi">10.1007/s00018-018-2903-z</pub-id><pub-id pub-id-type="pmid">30151692</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burmester</surname><given-names>T</given-names></name><name><surname>Hankeln</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Function and evolution of vertebrate globins</article-title><source>Acta Physiologica</source><volume>211</volume><fpage>501</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1111/apha.12312</pub-id><pub-id pub-id-type="pmid">24811692</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreau</surname><given-names>A</given-names></name><name><surname>El Hafny-Rahbi</surname><given-names>B</given-names></name><name><surname>Matejuk</surname><given-names>A</given-names></name><name><surname>Grillon</surname><given-names>C</given-names></name><name><surname>Kieda</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia</article-title><source>Journal of Cellular and Molecular Medicine</source><volume>15</volume><fpage>1239</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01258.x</pub-id><pub-id pub-id-type="pmid">21251211</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cascella</surname><given-names>B</given-names></name><name><surname>Mirica</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Kinetic analysis of iron-dependent histone demethylases: Î±-ketoglutarate substrate inhibition and potential relevance to the regulation of histone demethylation in cancer cells</article-title><source>Biochemistry</source><volume>51</volume><fpage>8699</fpage><lpage>8701</lpage><pub-id pub-id-type="doi">10.1021/bi3012466</pub-id><pub-id pub-id-type="pmid">23067339</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>AA</given-names></name><name><surname>Laukka</surname><given-names>T</given-names></name><name><surname>Myllykoski</surname><given-names>M</given-names></name><name><surname>Ringel</surname><given-names>AE</given-names></name><name><surname>Booker</surname><given-names>MA</given-names></name><name><surname>Tolstorukov</surname><given-names>MY</given-names></name><name><surname>Meng</surname><given-names>YJ</given-names></name><name><surname>Meier</surname><given-names>SR</given-names></name><name><surname>Jennings</surname><given-names>RB</given-names></name><name><surname>Creech</surname><given-names>AL</given-names></name><name><surname>Herbert</surname><given-names>ZT</given-names></name><name><surname>McBrayer</surname><given-names>SK</given-names></name><name><surname>Olenchock</surname><given-names>BA</given-names></name><name><surname>Jaffe</surname><given-names>JD</given-names></name><name><surname>Haigis</surname><given-names>MC</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Signoretti</surname><given-names>S</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate</article-title><source>Science</source><volume>363</volume><fpage>1217</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1126/science.aaw1026</pub-id><pub-id pub-id-type="pmid">30872525</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>Budinger</surname><given-names>GR</given-names></name><name><surname>Choe</surname><given-names>SH</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Cellular respiration during hypoxia: role of cytochrome oxidase as the oxygen sensor in hepatocytes</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>18808</fpage><lpage>18816</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.30.18808</pub-id><pub-id pub-id-type="pmid">9228055</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>McClintock</surname><given-names>DS</given-names></name><name><surname>Feliciano</surname><given-names>CE</given-names></name><name><surname>Wood</surname><given-names>TM</given-names></name><name><surname>Melendez</surname><given-names>JA</given-names></name><name><surname>Rodriguez</surname><given-names>AM</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>25130</fpage><lpage>25138</lpage><pub-id pub-id-type="doi">10.1074/jbc.M001914200</pub-id><pub-id pub-id-type="pmid">10833514</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekharan</surname><given-names>NV</given-names></name><name><surname>Simmons</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The cyclooxygenases</article-title><source>Genome Biology</source><volume>5</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/gb-2004-5-9-241</pub-id><pub-id pub-id-type="pmid">15345041</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XY</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The role of m6A RNA methylation in human cancer</article-title><source>Molecular Cancer</source><volume>18</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s12943-019-1033-z</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>J</given-names></name><name><surname>Agger</surname><given-names>K</given-names></name><name><surname>Cloos</surname><given-names>PAC</given-names></name><name><surname>Pasini</surname><given-names>D</given-names></name><name><surname>Rose</surname><given-names>S</given-names></name><name><surname>Sennels</surname><given-names>L</given-names></name><name><surname>Rappsilber</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>KH</given-names></name><name><surname>Salcini</surname><given-names>AE</given-names></name><name><surname>Helin</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3</article-title><source>Cell</source><volume>128</volume><fpage>1063</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.02.003</pub-id><pub-id pub-id-type="pmid">17320161</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cigognini</surname><given-names>D</given-names></name><name><surname>Gaspar</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Satyam</surname><given-names>A</given-names></name><name><surname>Alagesan</surname><given-names>S</given-names></name><name><surname>Sanz-NoguÃ©s</surname><given-names>C</given-names></name><name><surname>Griffin</surname><given-names>M</given-names></name><name><surname>OâBrien</surname><given-names>T</given-names></name><name><surname>Pandit</surname><given-names>A</given-names></name><name><surname>Zeugolis</surname><given-names>DI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>30746</elocation-id><pub-id pub-id-type="doi">10.1038/srep30746</pub-id><pub-id pub-id-type="pmid">27478033</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockman</surname><given-names>ME</given-names></name><name><surname>Webb</surname><given-names>JD</given-names></name><name><surname>Kramer</surname><given-names>HB</given-names></name><name><surname>Kessler</surname><given-names>BM</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>8</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1074/mcp.M800340-MCP200</pub-id><pub-id pub-id-type="pmid">18936059</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockman</surname><given-names>ME</given-names></name><name><surname>Webb</surname><given-names>JD</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins</article-title><source>Annals of the New York Academy of Sciences</source><volume>1177</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05042.x</pub-id><pub-id pub-id-type="pmid">19845602</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockman</surname><given-names>ME</given-names></name><name><surname>Lippl</surname><given-names>K</given-names></name><name><surname>Tian</surname><given-names>YM</given-names></name><name><surname>Pegg</surname><given-names>HB</given-names></name><name><surname>Figg</surname><given-names>WD</given-names></name><name><surname>Abboud</surname><given-names>MI</given-names></name><name><surname>Heilig</surname><given-names>R</given-names></name><name><surname>Fischer</surname><given-names>R</given-names></name><name><surname>Myllyharju</surname><given-names>J</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates</article-title><source>eLife</source><volume>8</volume><elocation-id>e46490</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.46490</pub-id><pub-id pub-id-type="pmid">31500697</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>JE</given-names></name><name><surname>Amaru</surname><given-names>R</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Julian</surname><given-names>CG</given-names></name><name><surname>Racimo</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>JY</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Ambale-Venkatesh</surname><given-names>B</given-names></name><name><surname>Lima</surname><given-names>JA</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Stehlik</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>LG</given-names></name><name><surname>Prchal</surname><given-names>JT</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Natural selection on genes related to cardiovascular health in high-altitude adapted andeans</article-title><source>American Journal of Human Genetics</source><volume>101</volume><fpage>752</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.09.023</pub-id><pub-id pub-id-type="pmid">29100088</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daff</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>NO synthase: structures and mechanisms</article-title><source>Nitric Oxide</source><volume>23</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2010.03.001</pub-id><pub-id pub-id-type="pmid">20303412</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielson</surname><given-names>PB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans</article-title><source>Current Drug Metabolism</source><volume>3</volume><fpage>561</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.2174/1389200023337054</pub-id><pub-id pub-id-type="pmid">12369887</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dao</surname><given-names>JH</given-names></name><name><surname>Kurzeja</surname><given-names>RJM</given-names></name><name><surname>Morachis</surname><given-names>JM</given-names></name><name><surname>Veith</surname><given-names>H</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>V</given-names></name><name><surname>Tegley</surname><given-names>CM</given-names></name><name><surname>Tagari</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology</article-title><source>Analytical Biochemistry</source><volume>384</volume><fpage>213</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2008.09.052</pub-id><pub-id pub-id-type="pmid">18952043</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daubner</surname><given-names>SC</given-names></name><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tyrosine hydroxylase and regulation of dopamine synthesis</article-title><source>Archives of Biochemistry and Biophysics</source><volume>508</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2010.12.017</pub-id><pub-id pub-id-type="pmid">21176768</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>VL</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Nitric oxide neurotoxicity</article-title><source>Journal of Chemical Neuroanatomy</source><volume>10</volume><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/0891-0618(96)00148-2</pub-id><pub-id pub-id-type="pmid">8811421</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>A</given-names></name><name><surname>Solomon</surname><given-names>EI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dioxygen activation by copper, heme and non-heme iron enzymes: comparison of electronic structures and reactivities</article-title><source>Current Opinion in Chemical Biology</source><volume>9</volume><fpage>152</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2005.02.012</pub-id><pub-id pub-id-type="pmid">15811799</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deschoemaeker</surname><given-names>S</given-names></name><name><surname>Di Conza</surname><given-names>G</given-names></name><name><surname>Lilla</surname><given-names>S</given-names></name><name><surname>MartÃ­n-PÃ©rez</surname><given-names>R</given-names></name><name><surname>Mennerich</surname><given-names>D</given-names></name><name><surname>Boon</surname><given-names>L</given-names></name><name><surname>Hendrikx</surname><given-names>S</given-names></name><name><surname>Maddocks</surname><given-names>ODK</given-names></name><name><surname>Marx</surname><given-names>C</given-names></name><name><surname>Radhakrishnan</surname><given-names>P</given-names></name><name><surname>Prenen</surname><given-names>H</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Myllyharju</surname><given-names>J</given-names></name><name><surname>Kietzmann</surname><given-names>T</given-names></name><name><surname>Vousden</surname><given-names>KH</given-names></name><name><surname>Zanivan</surname><given-names>S</given-names></name><name><surname>Mazzone</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PHD1 regulates p53-mediated colorectal cancer chemoresistance</article-title><source>EMBO Molecular Medicine</source><volume>7</volume><fpage>1350</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.15252/emmm.201505492</pub-id><pub-id pub-id-type="pmid">26290450</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhillon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Roxadustat: First Global Approval</article-title><source>Drugs</source><volume>79</volume><fpage>563</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1007/s40265-019-01077-1</pub-id><pub-id pub-id-type="pmid">30805897</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhillon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Daprodustat: First Approval</article-title><source>Drugs</source><volume>80</volume><fpage>1491</fpage><lpage>1497</lpage><pub-id pub-id-type="doi">10.1007/s40265-020-01384-y</pub-id><pub-id pub-id-type="pmid">32880805</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrynin</surname><given-names>G</given-names></name><name><surname>McAllister</surname><given-names>TE</given-names></name><name><surname>Leszczynska</surname><given-names>KB</given-names></name><name><surname>Ramachandran</surname><given-names>S</given-names></name><name><surname>Krieg</surname><given-names>AJ</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Hammond</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>KDM4A regulates HIF-1 levels through H3K9me3</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>11094</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-11658-3</pub-id><pub-id pub-id-type="pmid">28894274</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DonkÃ³</surname><given-names>Ã</given-names></name><name><surname>PÃ©terfi</surname><given-names>Z</given-names></name><name><surname>Sum</surname><given-names>A</given-names></name><name><surname>Leto</surname><given-names>T</given-names></name><name><surname>Geiszt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dual oxidases</article-title><source>Philosophical Transactions of the Royal Society B</source><volume>360</volume><fpage>2301</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1098/rstb.2005.1767</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donovan</surname><given-names>L</given-names></name><name><surname>Welford</surname><given-names>SM</given-names></name><name><surname>Haaga</surname><given-names>J</given-names></name><name><surname>LaManna</surname><given-names>J</given-names></name><name><surname>Strohl</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hypoxia--implications for pharmaceutical developments</article-title><source>Sleep &amp; Breathing = Schlaf &amp; Atmung</source><volume>14</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1007/s11325-010-0368-x</pub-id><pub-id pub-id-type="pmid">20625934</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duranteau</surname><given-names>J</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>Kulisz</surname><given-names>A</given-names></name><name><surname>Shao</surname><given-names>Z</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>11619</fpage><lpage>11624</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.19.11619</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efimov</surname><given-names>I</given-names></name><name><surname>Basran</surname><given-names>J</given-names></name><name><surname>Thackray</surname><given-names>SJ</given-names></name><name><surname>Handa</surname><given-names>S</given-names></name><name><surname>Mowat</surname><given-names>CG</given-names></name><name><surname>Raven</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structure and reaction mechanism in the heme dioxygenases</article-title><source>Biochemistry</source><volume>50</volume><fpage>2717</fpage><lpage>2724</lpage><pub-id pub-id-type="doi">10.1021/bi101732n</pub-id><pub-id pub-id-type="pmid">21361337</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrismann</surname><given-names>D</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name><name><surname>Genn</surname><given-names>DN</given-names></name><name><surname>Mathioudakis</surname><given-names>N</given-names></name><name><surname>Hewitson</surname><given-names>KS</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay</article-title><source>The Biochemical Journal</source><volume>401</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1042/BJ20061151</pub-id><pub-id pub-id-type="pmid">16952279</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichstaedt</surname><given-names>CA</given-names></name><name><surname>AntÃ£o</surname><given-names>T</given-names></name><name><surname>Pagani</surname><given-names>L</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name><name><surname>Kivisild</surname><given-names>T</given-names></name><name><surname>Mormina</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The Andean adaptive toolkit to counteract high altitude maladaptation: genome-wide and phenotypic analysis of the Collas</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e93314</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0093314</pub-id><pub-id pub-id-type="pmid">24686296</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elayan</surname><given-names>IM</given-names></name><name><surname>Axley</surname><given-names>MJ</given-names></name><name><surname>Prasad</surname><given-names>PV</given-names></name><name><surname>Ahlers</surname><given-names>ST</given-names></name><name><surname>Auker</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain</article-title><source>Journal of Neurophysiology</source><volume>83</volume><fpage>2022</fpage><lpage>2029</lpage><pub-id pub-id-type="doi">10.1152/jn.2000.83.4.2022</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbers</surname><given-names>F</given-names></name><name><surname>Woite</surname><given-names>C</given-names></name><name><surname>Antoni</surname><given-names>V</given-names></name><name><surname>Stein</surname><given-names>S</given-names></name><name><surname>Funakoshi</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Schares</surname><given-names>G</given-names></name><name><surname>DÃ¤ubener</surname><given-names>W</given-names></name><name><surname>Eller</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Negative impact of hypoxia on tryptophan 2,3-Dioxygenase Function</article-title><source>Mediators of Inflammation</source><volume>2016</volume><elocation-id>1638916</elocation-id><pub-id pub-id-type="doi">10.1155/2016/1638916</pub-id><pub-id pub-id-type="pmid">27563172</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emerling</surname><given-names>BM</given-names></name><name><surname>Platanias</surname><given-names>LC</given-names></name><name><surname>Black</surname><given-names>E</given-names></name><name><surname>Nebreda</surname><given-names>AR</given-names></name><name><surname>Davis</surname><given-names>RJ</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>4853</fpage><lpage>4862</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.12.4853-4862.2005</pub-id><pub-id pub-id-type="pmid">15923604</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emerling</surname><given-names>BM</given-names></name><name><surname>Weinberg</surname><given-names>F</given-names></name><name><surname>Snyder</surname><given-names>C</given-names></name><name><surname>Burgess</surname><given-names>Z</given-names></name><name><surname>Mutlu</surname><given-names>GM</given-names></name><name><surname>Viollet</surname><given-names>B</given-names></name><name><surname>Budinger</surname><given-names>GRS</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio</article-title><source>Free Radical Biology &amp; Medicine</source><volume>46</volume><fpage>1386</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.02.019</pub-id><pub-id pub-id-type="pmid">19268526</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>AC</given-names></name><name><surname>Gleadle</surname><given-names>JM</given-names></name><name><surname>McNeill</surname><given-names>LA</given-names></name><name><surname>Hewitson</surname><given-names>KS</given-names></name><name><surname>OâRourke</surname><given-names>J</given-names></name><name><surname>Mole</surname><given-names>DR</given-names></name><name><surname>Mukherji</surname><given-names>M</given-names></name><name><surname>Metzen</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>MI</given-names></name><name><surname>Dhanda</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>YM</given-names></name><name><surname>Masson</surname><given-names>N</given-names></name><name><surname>Hamilton</surname><given-names>DL</given-names></name><name><surname>Jaakkola</surname><given-names>P</given-names></name><name><surname>Barstead</surname><given-names>R</given-names></name><name><surname>Hodgkin</surname><given-names>J</given-names></name><name><surname>Maxwell</surname><given-names>PH</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title><italic>C. elegans</italic> EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation</article-title><source>Cell</source><volume>107</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00507-4</pub-id><pub-id pub-id-type="pmid">11595184</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson-Miller</surname><given-names>S</given-names></name><name><surname>Babcock</surname><given-names>GT</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Heme/copper terminal oxidases</article-title><source>Chemical Reviews</source><volume>96</volume><fpage>2889</fpage><lpage>2908</lpage><pub-id pub-id-type="doi">10.1021/cr950051s</pub-id><pub-id pub-id-type="pmid">11848844</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finney</surname><given-names>J</given-names></name><name><surname>Moon</surname><given-names>HJ</given-names></name><name><surname>Ronnebaum</surname><given-names>T</given-names></name><name><surname>Lantz</surname><given-names>M</given-names></name><name><surname>Mure</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Human copper-dependent amine oxidases</article-title><source>Archives of Biochemistry and Biophysics</source><volume>546</volume><fpage>19</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2013.12.022</pub-id><pub-id pub-id-type="pmid">24407025</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>SC</given-names></name><name><surname>Coleman</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human 2-oxoglutarate-dependent oxygenases: nutrient sensors, stress responders, and disease mediators</article-title><source>Biochemical Society Transactions</source><volume>48</volume><fpage>1843</fpage><lpage>1858</lpage><pub-id pub-id-type="doi">10.1042/BST20190333</pub-id><pub-id pub-id-type="pmid">32985654</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fong</surname><given-names>G-H</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role and regulation of prolyl hydroxylase domain proteins</article-title><source>Cell Death &amp; Differentiation</source><volume>15</volume><fpage>635</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1038/cdd.2008.10</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fradette</surname><given-names>C</given-names></name><name><surname>Du Souich</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Effect of hypoxia on cytochrome P450 activity and expression</article-title><source>Current Drug Metabolism</source><volume>5</volume><fpage>257</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.2174/1389200043335577</pub-id><pub-id pub-id-type="pmid">15180495</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>SJ</given-names></name><name><surname>Sun</surname><given-names>ZYJ</given-names></name><name><surname>Poy</surname><given-names>F</given-names></name><name><surname>Kung</surname><given-names>AL</given-names></name><name><surname>Livingston</surname><given-names>DM</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Eck</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha</article-title><source>PNAS</source><volume>99</volume><fpage>5367</fpage><lpage>5372</lpage><pub-id pub-id-type="doi">10.1073/pnas.082117899</pub-id><pub-id pub-id-type="pmid">11959990</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrmann</surname><given-names>DC</given-names></name><name><surname>BrÃ¼ne</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondrial composition and function under the control of hypoxia</article-title><source>Redox Biology</source><volume>12</volume><fpage>208</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2017.02.012</pub-id><pub-id pub-id-type="pmid">28259101</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardie</surname><given-names>B</given-names></name><name><surname>Percy</surname><given-names>MJ</given-names></name><name><surname>Hoogewijs</surname><given-names>D</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Bento</surname><given-names>C</given-names></name><name><surname>Arsenault</surname><given-names>PR</given-names></name><name><surname>Richard</surname><given-names>S</given-names></name><name><surname>Almeida</surname><given-names>H</given-names></name><name><surname>Ewing</surname><given-names>J</given-names></name><name><surname>Lambert</surname><given-names>F</given-names></name><name><surname>McMullin</surname><given-names>MF</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The role of PHD2 mutations in the pathogenesis of erythrocytosis</article-title><source>Hypoxia</source><volume>2</volume><fpage>71</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.2147/HP.S54455</pub-id><pub-id pub-id-type="pmid">27774468</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>W</given-names></name><name><surname>Wolf</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Ho</surname><given-names>C-H</given-names></name><name><surname>Sekirnik</surname><given-names>R</given-names></name><name><surname>Zayer</surname><given-names>A</given-names></name><name><surname>Granatino</surname><given-names>N</given-names></name><name><surname>Cockman</surname><given-names>ME</given-names></name><name><surname>Loenarz</surname><given-names>C</given-names></name><name><surname>Loik</surname><given-names>ND</given-names></name><name><surname>Hardy</surname><given-names>AP</given-names></name><name><surname>Claridge</surname><given-names>TDW</given-names></name><name><surname>Hamed</surname><given-names>RB</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Trudgian</surname><given-names>DC</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Mackeen</surname><given-names>MM</given-names></name><name><surname>Mccullagh</surname><given-names>JS</given-names></name><name><surname>Gordiyenko</surname><given-names>Y</given-names></name><name><surname>Thalhammer</surname><given-names>A</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Liu-Yi</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Schmidt-Zachmann</surname><given-names>M</given-names></name><name><surname>Kessler</surname><given-names>BM</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Preston</surname><given-names>GM</given-names></name><name><surname>Coleman</surname><given-names>ML</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans</article-title><source>Nature Chemical Biology</source><volume>8</volume><fpage>960</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1093</pub-id><pub-id pub-id-type="pmid">23103944</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gnaiger</surname><given-names>E</given-names></name><name><surname>Steinlechner-Maran</surname><given-names>R</given-names></name><name><surname>MÃ©ndez</surname><given-names>G</given-names></name><name><surname>Eberl</surname><given-names>T</given-names></name><name><surname>Margreiter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Control of mitochondrial and cellular respiration by oxygen</article-title><source>Journal of Bioenergetics and Biomembranes</source><volume>27</volume><fpage>583</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1007/BF02111656</pub-id><pub-id pub-id-type="pmid">8746845</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>CD</given-names></name><name><surname>Olson</surname><given-names>LK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic Î²-cells by stearoyl-CoA desaturase and Elovl6</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>300</volume><fpage>E640</fpage><lpage>E649</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00544.2010</pub-id><pub-id pub-id-type="pmid">21266672</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guengerich</surname><given-names>FP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mechanisms of cytochrome P450 substrate oxidation: MiniReview</article-title><source>Journal of Biochemical and Molecular Toxicology</source><volume>21</volume><fpage>163</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1002/jbt.20174</pub-id><pub-id pub-id-type="pmid">17936929</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Chakraborty</surname><given-names>AA</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Gan</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Inuzuka</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>M</given-names></name><name><surname>Novak</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>JQ</given-names></name><name><surname>Toker</surname><given-names>A</given-names></name><name><surname>Signoretti</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Asara</surname><given-names>JM</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner</article-title><source>Science</source><volume>353</volume><fpage>929</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1126/science.aad5755</pub-id><pub-id pub-id-type="pmid">27563096</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Wish</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hypoxia-Inducible factor prolyl hydroxylase inhibitors: A potential new treatment for anemia in patients with CKD</article-title><source>American Journal of Kidney Diseases</source><volume>69</volume><fpage>815</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2016.12.011</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzy</surname><given-names>RD</given-names></name><name><surname>Mack</surname><given-names>MM</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mitochondrial complex III is required for hypoxia-induced ROS production and gene transcription in yeast</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>9</volume><fpage>1317</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1089/ars.2007.1708</pub-id><pub-id pub-id-type="pmid">17627464</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>VH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Regulation of erythropoiesis by hypoxia-inducible factors</article-title><source>Blood Reviews</source><volume>27</volume><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.blre.2012.12.003</pub-id><pub-id pub-id-type="pmid">23291219</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>RL</given-names></name><name><surname>Dunne</surname><given-names>K</given-names></name><name><surname>Walport</surname><given-names>LJ</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epigenetic regulation by histone demethylases in hypoxia</article-title><source>Epigenomics</source><volume>7</volume><fpage>791</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.2217/epi.15.24</pub-id><pub-id pub-id-type="pmid">25832587</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>RL</given-names></name><name><surname>Masson</surname><given-names>N</given-names></name><name><surname>Dunne</surname><given-names>K</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The activity of JmjC Histone lysine demethylase KDM4A is Highly sensitive to oxygen concentrations</article-title><source>ACS Chemical Biology</source><volume>12</volume><fpage>1011</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1021/acschembio.6b00958</pub-id><pub-id pub-id-type="pmid">28051298</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatefi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>The mitochondrial electron transport and oxidative phosphorylation system</article-title><source>Annual Review of Biochemistry</source><volume>54</volume><fpage>1015</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.54.070185.005055</pub-id><pub-id pub-id-type="pmid">2862839</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernansanz-AgustÃ­n</surname><given-names>P</given-names></name><name><surname>Ramos</surname><given-names>E</given-names></name><name><surname>Navarro</surname><given-names>E</given-names></name><name><surname>Parada</surname><given-names>E</given-names></name><name><surname>SÃ¡nchez-LÃ³pez</surname><given-names>N</given-names></name><name><surname>PelÃ¡ez-Aguado</surname><given-names>L</given-names></name><name><surname>Cabrera-GarcÃ­a</surname><given-names>JD</given-names></name><name><surname>Tello</surname><given-names>D</given-names></name><name><surname>Buendia</surname><given-names>I</given-names></name><name><surname>Marina</surname><given-names>A</given-names></name><name><surname>Egea</surname><given-names>J</given-names></name><name><surname>LÃ³pez</surname><given-names>MG</given-names></name><name><surname>Bogdanova</surname><given-names>A</given-names></name><name><surname>MartÃ­nez-Ruiz</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondrial complex I deactivation is related to superoxide production in acute hypoxia</article-title><source>Redox Biology</source><volume>12</volume><fpage>1040</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2017.04.025</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hess</surname><given-names>D</given-names></name><name><surname>Chisholm</surname><given-names>JW</given-names></name><name><surname>Igal</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e11394</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0011394</pub-id><pub-id pub-id-type="pmid">20613975</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillringhaus</surname><given-names>L</given-names></name><name><surname>Yue</surname><given-names>WW</given-names></name><name><surname>Rose</surname><given-names>NR</given-names></name><name><surname>Ng</surname><given-names>SS</given-names></name><name><surname>Gileadi</surname><given-names>C</given-names></name><name><surname>Loenarz</surname><given-names>C</given-names></name><name><surname>Bello</surname><given-names>SH</given-names></name><name><surname>Bray</surname><given-names>JE</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Oppermann</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>41616</fpage><lpage>41625</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.283689</pub-id><pub-id pub-id-type="pmid">21914792</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HirsilÃ¤</surname><given-names>M</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>GÃ¼nzler</surname><given-names>V</given-names></name><name><surname>Kivirikko</surname><given-names>KI</given-names></name><name><surname>Myllyharju</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Characterization of the human prolyl 4-Hydroxylases that modify the hypoxia-inducible factor</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>30772</fpage><lpage>30780</lpage><pub-id pub-id-type="doi">10.1074/jbc.M304982200</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>JJD</given-names></name><name><surname>Man</surname><given-names>HSJ</given-names></name><name><surname>Marsden</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nitric oxide signaling in hypoxia</article-title><source>Journal of Molecular Medicine</source><volume>90</volume><fpage>217</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1007/s00109-012-0880-5</pub-id><pub-id pub-id-type="pmid">22349396</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holdsworth</surname><given-names>MJ</given-names></name><name><surname>Gibbs</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Comparative biology of oxygen sensing in plants and animals</article-title><source>Current Biology</source><volume>30</volume><fpage>1979</fpage><lpage>1980</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.04.054</pub-id><pub-id pub-id-type="pmid">32428464</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HÃ¶lscher</surname><given-names>M</given-names></name><name><surname>Silter</surname><given-names>M</given-names></name><name><surname>Krull</surname><given-names>S</given-names></name><name><surname>von Ahlen</surname><given-names>M</given-names></name><name><surname>Hesse</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>P</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Breier</surname><given-names>G</given-names></name><name><surname>Katschinski</surname><given-names>DM</given-names></name><name><surname>Zieseniss</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>11185</fpage><lpage>11194</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.186809</pub-id><pub-id pub-id-type="pmid">21270129</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Cho</surname><given-names>YW</given-names></name><name><surname>Yu</surname><given-names>LR</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Veenstra</surname><given-names>TD</given-names></name><name><surname>Ge</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases</article-title><source>PNAS</source><volume>104</volume><fpage>18439</fpage><lpage>18444</lpage><pub-id pub-id-type="doi">10.1073/pnas.0707292104</pub-id><pub-id pub-id-type="pmid">18003914</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Groves</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Oxygen activation and radical transformations in heme proteins and metalloporphyrins</article-title><source>Chemical Reviews</source><volume>118</volume><fpage>2491</fpage><lpage>2553</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00373</pub-id><pub-id pub-id-type="pmid">29286645</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AL</given-names></name><name><surname>Todd</surname><given-names>BL</given-names></name><name><surname>Espenshade</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>SREBP Pathway responds to sterols and functions as an oxygen sensor in fission yeast</article-title><source>Cell</source><volume>120</volume><fpage>831</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.01.012</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>BT</given-names></name><name><surname>Espenshade</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oxygen-regulated degradation of fission yeast SREBP by Ofd1, a prolyl hydroxylase family member</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>1491</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.83</pub-id><pub-id pub-id-type="pmid">18418381</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>AS</given-names></name><name><surname>Striet</surname><given-names>JB</given-names></name><name><surname>Gudelsky</surname><given-names>G</given-names></name><name><surname>Soukhova</surname><given-names>GK</given-names></name><name><surname>Gozal</surname><given-names>E</given-names></name><name><surname>Beitner-Johnson</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>SZ</given-names></name><name><surname>Sachleben</surname><given-names>LR</given-names></name><name><surname>Haycock</surname><given-names>JW</given-names></name><name><surname>Gozal</surname><given-names>D</given-names></name><name><surname>Czyzyk-Krzeska</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons</article-title><source>Hypertension</source><volume>42</volume><fpage>1130</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000101691.12358.26</pub-id><pub-id pub-id-type="pmid">14597643</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MS</given-names></name><name><surname>Leissing</surname><given-names>TM</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Hopkinson</surname><given-names>RJ</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>2-Oxoglutarate-Dependent Oxygenases</article-title><source>Annual Review of Biochemistry</source><volume>87</volume><fpage>585</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-044724</pub-id><pub-id pub-id-type="pmid">29494239</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mononuclear copper active-oxygen complexes</article-title><source>Current Opinion in Chemical Biology</source><volume>10</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2006.02.012</pub-id><pub-id pub-id-type="pmid">16504568</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iturriaga</surname><given-names>R</given-names></name><name><surname>Alcayaga</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Neurotransmission in the carotid body: transmitters and modulators between glomus cells and petrosal ganglion nerve terminals</article-title><source>Brain Research. Brain Research Reviews</source><volume>47</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2004.05.007</pub-id><pub-id pub-id-type="pmid">15572162</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Iturriaga</surname><given-names>R</given-names></name><name><surname>Alcayaga</surname><given-names>J</given-names></name><name><surname>Gonzalez</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><chapter-title>Neurotransmitters in carotid body function: the case of dopamine â invited article</chapter-title><person-group person-group-type="editor"><name><surname>Gonzalez</surname><given-names>C</given-names></name><name><surname>Nurse</surname><given-names>CA</given-names></name><name><surname>Peers</surname><given-names>C</given-names></name></person-group><source>Arterial Chemoreceptors</source><publisher-name>Springer</publisher-name><fpage>137</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1007/978-90-481-2259-2</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivan</surname><given-names>M</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The EGLN-HIF O 2 -Sensing system: Multiple Inputs and feedbacks</article-title><source>Molecular Cell</source><volume>66</volume><fpage>772</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.06.002</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>I</given-names></name><name><surname>Saam</surname><given-names>J</given-names></name><name><surname>Kuhn</surname><given-names>H</given-names></name><name><surname>HolzhÃ¼tter</surname><given-names>HG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dual role of oxygen during lipoxygenase reactions</article-title><source>The FEBS Journal</source><volume>272</volume><fpage>2523</fpage><lpage>2535</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2005.04673.x</pub-id><pub-id pub-id-type="pmid">15885101</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>I</given-names></name><name><surname>Heydeck</surname><given-names>D</given-names></name><name><surname>Hofheinz</surname><given-names>K</given-names></name><name><surname>Roffeis</surname><given-names>J</given-names></name><name><surname>OâDonnell</surname><given-names>VB</given-names></name><name><surname>Kuhn</surname><given-names>H</given-names></name><name><surname>Walther</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Molecular enzymology of lipoxygenases</article-title><source>Archives of Biochemistry and Biophysics</source><volume>503</volume><fpage>161</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2010.08.016</pub-id><pub-id pub-id-type="pmid">20801095</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>I</given-names></name><name><surname>Kuhn</surname><given-names>H</given-names></name><name><surname>Heydeck</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15)</article-title><source>Gene</source><volume>573</volume><fpage>1</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2015.07.073</pub-id><pub-id pub-id-type="pmid">26216303</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname><given-names>S</given-names></name><name><surname>Lan</surname><given-names>F</given-names></name><name><surname>Bayliss</surname><given-names>P</given-names></name><name><surname>de la Torre-Ubieta</surname><given-names>L</given-names></name><name><surname>Huarte</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>HH</given-names></name><name><surname>Whetstine</surname><given-names>JR</given-names></name><name><surname>Bonni</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>TM</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases</article-title><source>Cell</source><volume>128</volume><fpage>1077</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.02.017</pub-id><pub-id pub-id-type="pmid">17320160</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>JabÅoÅska</surname><given-names>J</given-names></name><name><surname>Tawfik</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The evolution of oxygen-utilizing enzymes suggests early biosphere oxygenation</article-title><source>Nature Ecology &amp; Evolution</source><volume>5</volume><fpage>442</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1038/s41559-020-01386-9</pub-id><pub-id pub-id-type="pmid">33633374</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacovas</surname><given-names>VC</given-names></name><name><surname>Couto-Silva</surname><given-names>CM</given-names></name><name><surname>Nunes</surname><given-names>K</given-names></name><name><surname>Lemes</surname><given-names>RB</given-names></name><name><surname>de Oliveira</surname><given-names>MZ</given-names></name><name><surname>Salzano</surname><given-names>FM</given-names></name><name><surname>Bortolini</surname><given-names>MC</given-names></name><name><surname>HÃ¼nemeier</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Selection scan reveals three new loci related to high altitude adaptation in native andeans</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>12733</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-31100-6</pub-id><pub-id pub-id-type="pmid">30143708</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagannathan</surname><given-names>L</given-names></name><name><surname>Cuddapah</surname><given-names>S</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oxidative stress under ambient and physiological oxygen tension in tissue culture</article-title><source>Current Pharmacology Reports</source><volume>2</volume><fpage>64</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s40495-016-0050-5</pub-id><pub-id pub-id-type="pmid">27034917</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasniewski</surname><given-names>AJ</given-names></name><name><surname>Que</surname><given-names>L</given-names><suffix>Jr</suffix></name></person-group><year iso-8601-date="2018">2018</year><article-title>DIoxygen activation by nonheme diiron enzymes: diverse dioxygen adducts, high-valent intermediates, and related model complexes</article-title><source>Chemical Reviews</source><volume>118</volume><fpage>2554</fpage><lpage>2592</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00457</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>G</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yi</surname><given-names>C</given-names></name><name><surname>Lindahl</surname><given-names>T</given-names></name><name><surname>Pan</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y-G</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO</article-title><source>Nature Chemical Biology</source><volume>7</volume><fpage>885</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1038/nchembio.687</pub-id><pub-id pub-id-type="pmid">22002720</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>C</given-names></name><name><surname>Tumber</surname><given-names>A</given-names></name><name><surname>Che</surname><given-names>K</given-names></name><name><surname>Cain</surname><given-names>P</given-names></name><name><surname>Nowak</surname><given-names>R</given-names></name><name><surname>Gileadi</surname><given-names>C</given-names></name><name><surname>Oppermann</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The roles of Jumonji-type oxygenases in human disease</article-title><source>Epigenomics</source><volume>6</volume><fpage>89</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.2217/epi.13.79</pub-id><pub-id pub-id-type="pmid">24579949</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Hypoxia and drug metabolism</article-title><source>Biochemical Pharmacology</source><volume>30</volume><fpage>1019</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(81)90436-6</pub-id><pub-id pub-id-type="pmid">7259789</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>JurÃ¡nek</surname><given-names>I</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</source><volume>1436</volume><fpage>509</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1016/S0005-2760(98)00159-3</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaelin</surname><given-names>WG</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway</article-title><source>Molecular Cell</source><volume>30</volume><fpage>393</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.04.009</pub-id><pub-id pub-id-type="pmid">18498744</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamphorst</surname><given-names>JJ</given-names></name><name><surname>Cross</surname><given-names>JR</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>de Stanchina</surname><given-names>E</given-names></name><name><surname>Mathew</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>EP</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids</article-title><source>PNAS</source><volume>110</volume><fpage>8882</fpage><lpage>8887</lpage><pub-id pub-id-type="doi">10.1073/pnas.1307237110</pub-id><pub-id pub-id-type="pmid">23671091</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>IR</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Oxygen affinity of tyrosine and tryptophan hydroxylases in synaptosomes</article-title><source>Journal of Neurochemistry</source><volume>35</volume><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1980.tb03721.x</pub-id><pub-id pub-id-type="pmid">6108999</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J-H</given-names></name><name><surname>Choi</surname><given-names>TG</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Yun</surname><given-names>HR</given-names></name><name><surname>Nguyen</surname><given-names>NNY</given-names></name><name><surname>Jo</surname><given-names>YH</given-names></name><name><surname>Jang</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>I</given-names></name><name><surname>Ha</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name><name><surname>Tang</surname><given-names>DG</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial ROS-derived PTEN oxidation activates PI3K pathway for mTOR-induced myogenic autophagy</article-title><source>Cell Death and Differentiation</source><volume>25</volume><fpage>1921</fpage><lpage>1937</lpage><pub-id pub-id-type="doi">10.1038/s41418-018-0165-9</pub-id><pub-id pub-id-type="pmid">30042494</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>KÃ¶ditz</surname><given-names>J</given-names></name><name><surname>Nesper</surname><given-names>J</given-names></name><name><surname>Wottawa</surname><given-names>M</given-names></name><name><surname>Stiehl</surname><given-names>DP</given-names></name><name><surname>Camenisch</surname><given-names>G</given-names></name><name><surname>Franke</surname><given-names>C</given-names></name><name><surname>Myllyharju</surname><given-names>J</given-names></name><name><surname>Wenger</surname><given-names>RH</given-names></name><name><surname>Katschinski</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor</article-title><source>Blood</source><volume>110</volume><fpage>3610</fpage><lpage>3617</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-06-094441</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>HirsilÃ¤</surname><given-names>M</given-names></name><name><surname>GÃ¼nzler</surname><given-names>V</given-names></name><name><surname>Kivirikko</surname><given-names>KI</given-names></name><name><surname>Myllyharju</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>9899</fpage><lpage>9904</lpage><pub-id pub-id-type="doi">10.1074/jbc.M312254200</pub-id><pub-id pub-id-type="pmid">14701857</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolawole</surname><given-names>AO</given-names></name><name><surname>Hixon</surname><given-names>BP</given-names></name><name><surname>Dameron</surname><given-names>LS</given-names></name><name><surname>Chrisman</surname><given-names>IM</given-names></name><name><surname>Smirnov</surname><given-names>VV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen</article-title><source>Archives of Biochemistry and Biophysics</source><volume>570</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2015.02.014</pub-id><pub-id pub-id-type="pmid">25712221</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kooistra</surname><given-names>SM</given-names></name><name><surname>Helin</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Molecular mechanisms and potential functions of histone demethylases</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>13</volume><fpage>297</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1038/nrm3327</pub-id><pub-id pub-id-type="pmid">22473470</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koury</surname><given-names>MJ</given-names></name><name><surname>Haase</surname><given-names>VH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Anaemia in kidney disease: harnessing hypoxia responses for therapy</article-title><source>Nature Reviews. Nephrology</source><volume>11</volume><fpage>394</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2015.82</pub-id><pub-id pub-id-type="pmid">26055355</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>H</given-names></name><name><surname>Banthiya</surname><given-names>S</given-names></name><name><surname>van Leyen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mammalian lipoxygenases and their biological relevance</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</source><volume>1851</volume><fpage>308</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2014.10.002</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulisz</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>Shao</surname><given-names>Z</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>282</volume><fpage>L1324</fpage><lpage>L1329</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00326.2001</pub-id><pub-id pub-id-type="pmid">12003789</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>GK</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Ramachandran</surname><given-names>R</given-names></name><name><surname>Prabhakar</surname><given-names>NR</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Activation of tyrosine hydroxylase by intermittent hypoxia: involvement of serine phosphorylation</article-title><source>Journal of Applied Physiology</source><volume>95</volume><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00186.2003</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunze</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Veltkamp</surname><given-names>R</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Breier</surname><given-names>G</given-names></name><name><surname>Marti</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia</article-title><source>Stroke</source><volume>43</volume><fpage>2748</fpage><lpage>2756</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.112.669598</pub-id><pub-id pub-id-type="pmid">22933585</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lando</surname><given-names>D</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Gorman</surname><given-names>JJ</given-names></name><name><surname>Whelan</surname><given-names>DA</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name><name><surname>Bruick</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2002">2002a</year><article-title>FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>1466</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1101/gad.991402</pub-id><pub-id pub-id-type="pmid">12080085</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lando</surname><given-names>D</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Whelan</surname><given-names>DA</given-names></name><name><surname>Gorman</surname><given-names>JJ</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2002">2002b</year><article-title>Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch</article-title><source>Science</source><volume>295</volume><fpage>858</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1126/science.1068592</pub-id><pub-id pub-id-type="pmid">11823643</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laukka</surname><given-names>T</given-names></name><name><surname>Mariani</surname><given-names>CJ</given-names></name><name><surname>Ihantola</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>JZ</given-names></name><name><surname>Hokkanen</surname><given-names>J</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names><suffix>Jr</suffix></name><name><surname>Godley</surname><given-names>LA</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>4256</fpage><lpage>4265</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.688762</pub-id><pub-id pub-id-type="pmid">26703470</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lecomte</surname><given-names>JTJ</given-names></name><name><surname>Vuletich</surname><given-names>DA</given-names></name><name><surname>Lesk</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Structural divergence and distant relationships in proteins: evolution of the globins</article-title><source>Current Opinion in Structural Biology</source><volume>15</volume><fpage>290</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2005.05.008</pub-id><pub-id pub-id-type="pmid">15922591</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Ko</surname><given-names>J</given-names></name><name><surname>Ju</surname><given-names>C</given-names></name><name><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hypoxia signaling in human diseases and therapeutic targets</article-title><source>Experimental &amp; Molecular Medicine</source><volume>51</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s12276-019-0235-1</pub-id><pub-id pub-id-type="pmid">31221962</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>EA</given-names></name><name><surname>Tolman</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Reactivity of dioxygen-copper systems</article-title><source>Chemical Reviews</source><volume>104</volume><fpage>1047</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1021/cr020633r</pub-id><pub-id pub-id-type="pmid">14871149</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Sonveaux</surname><given-names>P</given-names></name><name><surname>Rabbani</surname><given-names>ZN</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Vujaskovic</surname><given-names>Z</given-names></name><name><surname>Dewhirst</surname><given-names>MW</given-names></name><name><surname>Li</surname><given-names>C-Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of HIF-1alpha stability through S-nitrosylation</article-title><source>Molecular Cell</source><volume>26</volume><fpage>63</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.02.024</pub-id><pub-id pub-id-type="pmid">17434127</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Ren</surname><given-names>T</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Lim</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>J-H</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Oxygen-sensitive methylation of ULK1 is required for hypoxia-induced autophagy</article-title><source>Nature Communications</source><volume>13</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41467-022-28831-6</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Boyer</surname><given-names>JA</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Jain</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Rodriguez</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Uryu</surname><given-names>H</given-names></name><name><surname>Liao</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Tsai</surname><given-names>Y-H</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Strahl</surname><given-names>BD</given-names></name><name><surname>von Kriegsheim</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>GG</given-names></name><name><surname>Baldwin</surname><given-names>AS</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Histone H3 proline 16 hydroxylation regulates mammalian gene expression</article-title><source>Nature Genetics</source><volume>54</volume><fpage>1721</fpage><lpage>1735</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01212-x</pub-id><pub-id pub-id-type="pmid">36347944</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LÃ³pez-Barneo</surname><given-names>J</given-names></name><name><surname>Ortega-SÃ¡enz</surname><given-names>P</given-names></name><name><surname>Pardal</surname><given-names>R</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Piruat</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Carotid body oxygen sensing</article-title><source>The European Respiratory Journal</source><volume>32</volume><fpage>1386</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1183/09031936.00056408</pub-id><pub-id pub-id-type="pmid">18978138</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>FR</given-names></name><name><surname>Huff</surname><given-names>C</given-names></name><name><surname>MyllymÃ¤ki</surname><given-names>M</given-names></name><name><surname>Olenchock</surname><given-names>B</given-names></name><name><surname>Swierczek</surname><given-names>S</given-names></name><name><surname>Tashi</surname><given-names>T</given-names></name><name><surname>Gordeuk</surname><given-names>V</given-names></name><name><surname>Wuren</surname><given-names>T</given-names></name><name><surname>Ri-Li</surname><given-names>G</given-names></name><name><surname>McClain</surname><given-names>DA</given-names></name><name><surname>Khan</surname><given-names>TM</given-names></name><name><surname>Koul</surname><given-names>PA</given-names></name><name><surname>Guchhait</surname><given-names>P</given-names></name><name><surname>Salama</surname><given-names>ME</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name><name><surname>Liberzon</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Simonson</surname><given-names>TS</given-names></name><name><surname>Jorde</surname><given-names>LB</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>Prchal</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A genetic mechanism for tibetan high-altitude adaptation</article-title><source>Nature Genetics</source><volume>46</volume><fpage>951</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1038/ng.3067</pub-id><pub-id pub-id-type="pmid">25129147</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahon</surname><given-names>PC</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>FIH-1: a novel protein that interacts with HIF-1Î± and VHL to mediate repression of HIF-1 transcriptional activity</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>2675</fpage><lpage>2686</lpage><pub-id pub-id-type="doi">10.1101/gad.924501</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majmundar</surname><given-names>AJ</given-names></name><name><surname>Wong</surname><given-names>WJ</given-names></name><name><surname>Simon</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hypoxia-inducible factors and the response to hypoxic stress</article-title><source>Molecular Cell</source><volume>40</volume><fpage>294</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.022</pub-id><pub-id pub-id-type="pmid">20965423</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markolovic</surname><given-names>S</given-names></name><name><surname>Wilkins</surname><given-names>SE</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Protein hydroxylation catalyzed by 2-oxoglutarate-dependent oxygenases</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>20712</fpage><lpage>20722</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.662627</pub-id><pub-id pub-id-type="pmid">26152730</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>DS</given-names></name><name><surname>Khosravi</surname><given-names>M</given-names></name><name><surname>Grocott</surname><given-names>MP</given-names></name><name><surname>Mythen</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Concepts in hypoxia reborn</article-title><source>Critical Care</source><volume>14</volume><elocation-id>315</elocation-id><pub-id pub-id-type="doi">10.1186/cc9078</pub-id><pub-id pub-id-type="pmid">20727228</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Hausinger</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Catalytic mechanisms of fe(ii)- and 2-oxoglutarate-dependent oxygenases</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>20702</fpage><lpage>20711</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.648691</pub-id><pub-id pub-id-type="pmid">26152721</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mas-Bargues</surname><given-names>C</given-names></name><name><surname>Sanz-Ros</surname><given-names>J</given-names></name><name><surname>RomÃ¡n-DomÃ­nguez</surname><given-names>A</given-names></name><name><surname>InglÃ©s</surname><given-names>M</given-names></name><name><surname>Gimeno-Mallench</surname><given-names>L</given-names></name><name><surname>El Alami</surname><given-names>M</given-names></name><name><surname>ViÃ±a-Almunia</surname><given-names>J</given-names></name><name><surname>Gambini</surname><given-names>J</given-names></name><name><surname>ViÃ±a</surname><given-names>J</given-names></name><name><surname>BorrÃ¡s</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Relevance of oxygen concentration in stem cell culture for regenerative medicine</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>1195</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20051195</pub-id><pub-id pub-id-type="pmid">30857245</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashima</surname><given-names>R</given-names></name><name><surname>Okuyama</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The role of lipoxygenases in pathophysiology; new insights and future perspectives</article-title><source>Redox Biology</source><volume>6</volume><fpage>297</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2015.08.006</pub-id><pub-id pub-id-type="pmid">26298204</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The reactivity of oxygen with flavoproteins</article-title><source>International Congress Series</source><volume>1233</volume><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0531-5131(02)00519-8</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masson</surname><given-names>N</given-names></name><name><surname>Keeley</surname><given-names>TP</given-names></name><name><surname>Giuntoli</surname><given-names>B</given-names></name><name><surname>White</surname><given-names>MD</given-names></name><name><surname>Puerta</surname><given-names>ML</given-names></name><name><surname>Perata</surname><given-names>P</given-names></name><name><surname>Hopkinson</surname><given-names>RJ</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name><name><surname>Licausi</surname><given-names>F</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants</article-title><source>Science</source><volume>365</volume><fpage>65</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1126/science.aaw0112</pub-id><pub-id pub-id-type="pmid">31273118</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauer</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Blanjoie</surname><given-names>A</given-names></name><name><surname>Jiao</surname><given-names>X</given-names></name><name><surname>Grozhik</surname><given-names>AV</given-names></name><name><surname>Patil</surname><given-names>DP</given-names></name><name><surname>Linder</surname><given-names>B</given-names></name><name><surname>Pickering</surname><given-names>BF</given-names></name><name><surname>Vasseur</surname><given-names>J-J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Gross</surname><given-names>SS</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Debart</surname><given-names>F</given-names></name><name><surname>Kiledjian</surname><given-names>M</given-names></name><name><surname>Jaffrey</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reversible methylation of m6Am in the 5â² cap controls mRNA stability</article-title><source>Nature</source><volume>541</volume><fpage>371</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/nature21022</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>NR</given-names></name><name><surname>Lowe</surname><given-names>EW</given-names></name><name><surname>Belof</surname><given-names>JL</given-names></name><name><surname>Ivkovic</surname><given-names>M</given-names></name><name><surname>Shafer</surname><given-names>J</given-names></name><name><surname>Space</surname><given-names>B</given-names></name><name><surname>Merkler</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evidence for substrate preorganization in the peptidylglycine Î±-amidating monooxygenase reaction describing the contribution of ground state structure to hydrogen tunneling</article-title><source>Journal of the American Chemical Society</source><volume>132</volume><fpage>16393</fpage><lpage>16402</lpage><pub-id pub-id-type="doi">10.1021/ja1019194</pub-id><pub-id pub-id-type="pmid">21043511</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKeown</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response</article-title><source>The British Journal of Radiology</source><volume>87</volume><elocation-id>20130676</elocation-id><pub-id pub-id-type="doi">10.1259/bjr.20130676</pub-id><pub-id pub-id-type="pmid">24588669</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merkler</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>C-terminal amidated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity</article-title><source>Enzyme and Microbial Technology</source><volume>16</volume><fpage>450</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/0141-0229(94)90014-0</pub-id><pub-id pub-id-type="pmid">7764886</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migita</surname><given-names>CT</given-names></name><name><surname>Matera</surname><given-names>KM</given-names></name><name><surname>Ikeda-Saito</surname><given-names>M</given-names></name><name><surname>Olson</surname><given-names>JS</given-names></name><name><surname>Fujii</surname><given-names>H</given-names></name><name><surname>Yoshimura</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The oxygen and carbon monoxide reactions of heme oxygenase</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>945</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.2.945</pub-id><pub-id pub-id-type="pmid">9422754</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minamishima</surname><given-names>YA</given-names></name><name><surname>Moslehi</surname><given-names>J</given-names></name><name><surname>Bardeesy</surname><given-names>N</given-names></name><name><surname>Cullen</surname><given-names>D</given-names></name><name><surname>Bronson</surname><given-names>RT</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names><suffix>Jr</suffix></name></person-group><year iso-8601-date="2008">2008</year><article-title>Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure</article-title><source>Blood</source><volume>111</volume><fpage>3236</fpage><lpage>3244</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-10-117812</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname><given-names>S</given-names></name><name><surname>Higgs</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Endogenous nitric oxide: physiology, pathology and clinical relevance</article-title><source>European Journal of Clinical Investigation</source><volume>21</volume><fpage>361</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2362.1991.tb01383.x</pub-id><pub-id pub-id-type="pmid">1718757</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monson</surname><given-names>EK</given-names></name><name><surname>Ditta</surname><given-names>GS</given-names></name><name><surname>Helinski</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>THe oxygen sensor protein, fixl, of rhizobium meliloti</article-title><source>Journal OF Biological Chemistry</source><volume>270</volume><fpage>5243</fpage><lpage>5250</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.10.5243</pub-id><pub-id pub-id-type="pmid">7890634</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>NJ</given-names></name><name><surname>Ducret</surname><given-names>A</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Ross</surname><given-names>SA</given-names></name><name><surname>Keller</surname><given-names>SR</given-names></name><name><surname>Lienhard</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Membrane amine oxidase cloning and identification as a major protein in the adipocyte plasma membrane</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>9388</fpage><lpage>9392</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.14.9388</pub-id><pub-id pub-id-type="pmid">9083076</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>SC</given-names></name><name><surname>Bensaddek</surname><given-names>D</given-names></name><name><surname>Ortmann</surname><given-names>B</given-names></name><name><surname>Maure</surname><given-names>J-F</given-names></name><name><surname>Mudie</surname><given-names>S</given-names></name><name><surname>Blow</surname><given-names>JJ</given-names></name><name><surname>Lamond</surname><given-names>AI</given-names></name><name><surname>Swedlow</surname><given-names>JR</given-names></name><name><surname>Rocha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PHD1 Links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein cep192</article-title><source>Developmental Cell</source><volume>26</volume><fpage>381</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.06.014</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namslauer</surname><given-names>A</given-names></name><name><surname>Brzezinski</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Structural elements involved in electron-coupled proton transfer in cytochrome c oxidase</article-title><source>FEBS Letters</source><volume>567</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2004.04.027</pub-id><pub-id pub-id-type="pmid">15165901</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nangaku</surname><given-names>M</given-names></name><name><surname>Eckardt</surname><given-names>KU</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Hypoxia and the HIF system in kidney disease</article-title><source>Journal of Molecular Medicine</source><volume>85</volume><fpage>1325</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1007/s00109-007-0278-y</pub-id><pub-id pub-id-type="pmid">18026918</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolfi-Donegan</surname><given-names>D</given-names></name><name><surname>Braganza</surname><given-names>A</given-names></name><name><surname>Shiva</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement</article-title><source>Redox Biology</source><volume>37</volume><elocation-id>101674</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2020.101674</pub-id><pub-id pub-id-type="pmid">32811789</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz-Prado</surname><given-names>E</given-names></name><name><surname>Dunn</surname><given-names>JF</given-names></name><name><surname>Vasconez</surname><given-names>J</given-names></name><name><surname>Castillo</surname><given-names>D</given-names></name><name><surname>Viscor</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Partial pressure of oxygen in the human body: a general review</article-title><source>American Journal of Blood Research</source><volume>9</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">30899601</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palfey</surname><given-names>BA</given-names></name><name><surname>McDonald</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Control of catalysis in flavin-dependent monooxygenases</article-title><source>Archives of Biochemistry and Biophysics</source><volume>493</volume><fpage>26</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2009.11.028</pub-id><pub-id pub-id-type="pmid">19944667</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>LA</given-names></name><name><surname>Doctor</surname><given-names>A</given-names></name><name><surname>Chhabra</surname><given-names>P</given-names></name><name><surname>Sheram</surname><given-names>ML</given-names></name><name><surname>Laubach</surname><given-names>VE</given-names></name><name><surname>Karlinsey</surname><given-names>MZ</given-names></name><name><surname>Forbes</surname><given-names>MS</given-names></name><name><surname>Macdonald</surname><given-names>T</given-names></name><name><surname>Gaston</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>S-nitrosothiols signal hypoxia-mimetic vascular pathology</article-title><source>The Journal of Clinical Investigation</source><volume>117</volume><fpage>2592</fpage><lpage>2601</lpage><pub-id pub-id-type="doi">10.1172/JCI29444</pub-id><pub-id pub-id-type="pmid">17786245</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parati</surname><given-names>G</given-names></name><name><surname>Agostoni</surname><given-names>P</given-names></name><name><surname>Basnyat</surname><given-names>B</given-names></name><name><surname>Bilo</surname><given-names>G</given-names></name><name><surname>Brugger</surname><given-names>H</given-names></name><name><surname>Coca</surname><given-names>A</given-names></name><name><surname>Festi</surname><given-names>L</given-names></name><name><surname>Giardini</surname><given-names>G</given-names></name><name><surname>Lironcurti</surname><given-names>A</given-names></name><name><surname>Luks</surname><given-names>AM</given-names></name><name><surname>Maggiorini</surname><given-names>M</given-names></name><name><surname>Modesti</surname><given-names>PA</given-names></name><name><surname>Swenson</surname><given-names>ER</given-names></name><name><surname>Williams</surname><given-names>B</given-names></name><name><surname>BÃ¤rtsch</surname><given-names>P</given-names></name><name><surname>Torlasco</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine</article-title><source>European Heart Journal</source><volume>39</volume><fpage>1546</fpage><lpage>1554</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehx720</pub-id><pub-id pub-id-type="pmid">29340578</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paton</surname><given-names>CM</given-names></name><name><surname>Ntambi</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Biochemical and physiological function of stearoyl-CoA desaturase</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>297</volume><fpage>E28</fpage><lpage>E37</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.90897.2008</pub-id><pub-id pub-id-type="pmid">19066317</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Tao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Genetic variations in Tibetan populations and high-altitude adaptation at the Himalayas</article-title><source>Molecular Biology and Evolution</source><volume>28</volume><fpage>1075</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1093/molbev/msq290</pub-id><pub-id pub-id-type="pmid">21030426</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Percy</surname><given-names>MJ</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Flores</surname><given-names>A</given-names></name><name><surname>Harrison</surname><given-names>C</given-names></name><name><surname>Lappin</surname><given-names>TRJ</given-names></name><name><surname>Maxwell</surname><given-names>PH</given-names></name><name><surname>McMullin</surname><given-names>MF</given-names></name><name><surname>Lee</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A family with erythrocytosis establishes A role for prolyl hydroxylase domain protein 2 in oxygen homeostasis</article-title><source>PNAS</source><volume>103</volume><fpage>654</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1073/pnas.0508423103</pub-id><pub-id pub-id-type="pmid">16407130</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>LC</given-names></name><name><surname>Nicholls</surname><given-names>P</given-names></name><name><surname>Degn</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>The effect of energization on the apparent Michaelis-Mentne constant for oxygen in mitochondrial respiration</article-title><source>The Biochemical Journal</source><volume>142</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1042/bj1420247</pub-id><pub-id pub-id-type="pmid">4374191</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Burdmann</surname><given-names>EA</given-names></name><name><surname>Chen</surname><given-names>C-Y</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>de Zeeuw</surname><given-names>D</given-names></name><name><surname>Eckardt</surname><given-names>K-U</given-names></name><name><surname>Feyzi</surname><given-names>JM</given-names></name><name><surname>Ivanovich</surname><given-names>P</given-names></name><name><surname>Kewalramani</surname><given-names>R</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Lewis</surname><given-names>EF</given-names></name><name><surname>McGill</surname><given-names>JB</given-names></name><name><surname>McMurray</surname><given-names>JJV</given-names></name><name><surname>Parfrey</surname><given-names>P</given-names></name><name><surname>Parving</surname><given-names>H-H</given-names></name><name><surname>Remuzzi</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Toto</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease</article-title><source>New England Journal of Medicine</source><volume>361</volume><fpage>2019</fpage><lpage>2032</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0907845</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Place</surname><given-names>TL</given-names></name><name><surname>Domann</surname><given-names>FE</given-names></name><name><surname>Case</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Limitations of oxygen delivery to cells in culture: An underappreciated problem in basic and translational research</article-title><source>Free Radical Biology &amp; Medicine</source><volume>113</volume><fpage>311</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.10.003</pub-id><pub-id pub-id-type="pmid">29032224</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponnaluri</surname><given-names>VKC</given-names></name><name><surname>Maciejewski</surname><given-names>JP</given-names></name><name><surname>Mukherji</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A mechanistic overview of TET-mediated 5-methylcytosine oxidation</article-title><source>Biochemical and Biophysical Research Communications</source><volume>436</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.05.077</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>PortolÃ©s</surname><given-names>J</given-names></name><name><surname>MartÃ­n</surname><given-names>L</given-names></name><name><surname>Broseta</surname><given-names>JJ</given-names></name><name><surname>Cases</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents</article-title><source>Frontiers in Medicine</source><volume>8</volume><elocation-id>328</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2021.642296</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Poulos</surname><given-names>TL</given-names></name><name><surname>Johnson</surname><given-names>EF</given-names></name></person-group><year iso-8601-date="2005">2005</year><chapter-title>Structures of cytochrome P450 enzymes</chapter-title><person-group person-group-type="editor"><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><source>Cytochrome P450: Structure, Mechanism, and Biochemistry</source><publisher-name>Springer</publisher-name><fpage>87</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1007/b139087</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prigge</surname><given-names>ST</given-names></name><name><surname>Eipper</surname><given-names>BA</given-names></name><name><surname>Mains</surname><given-names>RE</given-names></name><name><surname>Amzel</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Dioxygen Binds End-On to Mononuclear Copper in a Precatalytic Enzyme Complex</article-title><source>Science</source><volume>304</volume><fpage>864</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1126/science.1094583</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Xiang</surname><given-names>K</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetic evidence of paleolithic colonization and neolithic expansion of modern humans on the tibetan plateau</article-title><source>Molecular Biology and Evolution</source><volume>30</volume><fpage>1761</fpage><lpage>1778</lpage><pub-id pub-id-type="doi">10.1093/molbev/mst093</pub-id><pub-id pub-id-type="pmid">23682168</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>KDM3A Senses Oxygen Availability to Regulate PGC-1Î±-Mediated Mitochondrial Biogenesis</article-title><source>Molecular Cell</source><volume>76</volume><fpage>885</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.09.019</pub-id><pub-id pub-id-type="pmid">31629659</pub-id></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghuraman</surname><given-names>G</given-names></name><name><surname>Prabhakar</surname><given-names>NR</given-names></name><name><surname>Kumar</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential regulation of tyrosine hydroxylase by continuous and intermittent hypoxia</article-title><source>Arterial Chemoreception</source><volume>758</volume><fpage>381</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-4584-1</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragsdale</surname><given-names>SW</given-names></name><name><surname>Yi</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Thiol/Disulfide Redox Switches in the Regulation of Heme Binding to Proteins</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>14</volume><fpage>1039</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1089/ars.2010.3436</pub-id></element-citation></ref><ref id="bib184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raven</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A short history of heme dioxygenases: rise, fall and rise again</article-title><source>Journal of Biological Inorganic Chemistry</source><volume>22</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1007/s00775-016-1412-5</pub-id><pub-id pub-id-type="pmid">27909919</pub-id></element-citation></ref><ref id="bib185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>RepessÃ©</surname><given-names>X</given-names></name><name><surname>Moldes</surname><given-names>M</given-names></name><name><surname>Muscat</surname><given-names>A</given-names></name><name><surname>Vatier</surname><given-names>C</given-names></name><name><surname>Chetrite</surname><given-names>G</given-names></name><name><surname>Gille</surname><given-names>T</given-names></name><name><surname>Planes</surname><given-names>C</given-names></name><name><surname>Filip</surname><given-names>A</given-names></name><name><surname>Mercier</surname><given-names>N</given-names></name><name><surname>Duranteau</surname><given-names>J</given-names></name><name><surname>FÃ¨ve</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytes</article-title><source>Molecular and Cellular Endocrinology</source><volume>411</volume><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2015.04.011</pub-id><pub-id pub-id-type="pmid">25907140</pub-id></element-citation></ref><ref id="bib186"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>RC</given-names></name><name><surname>Hackett</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Frontiers of hypoxia research: acute mountain sickness</article-title><source>Journal of Experimental Biology</source><volume>204</volume><fpage>3161</fpage><lpage>3170</lpage><pub-id pub-id-type="doi">10.1242/jeb.204.18.3161</pub-id></element-citation></ref><ref id="bib187"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>KM</given-names></name><name><surname>Fitzpatrick</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanisms of tryptophan and tyrosine hydroxylase</article-title><source>IUBMB Life</source><volume>65</volume><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1002/iub.1144</pub-id><pub-id pub-id-type="pmid">23441081</pub-id></element-citation></ref><ref id="bib188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MA</given-names></name><name><surname>Baumgardner</surname><given-names>JE</given-names></name><name><surname>Otto</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase</article-title><source>Free Radical Biology &amp; Medicine</source><volume>51</volume><fpage>1952</fpage><lpage>1965</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.08.034</pub-id><pub-id pub-id-type="pmid">21958548</pub-id></element-citation></ref><ref id="bib189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>J</given-names></name><name><surname>Herrero</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Rauch</surname><given-names>N</given-names></name><name><surname>Quintanilla</surname><given-names>A</given-names></name><name><surname>Wynne</surname><given-names>K</given-names></name><name><surname>Krstic</surname><given-names>A</given-names></name><name><surname>Acosta</surname><given-names>JC</given-names></name><name><surname>Taylor</surname><given-names>C</given-names></name><name><surname>Schlisio</surname><given-names>S</given-names></name><name><surname>von Kriegsheim</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359</article-title><source>Cell Reports</source><volume>24</volume><fpage>1316</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.06.108</pub-id><pub-id pub-id-type="pmid">30067985</pub-id></element-citation></ref><ref id="bib190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>E</given-names></name><name><surname>GÃ³mez Castellanos</surname><given-names>JR</given-names></name><name><surname>Gadda</surname><given-names>G</given-names></name><name><surname>Fraaije</surname><given-names>MW</given-names></name><name><surname>Mattevi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Same Substrate, Many Reactions: Oxygen Activation in Flavoenzymes</article-title><source>Chemical Reviews</source><volume>118</volume><fpage>1742</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00650</pub-id><pub-id pub-id-type="pmid">29323892</pub-id></element-citation></ref><ref id="bib191"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>NR</given-names></name><name><surname>McDonough</surname><given-names>MA</given-names></name><name><surname>King</surname><given-names>ONF</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Inhibition of 2-oxoglutarate dependent oxygenases</article-title><source>Chemical Society Reviews</source><volume>40</volume><fpage>4364</fpage><lpage>4397</lpage><pub-id pub-id-type="doi">10.1039/c0cs00203h</pub-id><pub-id pub-id-type="pmid">21390379</pub-id></element-citation></ref><ref id="bib192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostrup</surname><given-names>M</given-names></name><name><surname>Fossbakk</surname><given-names>A</given-names></name><name><surname>Hauge</surname><given-names>A</given-names></name><name><surname>Kleppe</surname><given-names>R</given-names></name><name><surname>Gnaiger</surname><given-names>E</given-names></name><name><surname>Haavik</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oxygen dependence of tyrosine hydroxylase</article-title><source>Amino Acids</source><volume>34</volume><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1007/s00726-007-0547-7</pub-id><pub-id pub-id-type="pmid">17520326</pub-id></element-citation></ref><ref id="bib193"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santolini</surname><given-names>J</given-names></name><name><surname>Adak</surname><given-names>S</given-names></name><name><surname>Curran</surname><given-names>CM</given-names></name><name><surname>Stuehr</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2001">2001a</year><article-title>A kinetic simulation model that describes catalysis and regulation in nitric-oxide synthase</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>1233</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1074/jbc.M006858200</pub-id><pub-id pub-id-type="pmid">11038356</pub-id></element-citation></ref><ref id="bib194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santolini</surname><given-names>J</given-names></name><name><surname>Meade</surname><given-names>AL</given-names></name><name><surname>Stuehr</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2001">2001b</year><article-title>Differences in three kinetic parameters underpin the unique catalytic profiles of nitric-oxide synthases I, II, and III</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>48887</fpage><lpage>48898</lpage><pub-id pub-id-type="doi">10.1074/jbc.M108666200</pub-id><pub-id pub-id-type="pmid">11684690</pub-id></element-citation></ref><ref id="bib195"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scandurra</surname><given-names>FM</given-names></name><name><surname>Gnaiger</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell respiration under hypoxia: facts and artefacts in mitochondrial oxygen kinetics</article-title><source>Oxygen Transport to Tissue</source><volume>XXXI</volume><fpage>7</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1007/978-1-4419-1241-1</pub-id></element-citation></ref><ref id="bib196"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarpulla</surname><given-names>RC</given-names></name><name><surname>Vega</surname><given-names>RB</given-names></name><name><surname>Kelly</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcriptional integration of mitochondrial biogenesis</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>23</volume><fpage>459</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2012.06.006</pub-id></element-citation></ref><ref id="bib197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheinfeldt</surname><given-names>LB</given-names></name><name><surname>Soi</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>S</given-names></name><name><surname>Ranciaro</surname><given-names>A</given-names></name><name><surname>Woldemeskel</surname><given-names>D</given-names></name><name><surname>Beggs</surname><given-names>W</given-names></name><name><surname>Lambert</surname><given-names>C</given-names></name><name><surname>Jarvis</surname><given-names>JP</given-names></name><name><surname>Abate</surname><given-names>D</given-names></name><name><surname>Belay</surname><given-names>G</given-names></name><name><surname>Tishkoff</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genetic adaptation to high altitude in the Ethiopian highlands</article-title><source>Genome Biology</source><volume>13</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/gb-2012-13-1-r1</pub-id><pub-id pub-id-type="pmid">22264333</pub-id></element-citation></ref><ref id="bib198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>SK</given-names></name><name><surname>Ebel</surname><given-names>S</given-names></name><name><surname>Keil</surname><given-names>E</given-names></name><name><surname>Woite</surname><given-names>C</given-names></name><name><surname>Ernst</surname><given-names>JF</given-names></name><name><surname>Benzin</surname><given-names>AE</given-names></name><name><surname>Rupp</surname><given-names>J</given-names></name><name><surname>DÃ¤ubener</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e63301</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0063301</pub-id><pub-id pub-id-type="pmid">23675474</pub-id></element-citation></ref><ref id="bib199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnell</surname><given-names>PO</given-names></name><name><surname>Ignacak</surname><given-names>ML</given-names></name><name><surname>Bauer</surname><given-names>AL</given-names></name><name><surname>Striet</surname><given-names>JB</given-names></name><name><surname>Paulding</surname><given-names>WR</given-names></name><name><surname>Czyzyk-Krzeska</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors</article-title><source>Journal of Neurochemistry</source><volume>85</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01696.x</pub-id><pub-id pub-id-type="pmid">12675925</pub-id></element-citation></ref><ref id="bib200"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Oxygen sensing by HIF hydroxylases</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>5</volume><fpage>343</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1038/nrm1366</pub-id><pub-id pub-id-type="pmid">15122348</pub-id></element-citation></ref><ref id="bib201"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholz</surname><given-names>CC</given-names></name><name><surname>Rodriguez</surname><given-names>J</given-names></name><name><surname>Pickel</surname><given-names>C</given-names></name><name><surname>Burr</surname><given-names>S</given-names></name><name><surname>Fabrizio</surname><given-names>JA</given-names></name><name><surname>Nolan</surname><given-names>KA</given-names></name><name><surname>Spielmann</surname><given-names>P</given-names></name><name><surname>Cavadas</surname><given-names>MAS</given-names></name><name><surname>Crifo</surname><given-names>B</given-names></name><name><surname>Halligan</surname><given-names>DN</given-names></name><name><surname>Nathan</surname><given-names>JA</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Wenger</surname><given-names>RH</given-names></name><name><surname>Von Kriegsheim</surname><given-names>A</given-names></name><name><surname>Cummins</surname><given-names>EP</given-names></name><name><surname>Taylor</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FIH Regulates cellular metabolism through hydroxylation of the deubiquitinase OTUB1</article-title><source>PLOS Biology</source><volume>14</volume><elocation-id>e1002347</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002347</pub-id><pub-id pub-id-type="pmid">26752685</pub-id></element-citation></ref><ref id="bib202"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segura</surname><given-names>I</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Knevels</surname><given-names>E</given-names></name><name><surname>Moskalyuk</surname><given-names>A</given-names></name><name><surname>Pulizzi</surname><given-names>R</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Chaze</surname><given-names>T</given-names></name><name><surname>Tudor</surname><given-names>C</given-names></name><name><surname>Boulegue</surname><given-names>C</given-names></name><name><surname>Holt</surname><given-names>M</given-names></name><name><surname>Daelemans</surname><given-names>D</given-names></name><name><surname>Matondo</surname><given-names>M</given-names></name><name><surname>GhesquiÃ¨re</surname><given-names>B</given-names></name><name><surname>Giugliano</surname><given-names>M</given-names></name><name><surname>Ruiz de Almodovar</surname><given-names>C</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The oxygen sensor PHD2 Controls dendritic spines and synapses via modification of filamin A</article-title><source>Cell Reports</source><volume>14</volume><fpage>2653</fpage><lpage>2667</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.047</pub-id><pub-id pub-id-type="pmid">26972007</pub-id></element-citation></ref><ref id="bib203"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>New insights into nNOS regulation of vascular homeostasis</article-title><source>Journal of Clinical Investigation</source><volume>115</volume><fpage>2976</fpage><lpage>2978</lpage><pub-id pub-id-type="doi">10.1172/JCI26792</pub-id></element-citation></ref><ref id="bib204"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>SH</given-names></name><name><surname>Wertz</surname><given-names>DL</given-names></name><name><surname>Klinman</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Implication for functions of the ectopic adipocyte copper amine oxidase (AOC3) from purified enzyme and cell-based kinetic studies</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e29270</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0029270</pub-id><pub-id pub-id-type="pmid">22238597</pub-id></element-citation></ref><ref id="bib205"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shmakova</surname><given-names>A</given-names></name><name><surname>Batie</surname><given-names>M</given-names></name><name><surname>Druker</surname><given-names>J</given-names></name><name><surname>Rocha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chromatin and oxygen sensing in the context of JmjC histone demethylases</article-title><source>The Biochemical Journal</source><volume>462</volume><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1042/BJ20140754</pub-id><pub-id pub-id-type="pmid">25145438</pub-id></element-citation></ref><ref id="bib206"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>J</given-names></name><name><surname>Cowburn</surname><given-names>AS</given-names></name><name><surname>Palazon</surname><given-names>A</given-names></name><name><surname>Madhu</surname><given-names>B</given-names></name><name><surname>Tyrakis</surname><given-names>PA</given-names></name><name><surname>MacÃ­as</surname><given-names>D</given-names></name><name><surname>Bargiela</surname><given-names>DM</given-names></name><name><surname>Pietsch</surname><given-names>S</given-names></name><name><surname>Gralla</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>CE</given-names></name><name><surname>Kittipassorn</surname><given-names>T</given-names></name><name><surname>Chey</surname><given-names>YCJ</given-names></name><name><surname>Branco</surname><given-names>CM</given-names></name><name><surname>Rundqvist</surname><given-names>H</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The factor inhibiting HIF Asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>898</fpage><lpage>913</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.02.020</pub-id><pub-id pub-id-type="pmid">29617647</pub-id></element-citation></ref><ref id="bib207"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonson</surname><given-names>TS</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Huff</surname><given-names>CD</given-names></name><name><surname>Yun</surname><given-names>H</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Witherspoon</surname><given-names>DJ</given-names></name><name><surname>Bai</surname><given-names>Z</given-names></name><name><surname>Lorenzo</surname><given-names>FR</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Jorde</surname><given-names>LB</given-names></name><name><surname>Prchal</surname><given-names>JT</given-names></name><name><surname>Ge</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genetic evidence for high-altitude adaptation in tibet</article-title><source>Science</source><volume>329</volume><fpage>72</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1126/science.1189406</pub-id></element-citation></ref><ref id="bib208"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>PD</given-names></name><name><surname>Eipper</surname><given-names>BA</given-names></name><name><surname>Katz</surname><given-names>MJ</given-names></name><name><surname>Gandara</surname><given-names>L</given-names></name><name><surname>Wappner</surname><given-names>P</given-names></name><name><surname>Fischer</surname><given-names>R</given-names></name><name><surname>Hodson</surname><given-names>EJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Masson</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Striking oxygen sensitivity of the peptidylglycine Î±-amidating monooxygenase (pam) in neuroendocrine cells</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>24891</fpage><lpage>24901</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.667246</pub-id><pub-id pub-id-type="pmid">26296884</pub-id></element-citation></ref><ref id="bib209"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Szczech</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>KL</given-names></name><name><surname>Barnhart</surname><given-names>H</given-names></name><name><surname>Sapp</surname><given-names>S</given-names></name><name><surname>Wolfson</surname><given-names>M</given-names></name><name><surname>Reddan</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Correction of anemia with epoetin alfa in chronic kidney disease</article-title><source>New England Journal of Medicine</source><volume>355</volume><fpage>2085</fpage><lpage>2098</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa065485</pub-id></element-citation></ref><ref id="bib210"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singleton</surname><given-names>RS</given-names></name><name><surname>Liu-Yi</surname><given-names>P</given-names></name><name><surname>Formenti</surname><given-names>F</given-names></name><name><surname>Ge</surname><given-names>W</given-names></name><name><surname>Sekirnik</surname><given-names>R</given-names></name><name><surname>Fischer</surname><given-names>R</given-names></name><name><surname>Adam</surname><given-names>J</given-names></name><name><surname>Pollard</surname><given-names>PJ</given-names></name><name><surname>Wolf</surname><given-names>A</given-names></name><name><surname>Thalhammer</surname><given-names>A</given-names></name><name><surname>Loenarz</surname><given-names>C</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Coleman</surname><given-names>ML</given-names></name><name><surname>Kessler</surname><given-names>BM</given-names></name><name><surname>Wappner</surname><given-names>P</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Cockman</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation</article-title><source>PNAS</source><volume>111</volume><fpage>4031</fpage><lpage>4036</lpage><pub-id pub-id-type="doi">10.1073/pnas.1314482111</pub-id><pub-id pub-id-type="pmid">24550447</pub-id></element-citation></ref><ref id="bib211"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>EI</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Metz</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Palmer</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Oxygen binding, activation, and reduction to water by copper proteins</article-title><source>Angewandte Chemie</source><volume>40</volume><fpage>4570</fpage><lpage>4590</lpage><pub-id pub-id-type="doi">10.1002/1521-3773(20011217)40:24&lt;4570::aid-anie4570&gt;3.0.co;2-4</pub-id><pub-id pub-id-type="pmid">12404359</pub-id></element-citation></ref><ref id="bib212"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sono</surname><given-names>M</given-names></name><name><surname>Roach</surname><given-names>MP</given-names></name><name><surname>Coulter</surname><given-names>ED</given-names></name><name><surname>Dawson</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Heme-containing oxygenases</article-title><source>Chemical Reviews</source><volume>96</volume><fpage>2841</fpage><lpage>2888</lpage><pub-id pub-id-type="doi">10.1021/cr9500500</pub-id><pub-id pub-id-type="pmid">11848843</pub-id></element-citation></ref><ref id="bib213"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souvannakitti</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>GK</given-names></name><name><surname>Fox</surname><given-names>A</given-names></name><name><surname>Prabhakar</surname><given-names>NR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neonatal intermittent hypoxia leads to long-lasting facilitation of acute hypoxia-evoked catecholamine secretion from rat chromaffin cells</article-title><source>Journal of Neurophysiology</source><volume>101</volume><fpage>2837</fpage><lpage>2846</lpage><pub-id pub-id-type="doi">10.1152/jn.00036.2009</pub-id><pub-id pub-id-type="pmid">19339466</pub-id></element-citation></ref><ref id="bib214"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strowitzki</surname><given-names>MJ</given-names></name><name><surname>Cummins</surname><given-names>EP</given-names></name><name><surname>Taylor</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Protein hydroxylation by hypoxia-inducible factor (HIF) Hydroxylases: Unique or ubiquitous?</article-title><source>Cells</source><volume>8</volume><elocation-id>384</elocation-id><pub-id pub-id-type="doi">10.3390/cells8050384</pub-id><pub-id pub-id-type="pmid">31035491</pub-id></element-citation></ref><ref id="bib215"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuehr</surname><given-names>DJ</given-names></name><name><surname>Santolini</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>ZQ</given-names></name><name><surname>Wei</surname><given-names>CC</given-names></name><name><surname>Adak</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Update on mechanism and catalytic regulation in the NO synthases</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>36167</fpage><lpage>36170</lpage><pub-id pub-id-type="doi">10.1074/jbc.R400017200</pub-id><pub-id pub-id-type="pmid">15133020</pub-id></element-citation></ref><ref id="bib216"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Ho</surname><given-names>VC</given-names></name><name><surname>Takeda</surname><given-names>H</given-names></name><name><surname>Duan</surname><given-names>L-J</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Fong</surname><given-names>G-H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>8336</fpage><lpage>8346</lpage><pub-id pub-id-type="doi">10.1128/MCB.00425-06</pub-id><pub-id pub-id-type="pmid">16966370</pub-id></element-citation></ref><ref id="bib217"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarhonskaya</surname><given-names>H</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Leung</surname><given-names>IKH</given-names></name><name><surname>Loik</surname><given-names>ND</given-names></name><name><surname>McCullagh</surname><given-names>JSO</given-names></name><name><surname>Claridge</surname><given-names>TDW</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen</article-title><source>The Biochemical Journal</source><volume>463</volume><fpage>363</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1042/BJ20140779</pub-id><pub-id pub-id-type="pmid">25120187</pub-id></element-citation></ref><ref id="bib218"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>CT</given-names></name><name><surname>McElwain</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans</article-title><source>Physiology</source><volume>25</volume><fpage>272</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1152/physiol.00029.2010</pub-id><pub-id pub-id-type="pmid">20940432</pub-id></element-citation></ref><ref id="bib219"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thackray</surname><given-names>SJ</given-names></name><name><surname>Bruckmann</surname><given-names>C</given-names></name><name><surname>Mowat</surname><given-names>CG</given-names></name><name><surname>Forouhar</surname><given-names>F</given-names></name><name><surname>Chapman</surname><given-names>SK</given-names></name><name><surname>Tong</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><chapter-title>Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase</chapter-title><person-group person-group-type="editor"><name><surname>Scott</surname><given-names>RA</given-names></name></person-group><source>Encyclopedia of Inorganic and Bioinorganic Chemistry</source><publisher-name>John Wiley &amp; Sons</publisher-name><pub-id pub-id-type="doi">10.1002/9781119951438.eibc0650</pub-id></element-citation></ref><ref id="bib220"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thienpont</surname><given-names>B</given-names></name><name><surname>Steinbacher</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>DâAnna</surname><given-names>F</given-names></name><name><surname>Kuchnio</surname><given-names>A</given-names></name><name><surname>Ploumakis</surname><given-names>A</given-names></name><name><surname>GhesquiÃ¨re</surname><given-names>B</given-names></name><name><surname>Van Dyck</surname><given-names>L</given-names></name><name><surname>Boeckx</surname><given-names>B</given-names></name><name><surname>Schoonjans</surname><given-names>L</given-names></name><name><surname>Hermans</surname><given-names>E</given-names></name><name><surname>Amant</surname><given-names>F</given-names></name><name><surname>Kristensen</surname><given-names>VN</given-names></name><name><surname>Peng Koh</surname><given-names>K</given-names></name><name><surname>Mazzone</surname><given-names>M</given-names></name><name><surname>Coleman</surname><given-names>M</given-names></name><name><surname>Carell</surname><given-names>T</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tumour hypoxia causes DNA hypermethylation by reducing TET activity</article-title><source>Nature</source><volume>537</volume><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/nature19081</pub-id><pub-id pub-id-type="pmid">27533040</pub-id></element-citation></ref><ref id="bib221"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y-M</given-names></name><name><surname>Yeoh</surname><given-names>KK</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><name><surname>Eriksson</surname><given-names>T</given-names></name><name><surname>Kessler</surname><given-names>BM</given-names></name><name><surname>Kramer</surname><given-names>HB</given-names></name><name><surname>Edelmann</surname><given-names>MJ</given-names></name><name><surname>Willam</surname><given-names>C</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>13041</fpage><lpage>13051</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.211110</pub-id><pub-id pub-id-type="pmid">21335549</pub-id></element-citation></ref><ref id="bib222"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullah</surname><given-names>K</given-names></name><name><surname>Rosendahl</surname><given-names>AH</given-names></name><name><surname>Izzi</surname><given-names>V</given-names></name><name><surname>Bergmann</surname><given-names>U</given-names></name><name><surname>Pihlajaniemi</surname><given-names>T</given-names></name><name><surname>MÃ¤ki</surname><given-names>JM</given-names></name><name><surname>Myllyharju</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-ÎºB and p53 signaling pathways</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>17220</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-17376-0</pub-id><pub-id pub-id-type="pmid">29222481</pub-id></element-citation></ref><ref id="bib223"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villafuerte</surname><given-names>FC</given-names></name><name><surname>Corante</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Chronic mountain sickness: Clinical aspects, etiology, management, and treatment</article-title><source>High Altitude Medicine &amp; Biology</source><volume>17</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1089/ham.2016.0031</pub-id><pub-id pub-id-type="pmid">27218284</pub-id></element-citation></ref><ref id="bib224"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volmer</surname><given-names>R</given-names></name><name><surname>van der Ploeg</surname><given-names>K</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains</article-title><source>PNAS</source><volume>110</volume><fpage>4628</fpage><lpage>4633</lpage><pub-id pub-id-type="doi">10.1073/pnas.1217611110</pub-id><pub-id pub-id-type="pmid">23487760</pub-id></element-citation></ref><ref id="bib225"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vozdek</surname><given-names>R</given-names></name><name><surname>Long</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The receptor tyrosine kinase HIR-1 coordinates HIF-independent responses to hypoxia and extracellular matrix injury</article-title><source>Science Signaling</source><volume>11</volume><elocation-id>eaat0138</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aat0138</pub-id><pub-id pub-id-type="pmid">30279166</pub-id></element-citation></ref><ref id="bib226"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walport</surname><given-names>LJ</given-names></name><name><surname>Hopkinson</surname><given-names>RJ</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Schiller</surname><given-names>R</given-names></name><name><surname>Ge</surname><given-names>W</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11974</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11974</pub-id><pub-id pub-id-type="pmid">27337104</pub-id></element-citation></ref><ref id="bib227"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Pagliassotti</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis</article-title><source>Endocrinology</source><volume>147</volume><fpage>943</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1210/en.2005-0570</pub-id><pub-id pub-id-type="pmid">16269465</pub-id></element-citation></ref><ref id="bib228"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>ME</given-names></name><name><surname>Toporsian</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>JA</given-names></name><name><surname>Teoh</surname><given-names>H</given-names></name><name><surname>Govindaraju</surname><given-names>V</given-names></name><name><surname>Quan</surname><given-names>A</given-names></name><name><surname>Wener</surname><given-names>AD</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Bevan</surname><given-names>SC</given-names></name><name><surname>Newton</surname><given-names>DC</given-names></name><name><surname>Marsden</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant</article-title><source>Journal of Clinical Investigation</source><volume>115</volume><fpage>3128</fpage><lpage>3139</lpage><pub-id pub-id-type="doi">10.1172/JCI20806</pub-id></element-citation></ref><ref id="bib229"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watschinger</surname><given-names>K</given-names></name><name><surname>Keller</surname><given-names>MA</given-names></name><name><surname>Golderer</surname><given-names>G</given-names></name><name><surname>Hermann</surname><given-names>M</given-names></name><name><surname>Maglione</surname><given-names>M</given-names></name><name><surname>Sarg</surname><given-names>B</given-names></name><name><surname>Lindner</surname><given-names>HH</given-names></name><name><surname>Hermetter</surname><given-names>A</given-names></name><name><surname>Werner-Felmayer</surname><given-names>G</given-names></name><name><surname>Konrat</surname><given-names>R</given-names></name><name><surname>Hulo</surname><given-names>N</given-names></name><name><surname>Werner</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes</article-title><source>PNAS</source><volume>107</volume><fpage>13672</fpage><lpage>13677</lpage><pub-id pub-id-type="doi">10.1073/pnas.1002404107</pub-id><pub-id pub-id-type="pmid">20643956</pub-id></element-citation></ref><ref id="bib230"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wecksler</surname><given-names>AT</given-names></name><name><surname>Jacquot</surname><given-names>C</given-names></name><name><surname>van der Donk</surname><given-names>WA</given-names></name><name><surname>Holman</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mechanistic investigations of human reticulocyte 15- and platelet 12-lipoxygenases with arachidonic acid</article-title><source>Biochemistry</source><volume>48</volume><fpage>6259</fpage><lpage>6267</lpage><pub-id pub-id-type="doi">10.1021/bi802332j</pub-id><pub-id pub-id-type="pmid">19469483</pub-id></element-citation></ref><ref id="bib231"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weits</surname><given-names>DA</given-names></name><name><surname>Giuntoli</surname><given-names>B</given-names></name><name><surname>Kosmacz</surname><given-names>M</given-names></name><name><surname>Parlanti</surname><given-names>S</given-names></name><name><surname>Hubberten</surname><given-names>HM</given-names></name><name><surname>Riegler</surname><given-names>H</given-names></name><name><surname>Hoefgen</surname><given-names>R</given-names></name><name><surname>Perata</surname><given-names>P</given-names></name><name><surname>van Dongen</surname><given-names>JT</given-names></name><name><surname>Licausi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Plant cysteine oxidases control the oxygen-dependent branch of the N-end-rule pathway</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3425</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4425</pub-id><pub-id pub-id-type="pmid">24599061</pub-id></element-citation></ref><ref id="bib232"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>MD</given-names></name><name><surname>Klecker</surname><given-names>M</given-names></name><name><surname>Hopkinson</surname><given-names>RJ</given-names></name><name><surname>Weits</surname><given-names>DA</given-names></name><name><surname>Mueller</surname><given-names>C</given-names></name><name><surname>Naumann</surname><given-names>C</given-names></name><name><surname>OâNeill</surname><given-names>R</given-names></name><name><surname>Wickens</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Brooks-Bartlett</surname><given-names>JC</given-names></name><name><surname>Garman</surname><given-names>EF</given-names></name><name><surname>Grossmann</surname><given-names>TN</given-names></name><name><surname>Dissmeyer</surname><given-names>N</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Plant cysteine oxidases are dioxygenases that directly enable arginyl transferase-catalysed arginylation of N-end rule targets</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14690</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14690</pub-id><pub-id pub-id-type="pmid">28332493</pub-id></element-citation></ref><ref id="bib233"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>MD</given-names></name><name><surname>Kamps</surname><given-names>JJAG</given-names></name><name><surname>East</surname><given-names>S</given-names></name><name><surname>Taylor Kearney</surname><given-names>LJ</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The plant cysteine oxidases from <italic>Arabidopsis thaliana</italic> are kinetically tailored to act as oxygen sensors</article-title><source>Journal of Biological Chemistry</source><volume>293</volume><fpage>11786</fpage><lpage>11795</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.003496</pub-id></element-citation></ref><ref id="bib234"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>WikstrÃ¶m</surname><given-names>M</given-names></name><name><surname>Krab</surname><given-names>K</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Oxygen activation and energy conservation by cytochrome c oxidase</article-title><source>Chemical Reviews</source><volume>118</volume><fpage>2469</fpage><lpage>2490</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00664</pub-id><pub-id pub-id-type="pmid">29350917</pub-id></element-citation></ref><ref id="bib235"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilks</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Heme oxygenase: evolution, structure, and mechanism</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>4</volume><fpage>603</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1089/15230860260220102</pub-id><pub-id pub-id-type="pmid">12230872</pub-id></element-citation></ref><ref id="bib236"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willam</surname><given-names>C</given-names></name><name><surname>Maxwell</surname><given-names>PH</given-names></name><name><surname>Nichols</surname><given-names>L</given-names></name><name><surname>Lygate</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>YM</given-names></name><name><surname>Bernhardt</surname><given-names>W</given-names></name><name><surname>Wiesener</surname><given-names>M</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Eckardt</surname><given-names>K-U</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>41</volume><fpage>68</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2006.04.009</pub-id><pub-id pub-id-type="pmid">16765982</pub-id></element-citation></ref><ref id="bib237"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JW</given-names></name><name><surname>Shakir</surname><given-names>D</given-names></name><name><surname>Batie</surname><given-names>M</given-names></name><name><surname>Frost</surname><given-names>M</given-names></name><name><surname>Rocha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Oxygen-sensing mechanisms in cells</article-title><source>The FEBS Journal</source><volume>287</volume><fpage>3888</fpage><lpage>3906</lpage><pub-id pub-id-type="doi">10.1111/febs.15374</pub-id><pub-id pub-id-type="pmid">32446269</pub-id></element-citation></ref><ref id="bib238"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windsor</surname><given-names>JS</given-names></name><name><surname>Rodway</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Heights and haematology: the story of haemoglobin at altitude</article-title><source>Postgraduate Medical Journal</source><volume>83</volume><fpage>148</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1136/pgmj.2006.049734</pub-id><pub-id pub-id-type="pmid">17344565</pub-id></element-citation></ref><ref id="bib239"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TET-mediated active DNA demethylation: mechanism, function and beyond</article-title><source>Nature Reviews. Genetics</source><volume>18</volume><fpage>517</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/nrg.2017.33</pub-id><pub-id pub-id-type="pmid">28555658</pub-id></element-citation></ref><ref id="bib240"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuren</surname><given-names>T</given-names></name><name><surname>Simonson</surname><given-names>TS</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Huff</surname><given-names>CD</given-names></name><name><surname>Witherspoon</surname><given-names>DJ</given-names></name><name><surname>Jorde</surname><given-names>LB</given-names></name><name><surname>Ge</surname><given-names>R-L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Shared and unique signals of high-altitude adaptation in geographically distinct Tibetan populations</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e88252</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0088252</pub-id><pub-id pub-id-type="pmid">24642866</pub-id></element-citation></ref><ref id="bib241"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>K</given-names></name><name><surname>Whalen</surname><given-names>EJ</given-names></name><name><surname>Forrester</surname><given-names>MT</given-names></name><name><surname>Freeman</surname><given-names>RS</given-names></name><name><surname>Fong</surname><given-names>G</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Lefkowitz</surname><given-names>RJ</given-names></name><name><surname>Stamler</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL</article-title><source>Science Signaling</source><volume>2</volume><elocation-id>ra33</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2000444</pub-id><pub-id pub-id-type="pmid">19584355</pub-id></element-citation></ref><ref id="bib242"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Lou</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A genome-wide search for signals of high-altitude adaptation in tibetans</article-title><source>Molecular Biology and Evolution</source><volume>28</volume><fpage>1003</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1093/molbev/msq277</pub-id></element-citation></ref><ref id="bib243"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>ZA</given-names></name><name><surname>Green</surname><given-names>RS</given-names></name><name><surname>West</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Role of the Skp1 prolyl-hydroxylation/glycosylation pathway in oxygen dependent submerged development of <italic>Dictyostelium</italic></article-title><source>BMC Developmental Biology</source><volume>12</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/1471-213X-12-31</pub-id></element-citation></ref><ref id="bib244"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname><given-names>K</given-names></name><name><surname>Toumazou</surname><given-names>C</given-names></name><name><surname>Tsukada</surname><given-names>Y</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor</article-title><source>Cell</source><volume>125</volume><fpage>483</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.03.027</pub-id><pub-id pub-id-type="pmid">16603237</pub-id></element-citation></ref><ref id="bib245"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>XF</given-names></name><name><surname>Li</surname><given-names>XM</given-names></name><name><surname>Liang</surname><given-names>YB</given-names></name><name><surname>Mao</surname><given-names>JY</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Bakshi</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>DD</given-names></name><name><surname>Zheng</surname><given-names>MQ</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Lu</surname><given-names>F</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic signatures of high-altitude adaptation in Tibetans</article-title><source>PNAS</source><volume>114</volume><fpage>4189</fpage><lpage>4194</lpage><pub-id pub-id-type="doi">10.1073/pnas.1617042114</pub-id><pub-id pub-id-type="pmid">28373541</pub-id></element-citation></ref><ref id="bib246"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Huerta-Sanchez</surname><given-names>E</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Cuo</surname><given-names>ZXP</given-names></name><name><surname>Pool</surname><given-names>JE</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Vinckenbosch</surname><given-names>N</given-names></name><name><surname>Korneliussen</surname><given-names>TS</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>R</given-names></name><name><surname>Nie</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Shan</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Ni</surname><given-names>P</given-names></name><name><surname>Tian</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Luosang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Bianba</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Gusang</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Ouyang</surname><given-names>W</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Bolund</surname><given-names>L</given-names></name><name><surname>Kristiansen</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sequencing of 50 human exomes reveals adaptation to high altitude</article-title><source>Science</source><volume>329</volume><fpage>75</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1126/science.1190371</pub-id><pub-id pub-id-type="pmid">20595611</pub-id></element-citation></ref><ref id="bib247"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Migita</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Mechanism of heme degradation by heme oxygenase</article-title><source>Journal of Inorganic Biochemistry</source><volume>82</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/s0162-0134(00)00156-2</pub-id><pub-id pub-id-type="pmid">11132636</pub-id></element-citation></ref><ref id="bib248"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaccara</surname><given-names>S</given-names></name><name><surname>Ries</surname><given-names>RJ</given-names></name><name><surname>Jaffrey</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reading, writing and erasing mRNA methylation</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>20</volume><fpage>608</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0168-5</pub-id><pub-id pub-id-type="pmid">31520073</pub-id></element-citation></ref><ref id="bib249"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Linke</surname><given-names>S</given-names></name><name><surname>Chicher</surname><given-names>J</given-names></name><name><surname>Gorman</surname><given-names>JJ</given-names></name><name><surname>Visk</surname><given-names>D</given-names></name><name><surname>Haddad</surname><given-names>GG</given-names></name><name><surname>Poellinger</surname><given-names>L</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Powell</surname><given-names>F</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The asparaginyl Hydroxylase factor inhibiting HIF-1Î± Is an Essential regulator of metabolism</article-title><source>Cell Metabolism</source><volume>11</volume><fpage>364</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2010.03.001</pub-id></element-citation></ref><ref id="bib250"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>G</given-names></name><name><surname>Dahl</surname><given-names>JA</given-names></name><name><surname>Niu</surname><given-names>Y</given-names></name><name><surname>Fedorcsak</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>C-M</given-names></name><name><surname>Li</surname><given-names>CJ</given-names></name><name><surname>VÃ¥gbÃ¸</surname><given-names>CB</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W-L</given-names></name><name><surname>Song</surname><given-names>S-H</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Bosmans</surname><given-names>RPG</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Hao</surname><given-names>Y-J</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>W-M</given-names></name><name><surname>Tong</surname><given-names>W-M</given-names></name><name><surname>Wang</surname><given-names>X-J</given-names></name><name><surname>Bogdan</surname><given-names>F</given-names></name><name><surname>Furu</surname><given-names>K</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Krokan</surname><given-names>HE</given-names></name><name><surname>Klungland</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>Y-G</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility</article-title><source>Molecular Cell</source><volume>49</volume><fpage>18</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.10.015</pub-id><pub-id pub-id-type="pmid">23177736</pub-id></element-citation></ref><ref id="bib251"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Zhai</surname><given-names>B</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Geisen</surname><given-names>C</given-names></name><name><surname>Chakraborty</surname><given-names>AA</given-names></name><name><surname>Moslehi</surname><given-names>JJ</given-names></name><name><surname>Smalley</surname><given-names>DM</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Beres</surname><given-names>JM</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Tsao</surname><given-names>JL</given-names></name><name><surname>Brenner</surname><given-names>MC</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>C</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name><name><surname>Paik</surname><given-names>J</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>1429</fpage><lpage>1444</lpage><pub-id pub-id-type="doi">10.1101/gad.242131.114</pub-id><pub-id pub-id-type="pmid">24990963</pub-id></element-citation></ref><ref id="bib252"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>D</given-names></name><name><surname>Ran</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension</article-title><source>The Journal of Physiological Sciences</source><volume>62</volume><fpage>163</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1007/s12576-012-0196-9</pub-id><pub-id pub-id-type="pmid">22331435</pub-id></element-citation></ref><ref id="bib253"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>Q</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Coleman</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Modifying the maker: Oxygenases target ribosome biology</article-title><source>Translation</source><volume>3</volume><elocation-id>e1009331</elocation-id><pub-id pub-id-type="doi">10.1080/21690731.2015.1009331</pub-id><pub-id pub-id-type="pmid">26779412</pub-id></element-citation></ref></ref-list></back></article>